<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d7" for="edge" attr.name="order" attr.type="long" />
  <key id="d6" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d5" for="edge" attr.name="description" attr.type="string" />
  <key id="d4" for="edge" attr.name="weight" attr.type="double" />
  <key id="d3" for="node" attr.name="clusters" attr.type="string" />
  <key id="d2" for="node" attr.name="source_id" attr.type="string" />
  <key id="d1" for="node" attr.name="description" attr.type="string" />
  <key id="d0" for="node" attr.name="entity_type" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="&quot;GENDER&quot;">
      <data key="d0">"GENDER"</data>
      <data key="d1">"The study examines the differences in general and demographic characteristics between men and women."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;MEN&quot;">
      <data key="d0">"GENDER"</data>
      <data key="d1">"The men were older than the women, while obese women were older than nonobese women."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;WOMEN&quot;">
      <data key="d0">"GENDER"</data>
      <data key="d1">"Women had much higher eGFR than men, indicating differences in renal function between genders."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;AGE&quot;">
      <data key="d0">"TIME FACTOR"</data>
      <data key="d1">"Age is a demographic factor and environmental influence on the prevalence of diabetes in populations."&lt;SEP&gt;"Age is a demographic factor that influences metabolic health and risk of diabetes."&lt;SEP&gt;"The study highlights age-related physiological changes and gender disparities."&lt;SEP&gt;"The mean age of all subjects was almost identical."&lt;SEP&gt;"Age is a significant variable that was adjusted for in the study's combined analyses."&lt;SEP&gt;"Age is an environmental factor that influences microbial composition in different populations."&lt;SEP&gt;"The average age of participants in this study was 76.64 ± 6.40 years."&lt;SEP&gt;&gt;&lt;"Each 1-year increase in age was estimated to increase social disinhibition score by 0.20 points (95% CI = 0.12–0.29)"&gt;&lt;SEP&gt;"Age is a demographic factor that varies among participants in the study.")&lt;SEP&gt;"Elevations in the percentage of CD8+ TEMRA cells were noted during infancy and normalized around age 4."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb&lt;SEP&gt;chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-4389e37ac64d551cdf89e7f4230a3589&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;OBESITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Metabolic syndrome was much higher in the obese group, indicating a link between obesity and disease risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SKELETAL MUSCLE MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The study shows differences in skeletal muscle mass, which could be linked to physical activity levels."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Diet and physical activity are lifestyle factors that further modulate cardiovascular health."&lt;SEP&gt;"No genotype-time interactions were noted in response to physical activity effects on body composition changes.")&lt;SEP&gt;"Regular exercise was inversely associated with the risk of obesity, indicating a link between lifestyle and disease risk."&lt;SEP&gt;26&gt; ("relationship"&lt;SEP&gt;"Physical activity is a lifestyle factor that further modulates cardiovascular health, including interactions with genetic variants in NOS1."&lt;SEP&gt;"Regular physical activity is an important lifestyle factor that modulates cardiovascular health and risk of AMD.")&lt;SEP&gt;"Diet and physical activity are lifestyle factors that modulate cardiovascular health.") ("relationship"&lt;SEP&gt;"The study controlled for physical activity, which is a lifestyle factor that may influence physiological processes such as alcohol consumption and cortisol levels among individuals with different genetic backgrounds."&lt;SEP&gt;"Physical activity is a lifestyle factor that modulates cardiovascular health, including dietary patterns and physiological processes like nitric oxide synthesis."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;DIETARY PATTERNS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Dietary patterns influence folate metabolism and the transcript of the NOS1 gene."&lt;SEP&gt;"Dietary patterns may include factors such as UVB exposure and intake of vitamin supplements influencing neonatal vitamin D status."&lt;SEP&gt;"No significant association of dietary patterns with obesity risk was found in this study."&lt;SEP&gt;"The study examined dietary patterns to determine their impact on obesity risk, which was found to be insignificant."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;ENERGY INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Daily energy intake was higher in the obese groups than the nonobese group, increasing obesity risk by 1.24-fold."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;PROTEIN INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The study also examines protein intake as a factor influencing obesity risk.") ("entity"</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;OBESE MEN&quot;">
      <data key="d0">"GENDER"</data>
      <data key="d1">"The study also looked at obese men, comparing their characteristics to those of nonobese counterparts and other demographics."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;NONOBESE WOMEN&quot;">
      <data key="d0">"GENDER"</data>
      <data key="d1">"These women did not have obesity but were included in the demographic analyses for comparison purposes."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1"> The GENE entities are involved in multiple physiological processes impacting energy balance, appetite regulation, lipid metabolism, dietary patterns, carbohydrate metabolism, risk of obesity, metabolic pathways, modulation of transcription factors such as AP-2 Beta influencing energy intake and affecting mechanisms that influence energy expenditure. These genes play a role in cognition via BDNF influencing neural activity related to physiological processes affecting energy balance. They impact the risk of obesity for CDKAL1, regulate Folate metabolism through DNAJC27, directly impacting energy expenditure and appetite regulation through FTO gene. Additionally, they influence metabolic pathways modulating the risk of obesity indirectly by aiding muscle contraction via MYL2 or potentially contributing to obesity risk via extracellular matrix organization in OLFM4 and endoplasmic reticulum export in SEC16B. Specific genetic involvement impacting metabolic processes includes TCF7L2 gene associated with an increased risk of type 2 diabetes through its interaction at SLC30A8 rs13266634; PNPLA3 influencing lipid metabolism by affecting the expression of genes involved in this pathway. The ARRDC4, EPHA4, and FBXO32 contribute to cytokines signaling, TGF-β1 signaling, and glucocorticoid receptor signaling processes impacting obesity risk. Furthermore, FOXO1 activation following cortisol exposure mediates a negative impact on neurogenesis by stress through its interaction with these pathways; HSF2 interacting in cytokines signaling, TGF-β1 signaling, and glucocorticoid receptor signaling. The isochorismatase Domain Containing 1 involved in multiple physiological processes influencing obesity risk via interactions involving cytokines signaling and glucocorticoid receptor signaling. Lastly, the gene encoding GCKR regulating BHB levels has implications for metabolic balance influenced by various physiological processes mediated by these GENE entities.&lt;SEP&gt;1&lt;SEP&gt;"PTPN2 is a gene involved in autoimmune diseases and has significant SNPs related to inflammatory conditions."&lt;SEP&gt;"Disease"&lt;SEP&gt;"Molecular Interaction"&lt;SEP&gt;1&lt;SEP&gt;"The STAT5B gene is involved in regulating nitric oxide production.")&lt;SEP&gt;"Age was analyzed as a gene that may have a correlation with disease progression."&lt;SEP&gt;"The text refers to a gene whose expression is compared to the characteristics of an immunodominant epitope."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-8276370dea9f12d2b305c355f74c7f6e&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-ba82b7eb40cf9eea561d839b20584f91&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7&lt;SEP&gt;chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954&lt;SEP&gt;chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;NUTRIENT INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Nutrient intake from dietary patterns affects obesity risk by modulating the activity of genes like FTO, which regulates appetite and body weight."&lt;SEP&gt;"The dietary patterns influence the transcript of NOS1 gene and folate metabolism."&lt;SEP&gt;"The dietary patterns influence the transcript of NOS1 gene and folate metabolism.")</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR&quot;">
      <data key="d0">"TRANSCRIPTION FACTORS"</data>
      <data key="d1">"Transcription factors are involved in gene regulation, affecting energy balance through their influence on target genes such as those related to metabolic pathways."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;ENERGY BALANCE&quot;">
      <data key="d0">"ENERGY BALANCE"</data>
      <data key="d1">"Energy balance is regulated by complex interactions between dietary patterns, genetic variants like SNPs, and physiological processes including the activity of transcription factors."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MENARCHE AGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Initial menstruation age interacts with PRS to influence obesity risk.")&lt;SEP&gt;"Initial menstruation age is an environmental factor that interacts with PRS for obesity risk.")&lt;SEP&gt;"Menarche age interacts with PRS for obesity risk; participants with early menarche have higher BMI scores compared to those with later menarche."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Plant-based dietary intake exhibits interaction with PRS, influencing obesity risk.")&lt;SEP&gt;"Plant-based dietary intake shows interaction with PRS to influence the obesity risk.")</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;HIGH PLANT-BASED DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Adults adhering to a high plant-based diet are protected against obesity risk.")&lt;SEP&gt;"Adults with a high plant-based diet are protected against obesity risk.")</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LOW PLANT-BASED DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"In those with low plant-based dietary intake, the genetic impact was lower for BMI.")&lt;SEP&gt;"Individuals with low plant-based dietary intake show lower genetic impact on BMI in early menarche age.")</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;FRIED FOOD INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Consumption of fried foods exhibits interaction with PRS, influencing obesity risk.")&lt;SEP&gt;"Fried food intake exhibits interaction with PRS to influence obesity risk.")</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;HIGH FRIED-FOOD INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Participants who frequently consume high levels of fried food have offset genetic impact on BMI due to PRS.")&lt;SEP&gt;"Participants with high fried-food intake show offset of genetic impact on BMI by PRS.")</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;GENOMIC VARIANT&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-8276370dea9f12d2b305c355f74c7f6e&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-ba82b7eb40cf9eea561d839b20584f91&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1"> The comprehensive description related to genomic variant entities, including ALXO5, ABCC8, NOS1, TCF7L2, TUFM, IL1A, GPX4 (Cdx-2), and VDR genes, involves various studies and observations across different medical conditions. A genomic variant in the ALXO5 gene possibly rs1864414 has been linked to a reduced risk of ovarian cancer. The ABCC8 gene variant is associated with persistent hypoglycemia. In hypertension context, NOS1 alleles are found to increase risks for this condition. Regarding obesity, a genomic variant in GIPR (rs1444988703) impacts gene function and contributes to the risk of obesity. The TCF7L2 gene variants are linked with type 2 diabetes. Variations within the TUFM genes affect splicing regulation and transcription factor binding sites, while a variant in IL1A increases ovarian cancer risks close to TP53 for controlling cell cycle and DNA repair processes. In dental health research, genomic variants like those listed in Table 1 are investigated for their impact on Age at first tooth appearance and Number of teeth, specifically focusing on the NOS1 gene related to hypertension risk. Finally, studies around GPX4 gene mutations show a significant association with colorectal cancer risks while no significant association between Cdx-2 gene variant rs11568820 and ovarian cancer was found under dominant genetic models restricted subgroups of Caucasians. No deviations from Hardy-Weinberg equilibrium were found for analyzed VDR variants, indicating their reliability in epidemiological studies related to genetic risk factors.&lt;SEP&gt;"A genomic variant possibly present in the TAG72 gene is linked to increased specificity and activity against ovarian cancer cells."&gt;&lt;SEP&gt;"Three SNPs, including rs231775 and others mentioned in the text, were consulted in various studies for their associations with PBC susceptibility."&lt;SEP&gt;"The missense SNP at rs181206 in the IRF1 and STAT1 gene is associated with altered expression levels, specifically lowering both IRF1 and STAT1 transcripts. This variant may have functional implications for immune response."&lt;SEP&gt;3&lt;SEP&gt;"Genomic variant in the analysis is associated with disease risk factors such as age, sex, and other polymorphisms."&lt;SEP&gt;"No specific genomic variant mentioned in the context provided."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;RS1444988703&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"The genomic variant rs1444988703 in GIPR impacts this gene's function, contributing to obesity risk.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;FTO RS1558902&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">&gt;&lt;&gt;The FTO rs1558902 is a gene that has been associated with changes in weight, body composition, and dietary intervention outcomes. It plays a role in the regulation of body fat and may influence responses to different diet compositions including high-protein diets.&lt;/entity&gt;</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;A ALLELE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">&gt;&lt;&gt;The A allele is a risk allele that has been linked to greater weight loss when dietary protein intake is high, suggesting it may affect the body's response to high-protein diets specifically.&lt;/entity&gt;</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;HIGH PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">&gt;&lt;&gt;The study involved participants assigned to either high or low protein diets. The FTO rs1558902 gene has been observed to interact with dietary patterns, specifically protein intake levels, influencing weight loss outcomes.&lt;/entity&gt;) ("entity"</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d0">"MEASUREMENT"</data>
      <data key="d1">"Used as an indicator of body fatness and health risk in population studies."&lt;SEP&gt;&gt;&lt;&gt;BMI, or Body Mass Index, is a physiological process used as an indicator of body composition that was measured throughout the study period and adjusted for in various analyses.&lt;/entity&gt;</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE (WC)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">&gt;&lt;&gt;WC or waist circumference is another physiological measure indicating fat distribution changes over time, which was assessed at baseline and during intervention periods as part of the study parameters.&lt;/entity&gt;</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;GENOTYPE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"EBNA2's interaction with MS risk loci depends on the genotype of individuals, influencing how EBNA2 alters gene expression at these loci."&lt;SEP&gt;"EBNA2's interaction with MS risk loci depends on the genotype of individuals, influencing how EBNA2 alters gene expression at these loci.") To address the potential omissions and ensure a comprehensive identification of all relevant biomedical entities within your provided text, I will go through it step-by-step to identify any missing entities that align with the specified entity types (Gene, Genomic Variant, Transcript, Protein, Nutrient, Dietary Pattern, Physiological Process, Metabolic Pathway, Molecular Interaction, Environmental Factor, Disease&lt;SEP&gt;"Genotype is related to dietary intervention and serum fatty acid concentrations."&lt;SEP&gt;"The genotype at the SLC30A8 locus was analyzed in relation to fasting proinsulin levels and intervention effects on glucose metabolism."|&lt;SEP&gt;"The genotype is a genetic factor influencing fat distribution and dietary response."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;AA GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The AA genotype was observed in participants with significant differences in fat distribution responses to diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;TIME INTERACTION&quot;">
      <data key="d0">"GENOTYPE-TIME INTERACTION"</data>
      <data key="d1">"Genotype-time interactions were seen on changes in body composition and dietary response, suggesting complex genetic influences."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Different responses to low and high protein diets were influenced by participant genotypes."&lt;SEP&gt;"The low-protein diet had specific impacts based on genotypes, influencing fat distribution and loss differently."&lt;SEP&gt;12</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The high-protein diet showed different effects between participants with AA and non-AA genotypes."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;TOTAL FAT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Changes in total fat were observed as per the low-fat and high-fat dietary patterns, influenced by genetic factors."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TRUNK FAT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Percentage of trunk fat was measured within the study, showing genotype-time interactions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FAT MASS AND OBESITY RELATED PROTEINS (FTO)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FTO protein is involved in body composition changes influenced by diet patterns and genetic factors."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LIFESTYLE FACTOR&quot;">
      <data key="d0">"PHYSICAL ACTIVITY"</data>
      <data key="d1">"Lifestyle factor such as physical activity further modulates cardiovascular health."&lt;SEP&gt;"No genotype-time interactions were found for lifestyle factor effects like physical activity on fat distribution."&lt;SEP&gt;"Physical activity is a lifestyle factor that further modulates cardiovascular health."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FTO GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FTO gene and its protein product are part of lifestyle factors that influence body composition changes.")&lt;SEP&gt;"The FTO gene has been associated with nutritional intake like diet-related influences on body composition changes.")&lt;SEP&gt;"The FTO gene is a genetic factor that influences obesity predisposition, as per study data."&lt;SEP&gt;"The FTO gene is associated with obesity predisposition as per the study findings."&lt;SEP&gt;"The FTO gene is involved in the predisposition to obesity as per the study findings."&lt;SEP&gt;"The FTO gene plays a role in predisposing individuals to obesity, according to GWAS data."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"VEGF is involved in vascular endothelial growth and plays a significant role in cardiovascular function."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"eNOS, an enzyme for nitric oxide synthesis, contributes to vascular health as influenced by genetic factors."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;NITRIC OXIDE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Nitric oxide is a key vasodilator regulated by the eNOS protein and influences cardiovascular physiology."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LOW-FAT DIET&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d1">"Genotype-time interactions were noted for body composition changes as per the low-fat dietary pattern, influencing total and trunk fat loss.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGH-FAT DIET&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d1">"No genotype-time interactions found in response to high-fat diets, suggesting different influences on trunk fat compared to other diet patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1"> The comprehensive summary for the biomedical entity "PHYSIOLOGICAL PROCESS" based on the provided descriptions is as follows: 

Physiological processes encompass a wide array of biological phenomena, including those related to autoimmune diseases. For instance, genetic variants such as rs478582 in PTPN2 have been associated with inflammation in autoimmune conditions (1). These genetic variations can influence gene expression and protein function, thereby affecting physiological states within the body.

Another aspect of physiological processes is observed through differential gene expression between patients with Diamond-Blackfan anemia (DBA) and healthy controls. Genes such as AMPD3, CCND2, SOD2, TNFAIP3, COMP, WARS, ZIC1 show altered expressions in this context, highlighting the complex interplay of genetic factors affecting disease states versus normal physiological processes (2).

In relation to glucose metabolism, fasting proinsulin levels are part of broader physiological processes that include insulin resistance and may be influenced by various gene variants such as those related to the TCF7L2 gene which could implicate individuals at risk for type 2 diabetes (3). Furthermore, genetic factors in physiological processes like VEGF have been shown to play a critical role in angiogenesis and vascular remodeling, crucial processes that are influenced by both genetic background and dietary patterns (4).

The maintenance of normal glucose levels can also be disrupted by genomic variants which suggest complex interactions within tissues affecting tooth development among other potential physiological outcomes (5). The nitric oxide synthesis pathway is another example where the NOS3 protein influences vascular function, with dietary patterns and specific gene variants potentially influencing ovarian cancer risk through their effects on this physiological process (6-8).

Folate metabolism in its entirety also interacts with factors such as the NOS1 protein to maintain vascular function. This interaction points towards a broader range of physiological processes that are affected by genetic variations, including those related to CDX2 gene variant rs11568820 which may influence ovarian cancer risk and Hardy-Weinberg equilibrium (9).

Lastly, baseline CD4 counts represent another aspect of physiological processes within the immune system. These counts can correlate with disease progression and are considered a potential risk factor in multivariate logistic regression analyses (10). In summary, these descriptions collectively highlight how genetic factors influence various aspects of physiological processes that underpin human health and disease states across different tissues and metabolic pathways.</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;DIETARY PATTERN&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-9a35876dc1aaf7342f023cab4f5b9914&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1"> The comprehensive summary for the biomedical entity "DIETARY PATTERN" is as follows: Dietary patterns significantly influence cardiovascular health, modulating interactions between folate intake and genetic variants related to nitric oxide synthesis. These dietary habits have potential effects on transcript activities of genes like IL1A, affecting disease states including ulcerative colitis. Healthy eating patterns impact concentrations of 20:4, n-6 (AA) in the colon, while also influencing gene variants associated with risk for Clear cell ovarian carcinoma and potentially impacting nitric oxide metabolism. Dietary treatments such as low-protein diets and diazoxide influence metabolic pathways related to glucose management and iodide supplementation is necessary post-treatment due to effects on disease states.

Dietary patterns may differ between asthmatic patients and healthy controls, with increased calorie intake observed in cases. A high meat diet influences vitamin B6 levels possibly impacting gene expression related to autoimmune diseases like CD via regulation of genes such as PTPN1/PTPN2. Additionally, dietary patterns can influence various factors related to PFI including nutritional status which may affect cellular functions critical for disease-free survival. Leafy greens are associated with high levels of folate and may play a role in influencing gene expression related to inflammatory diseases like CD.&lt;SEP&gt;5&lt;SEP&gt;"Dietary patterns and tobacco usage are analyzed for their impact on HIV disease progression as lifestyle factors."&lt;SEP&gt;"No specific dietary pattern is mentioned in the context provided as related to this gene and its expression at an immunodominant epitope level."</data>
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;LIFESTYLE BEHAVIOR&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d1">"Diet and lifestyle behaviors are significant environmental influences on cardiovascular health as per the study findings.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;FTO&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FTO gene is associated with greater weight, BMI and waist circumference in individuals of primary and secondary studies but not university-level subjects."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;FTO SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO SNP is a genetic variant associated with obesity risk, as indicated by its statistically significant interaction term between education in the joint analysis of GP and OHP."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;GP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GP (General Population) and OHP (Ontario Health Program) are populations studied for their respective associations with education and the FTO SNP regarding obesity risk, indicating potential physiological implications of these factors."&lt;SEP&gt;"General Population (GP) refers to the group studied in association with education and FTO SNP for potential physiological implications regarding obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;OHP&quot;">
      <data key="d0">"POPULATION"</data>
      <data key="d1">"In the Ontario Health Program, individuals were analyzed alongside those in the GP to investigate the relationship between education level and obesity risk based on the FTO SNP. This joint analysis revealed a significant interaction term between education and the FTO SNP.")&gt;0&lt;SEP&gt;"Ontario Health Program (OHP) is a population used alongside GP studies on associations between socioeconomic status, genetics, and obesity risks based on the FTO gene."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;HCR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In the Health Correlates Report (HCR), analysis showed no significant interaction between education and FTO SNP regarding obesity risk. This suggests that additional factors such as physical activity may be influencing outcomes in this population.")</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;PA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Physical Activity was not found to have a significant interactive effect on the relationship between education, the FTO SNP, and obesity risk in individuals analyzed within the Health Correlates Report.")&gt;0) ("entity"</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;EDUCATION&quot;">
      <data key="d0">"DEMOGRAPHIC CHARACTERISTICS"</data>
      <data key="d1">"Educational level was investigated for its potential influence on obesity risk in relation to the genetic variant of the FTO SNP identified within populations such as OHP and GP."&lt;SEP&gt;"Fertile controls were significantly more educated than infertile cases."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;EDUCATIONAL LEVEL&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d1">"In the stratified analysis by educational level, there was no significant association between the FTO gene and obesity risk in university education individuals. However, non-university individuals showed a higher obesity risk with two A-alleles."&gt;)&gt; ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91&lt;SEP&gt;chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d1">"A genomic variant in the NOS1 gene is linked to an increased risk of ulcerative colitis."&lt;SEP&gt;"CHI (chronic hypoglycemia in infants) is a disease condition associated with genetic mutations in ABCC8 and other genes involved in regulating glucose levels."&lt;SEP&gt;"Fasting proinsulin levels are associated with diseases such as type 2 diabetes and insulin resistance, which can be influenced by lifestyle factors and genetic variants like those at SLC30A8."|&lt;SEP&gt;"The presence of specific genetic variants in the TCF7L2 gene is associated with an increased risk for type 2 diabetes."&lt;SEP&gt;"There was no significant association of the FTO SNP with obesity risk in individuals who had university studies, though there were indications of an effect within different socioeconomic groups.")&lt;SEP&gt;"Patients with hypoglycaemia underwent various management strategies including diazoxide treatments and dietary adjustments."&gt;13&lt;SEP&gt;&gt;"The impact of the identified genomic variants on disease risk is not directly discussed in this text; only their potential effect on gene regulation and splicing is noted."&lt;SEP&gt;"These associations suggest that there is a link between genes, genomic variants, and disease states such as differences in age at first tooth appearance or number of teeth."&lt;SEP&gt;"Cardiovascular disease is a condition influenced by both genetic and environmental factors, including the NOS1 gene and dietary patterns."&lt;SEP&gt;"Type 2 diabetes mellitus is influenced by genetic factors including those associated with the NOS1 and IRF1 genes."&lt;SEP&gt;"This study reviews the association between Cdx-2 gene variants rs11568820 and TaqI alleles with risk of ovarian cancer based on six subgroup studies comprising 784 cases and 1,248 controls."&lt;SEP&gt;13) ("entity"&lt;SEP&gt;5&lt;SEP&gt;9&lt;SEP&gt;"Cardiovascular disease is influenced by factors such as genetic variants, dietary patterns, and nutrient intake, including folate."&gt;&gt;11&lt;SEP&gt;"Cardiovascular disease is a condition influenced by both genetic and environmental factors, including the NOS1 gene and dietary patterns."&lt;SEP&gt;7&lt;SEP&gt;"The multivariate logistic regression analysis examines how various genetic and environmental factors relate to disease progression in the context of HIV.") ("entity"&lt;SEP&gt;"No specific disease is mentioned in the context provided as being connected with a gene whose expression compares to an immunodominant epitope."</data>
      <data key="d0">"DISEASE"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;OBESITY RISK&quot;">
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d1">"There was no significant association of the FTO SNP with obesity risk in individuals who had university studies, though there were indications of an effect within different socioeconomic groups.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;NHS&quot;">
      <data key="d0">"ORGANIZATION"</data>
      <data key="d1">"The Nurses' Health Study (NHS) is an organization that has conducted several publications related to health and diet."&gt;)&gt;1</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;HPFS&quot;">
      <data key="d0">"ORGANIZATION"</data>
      <data key="d1">"The Health Professionals Follow-Up Study (HPFS) is another organization closely associated with medical research, particularly in the field of cardiovascular diseases."&gt;)&gt;2</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;MDCS&quot;">
      <data key="d0">"ORGANIZATION"</data>
      <data key="d1">"The Malmö Diet and Cancer Study (MDCS) has published several important findings related to diet and disease risk."&gt;)&gt;3</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;EPIC&quot;">
      <data key="d0">"ORGANIZATION"</data>
      <data key="d1">"The European Prospective Investigation into Cancer-InterAct is a large cohort study that investigates the relationship between dietary patterns, genetic variants, and disease outcomes."&gt;)&gt;4</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;SHANGHAI DIABETES GWAS STUDY&quot;">
      <data key="d0">"STUDY"</data>
      <data key="d1">"This study focuses on exploring the link between diabetes risk factors and specific genes in populations from Shanghai."&gt;)&gt;5</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;KOGES&quot;">
      <data key="d0">"ORGANIZATION"</data>
      <data key="d1">"The Korea Association Resource (KARE) is another organization involved in medical research, particularly focusing on genetic variants that influence disease outcomes."&gt;)&gt;6</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;DESIR&quot;">
      <data key="d0">"ORGANIZATION"</data>
      <data key="d1">"The Epidemiological Study on the Insulin Resistance Syndrome (DESIR) conducts studies to investigate metabolic pathways and their relationship with dietary factors."&gt;)&gt;7</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;KARE&quot;">
      <data key="d0">"ORGANIZATION"</data>
      <data key="d1">"The Korea Association Resource (KARE) is involved in research related to genetic variants, diet, and disease outcomes."&gt;)&gt;8</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;PREDIMED&quot;">
      <data key="d0">"STUDY"</data>
      <data key="d1">"This study assesses the impact of different dietary patterns on health among participants with high cardiovascular risk."&gt;)&gt;9</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;DPP&quot;">
      <data key="d0">"ORGANIZATION"</data>
      <data key="d1">"The American Diabetes Prevention Project (DPP) is conducting studies to identify factors that can prevent diabetes."&gt;)&gt;10</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;DPS&quot;">
      <data key="d0">"STUDY"</data>
      <data key="d1">"The Finish Diabetes Prevention Study (DPS) investigates lifestyle interventions aimed at preventing type 2 diabetes in high-risk populations."&gt;)&gt;11</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;DPP PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"3234 participants with impaired glucose tolerance and elevated fasting glucose were part of the DPP study, which investigated various intervention strategies to prevent diabetes."&gt;)&gt;12) ("entity"</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;NHS PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"The Nurses' Health Study includes mainly health sector staff, with participants being recruited from various locations."&gt;)&gt;14</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;MDCS PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"The Malmö Diet and Cancer Study includes individuals from the general population with a focus on dietary patterns and cancer risk."&gt;)&gt;16</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;SHANGHAI DIABETES GWAS PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"This study involves participants from Shanghai, focusing on diabetes-related genetic variants within the population."&gt;)&gt;17</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;KOGES PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"The Korea Association Resource (KARE) includes individuals involved in research to understand dietary patterns and their impact on health outcomes."&gt;)&gt;18</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;DESIR PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"The Epidemiological Study on the Insulin Resistance Syndrome recruits volunteers from various health facilities with a focus on metabolic pathways and disease risk."&gt;)&gt;19</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;PREDIMED PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"In PREDIMED, participants are selected based on high cardiovascular risk, focusing on different dietary patterns to assess their impact on health outcomes."&gt;)&gt;20</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;ITALIAN STUDY PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"The Italian study involves individuals from Asti with a focus on lifestyle interventions and reducing metabolic abnormalities through individualized recommendations."&gt;)&gt;21</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;NOS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NOS1 gene plays a critical role in regulating nitric oxide production and cardiovascular health."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;1&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production.")&gt;1&lt;SEP&gt;&gt;&lt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&gt;&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1"> The comprehensive summary for the biomedical entity "TRANSCRIPT," as described in the provided descriptions, reveals that it primarily focuses on genes and their associated transcripts. These transcripts are involved in various physiological processes including disease susceptibility, vascular function, iron metabolism, dietary patterns such as folate intake, cytokine signaling through TGF-β1, hypoglycemic insulin secretion via ABCC8 gene expression, genomic variant associations linked to ovarian cancer risk at the IL1A locus, stress-induced reward learning deficits mediated by CRHRIC Single Nucleotide Polymorphisms (SNPs), dental development processes and dietary patterns influencing nitric oxide production. The descriptions also highlight alterations in transcript processing like splicing associated with TUFM genomic variants. Overall, this comprehensive summary underscores the significant influence of transcripts on disease susceptibility and physiological processes through various gene-diet interactions as well as genetic variant associations across different research domains.&lt;SEP&gt;"The expression of LCT mRNA was reduced by 20% due to silencing of LOC100507600."&lt;SEP&gt;"The transcript of the NOS1 gene is influenced by dietary patterns, particularly folate intake."&lt;SEP&gt;"The transcript of the NOS1 gene is influenced by dietary patterns, particularly folate intake."&lt;SEP&gt;"The transcript of PTPN1 may also show differential expression related to inflammatory conditions, potentially influenced by similar genetic variants as seen in PTPN2."&lt;SEP&gt;"The transcript of the NOS1 gene is influenced by dietary patterns, particularly folate intake."&lt;SEP&gt;"The transcript of the PTPN2 gene shows differential expression between CD and healthy control subjects, related to SNP rs478582."&lt;SEP&gt;"The transcript of the TAG72 gene, which codes for a protein involved in CAR-T cell targeting, might be differentially expressed on certain human ovarian cancer cell lines."&gt;&lt;SEP&gt;"The SNP rs231775 is related to the transcript of the CTLA4 gene, which has been identified as significantly associated with PBC susceptibility."&lt;SEP&gt;"The transcript of genes involved in interferon signaling pathways like IRF1 and STAT1 are influenced by genetic variants such as the missense SNP rs181206 at the IL27 locus, which affects both genes."&lt;SEP&gt;"Transcripts from genes like TLR7 are analyzed for their correlation with HIV disease progression."&lt;SEP&gt;"The text does not provide information on any specific transcript associated with this gene expression compared to an immunodominant epitope."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-8276370dea9f12d2b305c355f74c7f6e&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-ba82b7eb40cf9eea561d839b20584f91&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;TCF7L2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TCF7L2 variant rs7903146 is strongly associated with T2D risk and modifies effect of incretins on insulin secretion."&lt;SEP&gt;"The TCF7L2 gene variant rs7903146 is associated with obesity risk at baseline as per GWAS data."&lt;SEP&gt;"The TCF7L2 gene's rs7903146 variant plays a role in BMI levels at baseline."&lt;SEP&gt;"The TCF7L2 gene's rs7903146 variant shows a significant association with BMI at baseline."&lt;SEP&gt;"The TCF7L2 gene's variant rs7903146 contributes to genetic predisposition to obesity as per GWAS findings.") ("entity"</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;CARDIOVASCULAR HEALTH&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular disease is a condition influenced by both genetic factors related to NOS1 gene variants and environmental factors such as diet."&lt;SEP&gt;"Cardiovascular health involves physiological processes influenced by factors including diet, genetic variants, and environmental exposures."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;NUTRIENT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1"> The dietary patterns or specific nutrients, such as folate, may influence metabolic pathways that impact genes related to dental health. Folate, found in leafy greens, plays a role in nitric oxide production through its interactions with genes like NOS3, which may influence the risk of ovarian cancer. Dietary patterns and genomic variants also affect vascular function by influencing nitric oxide synthesis and regulation. Key nutrients such as iron are linked to genomic variants that may impact cardiovascular disease risk factors, particularly hypertension.

The relationship between dietary patterns and gene variants like TCF7L2 influences diabetes risk. In the DPP intervention, a significant decrease in fasting proinsulin levels was observed with reduced carbohydrate intake, highlighting the influence of dietary patterns on metabolic pathways related to genes such as TCF7L2. Folate-rich foods play a role in nitric oxide production for cardiovascular health.

Essential amino acid leucine may modulate inflammation processes associated with gene variants like those found in IL1A, which are linked to ovarian cancer risk. Dietary treatment for hypoglycemia in diazoxide-responsive individuals is related to the ABCC8 gene, an essential component of potassium leak channel regulation within cells.

In summary, dietary patterns and specific nutrients such as folate play a significant role in modulating various health outcomes including cardiovascular function, diabetes risk, inflammation processes, and cancer susceptibility through their interactions with genes associated with these conditions.&lt;SEP&gt;15&lt;SEP&gt;"Folate is a nutrient found in leafy greens and is critical for cardiovascular health."&gt;&gt;8&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a nutrient found to influence the genetic variant rs478582 of PTPN2, which may impact autoimmune disease susceptibility."&lt;SEP&gt;"Vitamin B6 may be relevant to the study of genetic variants like rs478582, which influence PTPN1/PTPN2 protein expression in inflammatory conditions."&lt;SEP&gt;"Dietary patterns or nutrients may influence which genes are expressed and how they function, potentially impacting the targeting of tumors by CAR-T cells."&gt;) ("entity"&lt;SEP&gt;"Nutrients, including baseline CD4 counts, were considered in the multivariate logistic regression analysis of disease risk."&lt;SEP&gt;"The text does not specify any nutrient or dietary factor being compared to an immunodominant epitope."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-ba82b7eb40cf9eea561d839b20584f91&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;HFE VARIANT&quot;">
      <data key="d0">"RS1800562 (C282Y)"</data>
      <data key="d1">"Genomic Variant of the HFE gene associated with increased risk of hypertension.")</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;3758947&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene associated with the GG genotype and nonrisk haplotype in SLC2A2 variants."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;SLC2A2 RS5393, RS5394, RS5400, RS5404&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are genomic variants related to the GG genotype and nonrisk haplotype in SLC2A2."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5393, RS5394, RS5400, RS5404&quot;">
      <data key="d0">"GENETIC MARKER"</data>
      <data key="d1">"These genetic markers correspond to the genomic variants associated with the GG genotype and nonrisk haplotype in SLC2A2."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS12255372 TCF7L2&quot;">
      <data key="d0">"RISK ALLELE"</data>
      <data key="d1">"The risk allele of rs12255372 TCF7L2 is associated with a lower incidence of T2D in the intervention group compared to controls."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS7903146 SLC2A2&quot;">
      <data key="d0">"RISK ALLELE"</data>
      <data key="d1">"The risk allele (possibly rs5400 or rs5404) of SLC2A2 is associated with a lower T2D incidence in the intervention group."&lt;SEP&gt;"The risk allele of rs7903146 (possibly rs5400 or rs5404) is associated with a lower incidence of T2D in the intervention group compared to controls."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;MC4R RS17066829&quot;">
      <data key="d0">"RISK ALLELE"</data>
      <data key="d1">"The risk allele of MC4R (rs17066829) shows a trend for interaction with weight loss intervention leading to lower T2D incidence."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;PARPΓ RS1152003 CC-GENOTYPE, TNFΑ RS1800629 GG-GENOTYPE, ADRA2B GLU9-ALLELE, LIPC RS2070895 A-ALLELE&quot;">
      <data key="d0">"GENETIC MARKER"</data>
      <data key="d1">"These genetic markers correspond to individuals with a weight loss intervention leading to reduced T2D incidence."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ENPP1 RS1044498&quot;">
      <data key="d0">"DIABETOGENIC VARIANT"</data>
      <data key="d1">"The diabetogenic variant of ENPP1 (rs1044498) is associated with a lower T2D incidence in the intervention group."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;DPP ASTI STUDY, DPS DPP STUDY&quot;">
      <data key="d0">"RESEARCH STUDY"</data>
      <data key="d1">"Both studies investigated genetic variants and their interactions with weight loss interventions to reduce diabetes risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A genomic variant in the HFE gene has been linked to increased risk of hypertension.")&lt;SEP&gt;"Cardiovascular disease is a condition influenced by both genetic and environmental factors, including the NOS1 gene and dietary patterns."&lt;SEP&gt;"Cardiovascular disease is a condition influenced by genetic factors, including the NOS1 gene, as well as environmental influences such as dietary patterns."&lt;SEP&gt;"Cardiovascular disease is a condition influenced by genetic factors and environmental factors, including folate metabolism."&lt;SEP&gt;"Cardiovascular disease involves the NOS1 gene and its regulation by dietary factors."&lt;SEP&gt;"Cardiovascular disease is influenced by genetic and environmental factors, including dietary patterns and physical activity."</data>
      <data key="d0">"DISEASE"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;HEME IRON INTAKE&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"The intake of heme iron showed an interaction with the SLC40A1 rs744653 variant in men, suggesting a potential link to cardiovascular disease risk factors such as hypertension.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;NHS AND HPFS PARTICIPANTS&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"The NOS1 protein interacts with folate metabolism to maintain vascular function among participants of the NHS and HPFS studies. This interaction may be influenced by genetic variants, including SLC40A1 rs744653.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;PROTEIN&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-ba82b7eb40cf9eea561d839b20584f91&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1"> The PROTEIN entity, identified through the provided descriptions, plays diverse roles within biomedical contexts. This includes its critical involvement in regulating glucose levels, as demonstrated by ABCC8 protein specifically in diazoxide-unresponsive patients. Additionally, beyond protein-level analysis, there is a necessity to further study TCF7LIC's function to understand its impact on diabetes risk. The NOS1 protein stands out for its interaction with folate metabolism and vascular function among participants of the NHS and HPFS studies, mediated potentially by genetic variants including SLC40A1 rs744653. Moreover, it is involved in nitric oxide signaling through interactions with NOSRL2.

The regulation of fasting proinsulin levels, notably influenced by proteins such as those encoded by the SLC30A8 gene, further demonstrates its involvement in glucose metabolism. The genomic variants may alter protein production or function within the context of the TUFM gene. Additionally, it is linked to signaling pathways triggered by IL1A and influences ovarian cancer risk.

The encoding proteins also contribute significantly in autoimmune diseases such as those involved with PTPN2 and PTPN1 proteins, influencing processes like inflammation and gene expression. The NOS1 protein's involvement extends further into DNA damage response and repair, suggesting a broad spectrum of functions contributing to various biological pathways crucial for maintaining health and well-being.&lt;SEP&gt;"The protein coded by the TAG72 gene is involved in activating CAR-T cells against specific targets such as those found on ovarian cancer cells."&gt;&lt;SEP&gt;"Both IRF1 and STAT1 are proteins that function in response to interferon signaling; their expression is modulated by genetic variants such as the missense SNP rs181206 at the IL27 locus, which affects transcription of these genes."&lt;SEP&gt;4&lt;SEP&gt;"The STAT3 protein plays a role in maintaining T cell levels and activation.")&lt;SEP&gt;"The STAT5B protein is important for maintaining T cell levels.")&lt;SEP&gt;"Molecular Interaction"&lt;SEP&gt;"No mention of a protein in the context provided as related to this gene expression compared to an immunodominant epitope."&lt;SEP&gt;"No mention of a protein in the context provided, only reference to a gene and its related entity."</data>
      <data key="d0">"PROTEIN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Alterations in metabolic pathways related to ABCC8 and GLUD1 were linked to chronic hypoglycemia in infants."&lt;SEP&gt;"Potential alterations in metabolic pathways may be linked to the effects of the TCF7L2 gene on diabetes risk."&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to the regulation of vascular function, which may be influenced by genetic variants and dietary patterns such as heme iron intake.")&lt;SEP&gt;"The DPP intervention targeted metabolic pathways involved in blood glucose regulation, including those related to the SLC30A8 gene.")&lt;SEP&gt;&gt;"No specific metabolic pathways are described that are directly affected by the genomic variants in TUFM."&lt;SEP&gt;"Alterations in specific metabolic pathways may be associated with variations seen in genes related to dental health."&lt;SEP&gt;"Alterations in specific metabolic pathways may be linked to disease states such as variations seen in Age at first tooth appearance or number of teeth.")&lt;SEP&gt;"Interferon-gamma (IFN-γ) is a pathway that may be affected by the gene variant PTPN2, which influences disease expression in autoimmune diseases.") ("entity"&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to the interaction between the NOS1 gene and cardiovascular health."&lt;SEP&gt;"Metabolic pathways involving TLR7 polymorphisms may play a role in the progression of diseases such as HIV."&lt;SEP&gt;"Metabolic pathways like those involving TLR7 polymorphisms are associated with disease progression such as HIV."&lt;SEP&gt;"No mention of a specific metabolic pathway related to the gene expression compared to an immunodominant epitope is present in the context provided."</data>
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Nitric oxide synthesis is a physiological process that plays a critical role in regulating vascular function."&lt;SEP&gt;"The NOS1 gene is critical for maintaining vascular function through its interactions with folate metabolism."&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to maintaining vascular function."&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to the interaction between dietary patterns and cardiovascular health."&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to the regulation of vascular function, which may be influenced by genetic variants and dietary patterns such as heme iron intake.")&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to this interaction between the NOS1 gene and cardiovascular health."&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to the regulation of vascular function."</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;IRON METABOLISM&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"The HFE gene and its variants are involved in iron metabolism, which may influence cardiovascular disease risk factors such as hypertension. This pathway includes mechanisms for heme iron intake and the regulation of nitric oxide synthesis.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;FOLATE&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-f433e179cd5e32035a0303b9a14da3f1&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a nutrient found in leafy greens that interacts with genes like NOS1 to regulate nitric oxide production and vascular function, which may be influenced by dietary patterns and genomic variants such as HFE rs1799945.")&lt;SEP&gt;"Maternal folate levels are not likely mediated by maternal B12 levels when it comes to offspring birthweight."&lt;SEP&gt;"Similarly, there is no evidence that folate levels mediate the relationship between maternal B12 and offspring birthweight."&lt;SEP&gt;"Folate is a nutrient found in leafy greens and is critical for cardiovascular health."&lt;SEP&gt;"Folate is a nutrient that influences CYP2C9 activity, which in turn affects warfarin dosing.")&lt;SEP&gt;"Folate is a nutrient found in leafy greens and plays a critical role in the regulation of nitric oxide synthesis through its influence on the NOS1 transcript.")&gt;5&lt;SEP&gt;&gt;&lt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&gt;</data>
      <data key="d0">"NUTRIENT"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;WESTERN DIET&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A Western dietary pattern is associated with higher risk of developing type 2 diabetes among individuals with genetic predispositions, as indicated by the T2D-GRS score. This includes interactions between individual food items like red and processed meat.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;FOOD ITEM&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"High intake of red meat increases risk of developing type 2 diabetes among men with a high T2D-GRS, indicating potential interaction with genetic factors such as the HFE gene variants rs1799945 and rs1800562.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RED MEAT&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"High intake of red meat increases risk of developing type 2 diabetes among men with a high T2D-GRS, indicating potential interaction with genetic factors such as the HFE gene variants rs1799945 and rs1800562.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGH PA ADHERENCE&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Low adherence to T2D-GRS is associated with a weaker association between physical activity and lower risk of developing type 2 diabetes in communities like the Atherosclerosis Risk in Communities study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D-ESRD GROUP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The T2D-ESRD group refers to individuals with Type 2 Diabetes and End Stage Renal Disease, a clinical condition characterized by the presence of diabetes and severe kidney impairment."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;TABLE 1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A table containing baseline clinical characteristics of participants."&lt;SEP&gt;"Table 1 is a document that lists clinical characteristics of the study samples, including demographic data and relevant health metrics."&lt;SEP&gt;"Information on probands with GCK variants was summarized in Table 1, primarily focusing on clinical findings that were similar to previously described pathogenic GCK variants."&lt;SEP&gt;"rs731236"&lt;SEP&gt;"The demographic profile of HIV-infected individuals and healthy controls was detailed in Table 1, showing differences in age and possibly other relevant physiological aspects."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;TCF7L2 VARIANT RS7903146&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant rs7903146 in the TCF7L2 gene is associated with an increased risk of Type 2 Diabetes and End Stage Renal Disease."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS10010131 IN WFS1&quot;">
      <data key="d0">"NONDIABETIC CONTROL GROUP"</data>
      <data key="d1">7</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CDKAL1 RS10946398&quot;">
      <data key="d0">"T2D CASE SUBJECTS"</data>
      <data key="d1">9</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;JAZF1 RS864745&quot;">
      <data key="d0">"CASE GROUPS OF T2D-ESRD"</data>
      <data key="d1">11</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS4607103 IN ADAMTS9&quot;">
      <data key="d0">"T2D CASE SUBJECTS AND CONTROL SUBJECTS"</data>
      <data key="d1">13&lt;SEP&gt;17</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;AFRICAN ANCESTRY PROPORTIONS 0.78±0.09&quot;">
      <data key="d0">"OVERALL COHORT OF AFRICAN AMERICANS SOUTHEAST"</data>
      <data key="d1">15</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Epigenetic modifications at regulatory regions in the NOS1 gene are associated with its regulation through molecular interactions like histone marks and DNase I hypersensitivity sites."&lt;SEP&gt;"Fasting proinsulin levels are influenced by molecular interactions between hormones and their receptors at the cellular level."|&lt;SEP&gt;"The molecular interactions involving the TCF7L2 protein and its genetic variants could impact disease susceptibility."&lt;SEP&gt;&gt;"The molecular interactions within and around the TUFM gene region, including transcription factor binding, are predicted to be altered due to these genomic variants."&lt;SEP&gt;"The missense change in IL1A (rs17561 A114S) may influence the risk of ovarian cancer differently than other linked variants according to histological subtype analysis.")|&gt;8&lt;SEP&gt;"The molecular interaction between the missense change (rs17561 A114S) in IL1A and its receptor, IL1RAg, may influence signaling pathways related to inflammation which can affect ovarian cancer risk.")|&gt;17&lt;SEP&gt;"These molecular interactions are likely complex and involve multiple factors including SNPs, transcripts, and proteins that influence tooth development."&lt;SEP&gt;"Nutrient Metabolism and Inflammation Pathway"&lt;SEP&gt;"This study investigates molecular interactions between Cdx-2 gene variants, alleles, and their carriers and the risk of ovarian cancer based on subgroup studies involving 1,567 cases and 2,226 controls."&lt;SEP&gt;"There is no reference to any molecular interaction in the text regarding this gene and its comparison to an immunodominant epitope."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Diet is an environmental factor that may influence the risk of ovarian cancer, as suggested by associations with certain gene and physiological process interactions found in this study.")|&gt;9&lt;SEP&gt;"Environmental factors may influence the expression or function of the TCF7L2 gene, which in turn can affect diabetes risk."&lt;SEP&gt;"The DPP intervention is an environmental factor that influences physiological processes related to glucose metabolism, including those involving the SLC30A8 gene.")&lt;SEP&gt;"The environmental factors, including dietary treatment, played a role in the management of chronic hypoglycemia identified in this study.") ("entity"&lt;SEP&gt;"No environmental factors are mentioned in relation to the genetic alterations that affect TUFM.")&lt;SEP&gt;&gt;"No specific environmental factors are mentioned in relation to the genetic changes affecting TUFM."&lt;SEP&gt;"Socioeconomic status is an environmental factor that may influence the availability of healthy dietary options and therefore could potentially impact gene-disease associations like those observed in IL1A, which are associated with inflammation processes.")|&gt;18&lt;SEP&gt;"The environmental context in which individuals develop may also play a role in the expression of genetic influences on Age at first tooth and Number of teeth."&lt;SEP&gt;"Dietary factors including the genetic variant in Cdx-2 gene have been explored for possible links with environmental influences leading to higher risk of ovarian cancer according to a meta-analysis involving three reports comprising 1,567 cases and 2,226 controls."&lt;SEP&gt;"Environmental factors, such as diet, modulate the relationship between the NOS1 gene and cardiovascular health."&lt;SEP&gt;"Dietary factors may indirectly influence the susceptibility to PBC as indicated by statistical associations between genetic variants and disease."&lt;SEP&gt;8&lt;SEP&gt;"Tobacco usage is an environmental factor that may correlate with risk factors for diseases including HIV."&lt;SEP&gt;"The text does not specify any environmental factor that could be related to this gene's expression compared to an immunodominant epitope."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-41c7131af28e2a745ef6b88b8601860f&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;TCF7L2 PROTEIN&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Potential molecular interactions involving the TCF7L2 protein could mediate disease susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;SUPPLEMENTARY TABLE 3&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"Additional tables showing ethnic distribution of glycemic status groups."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;FPG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FPG refers to fasting plasma glucose levels, which are a measure of blood sugar after not eating for at least 8 hours."&lt;SEP&gt;"Fasting plasma glucose is a nutrient measured in laboratory tests and linked to BMI level."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;2HPG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"2hPG refers to 2-hour plasma glucose levels measured during an oral glucose tolerance test."&lt;SEP&gt;"Two-hour plasma glucose is another nutrient measured in laboratory tests that influences BMI change during the follow-up period."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;BMI&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Body Mass Index (BMI) is a physiological process influenced by glycemic status and dietary patterns.") ("entity"&lt;SEP&gt;"Body mass index (BMI) is an environmental factor that influences the risk of T2D."&lt;SEP&gt;"There is a significant difference in BMI (a metabolic pathway indicator) according to the rs671 polymorphism between men of various genotypes."&lt;SEP&gt;"Higher average BMI was found among asthmatic patients compared to the control group."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;GLYCEMIC STATUS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Glycemic status, including measurements like fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG), is influenced by dietary patterns taken over time."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;BMI AT BASELINE&quot;">
      <data key="d0">"BODY MASS INDEX"</data>
      <data key="d1">"Baseline body mass index is measured."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;TAL1 SNP&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The TAL1 rs2984618 SNP is linked with BMI at baseline and may contribute to the risk of obesity."&lt;SEP&gt;"The TAL1 rs2984618 SNP is linked with BMI at baseline and may influence obesity risk."&lt;SEP&gt;"The TAL1 rs2984618 SNP was found to be significantly linked with BMI at baseline."&lt;SEP&gt;"The TAL1 rs2984618 SNP's effect on BMI at baseline supports the study findings."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;LEPR SNP&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"No main effect or interaction between the LEPR rs1011527 SNP and FPG on baseline BMI was observed."&lt;SEP&gt;"No main effect or significant interaction between the LEPR rs1011527 SNP and BMI change was observed."&lt;SEP&gt;"No significant association between the LEPR rs1011527 SNP and FPG was observed with or without interaction terms."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GRS (GENOTYPE RISK SCORE)&quot;">
      <data key="d0">"RISK SCORE"</data>
      <data key="d1">"The GRS based on 23 obesity-related SNPs showed a significant association with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;OBESITY PREDISPOSITION&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"The study investigated the predisposition to obesity among individuals through their genetic variations."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;FOLATE METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Folate metabolism interacts with the NOS1 protein to maintain vascular function, which can lead to cardiovascular disease."&lt;SEP&gt;"Folate metabolism involves multiple genes like S-FOL and WB-FOL that affect protein function.")&lt;SEP&gt;"Folate metabolism involves the proteins S-FOL and WB-FOL as part of their function.")&lt;SEP&gt;"Folate metabolism is a key metabolic pathway involved in cardiovascular health."&lt;SEP&gt;"Folate metabolism is a physiological process that interacts with the NOS1 protein to maintain vascular function."&lt;SEP&gt;"Folate metabolism is a physiological process that interacts with the NOS1 protein to maintain vascular function."&lt;SEP&gt;"Folate metabolism is a physiological process that involves the conversion of dietary folate into active forms within cells, playing a crucial role in maintaining cardiovascular health.")&lt;SEP&gt;"Folate metabolism is a physiological process that influences cardiovascular health."&lt;SEP&gt;"Folate metabolism is a physiological process that interacts with the NOS1 protein to maintain vascular function."&lt;SEP&gt;&gt;&lt;"Folate metabolism is a physiological process that interacts with the NOS1 protein to maintain vascular function."&gt;&lt;SEP&gt;"Folate metabolism is likely impacted in DBA patients due to mutations affecting RPS19, which can alter aminoacyl-tRNA biosynthesis pathways.")</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c&lt;SEP&gt;chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;EPIGENETIC MODIFICATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Diet, physical activity are environmental factors that can modulate epigenetic changes affecting nitric oxide synthesis."&lt;SEP&gt;"Epigenetic modifications linked to poor dietary patterns can alter nitric oxide synthesis."&lt;SEP&gt;"Poor dietary patterns can lead to epigenetic modifications that affect cardiovascular health."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;DIET&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Diet is an environmental factor that modulates the relationship between the NOS1 gene and cardiovascular health."&lt;SEP&gt;"Personalized therapies for cardiovascular health may be based on individual dietary patterns and lifestyle choices."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;STATINS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Statins are a drug therapy that may be used to manage diseases related to nitric oxide regulation by genes like NOS1.") ("entity"&lt;SEP&gt;"Statins are a drug therapy that targets dysregulated pathways in the context of cardiovascular disease risk."&lt;SEP&gt;"Statins are a drug therapy used to manage cardiovascular disease risk."&lt;SEP&gt;"Statins are drug therapies used to manage cardiovascular disease risk factors, such as the NOS1 gene and dietary patterns.") ("entity"</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;PERSONALIZED THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Personalized therapies based on genetic and nutritional profiles are being explored for better management of cardiovascular health."&lt;SEP&gt;"Personalized therapies based on genetic and nutritional profiles are being explored to manage cardiovascular health."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TMTA&quot;|&lt;&gt;&quot;INSTRUMENT&quot;">
      <data key="d0">"TEST FOR THE MENTAL ATTRIBUTES IS AN INSTRUMENT THAT MEASURES COGNITIVE FUNCTION.")</data>
      <data key="d1">2</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;PEGNDH&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PEGNDH is a protein involved in neurological processes related to mental abilities.")</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;TMTB&quot;|&lt;&gt;&quot;INSTRUMENT&quot;">
      <data key="d0">"TEST FOR THE MENTAL ABILITIES IS ANOTHER INSTRUMENT THAT MEASURES COGNITIVE FUNCTION.")</data>
      <data key="d1">4</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;GRS&quot;|&lt;&gt;&quot;BIOLOGICAL PATHWAY&quot;">
      <data key="d0">"THE GRS IS A GENETIC SCORE THAT INDICATES THE PRESENCE OF SPECIFIC GENE POLYMORPHISMS.")</data>
      <data key="d1">7</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;PEGDH&quot;|&lt;&gt;&quot;PROTEIN&quot;">
      <data key="d0">"PEGDH IS A PROTEIN INVOLVED IN NEUROLOGICAL PROCESSES RELATED TO MENTAL ABILITIES.")</data>
      <data key="d1">8</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;DIG&quot;|&lt;&gt;&quot;NUTRIENT&quot;">
      <data key="d0">"DIG IS AN INSTRUMENT USED FOR MEASURING COGNITIVE FUNCTION AND ASSESSING THE EFFECTS OF MEDICATION ON COGNITION.")</data>
      <data key="d1">10</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;CFL&quot;|&lt;&gt;&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"CFL STANDS FOR CENTRAL LABORATORY, WHICH IS A LOCATION WHERE MEDICAL TESTING TAKES PLACE TO MEASURE NEUROLOGICAL FUNCTIONS.")</data>
      <data key="d1">11</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;DIVERGT&quot;|&lt;&gt;&quot;INSTRUMENT&quot;">
      <data key="d0">"DIVERGT BATTERY MEASURES OVERALL COGNITIVE FUNCTION IN PATIENTS WITH NEUROLOGICAL DISORDERS.")</data>
      <data key="d1">12</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;IMPAIRMENT&quot;|&lt;&gt;&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d0">"IMPAIRMENT ON THE TMTA AND TMTB INSTRUMENTS INDICATES A DECREASE IN MENTAL ABILITIES.")</data>
      <data key="d1">13</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;CENTRAL LABORATORY&quot;|&lt;&gt;&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"THE CENTRAL LABORATORY IS A LOCATION WHERE MEDICAL TESTING TAKES PLACE TO MEASURE NEUROLOGICAL FUNCTIONS.")</data>
      <data key="d1">2</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;DIVERGT BATTERY&quot;|&lt;&gt;&quot;INSTRUMENT&quot;">
      <data key="d0">"DIVERGT BATTERY MEASURES OVERALL COGNITIVE FUNCTION IN PATIENTS WITH NEUROLOGICAL DISORDERS.")</data>
      <data key="d1">3</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;SLC30A8&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"At baseline, a genomic variant at SLC30A8 rs13266634 was significantly associated with higher fasting proinsulin levels."|</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;MRNA&quot;">
      <data key="d0">"PNPLA3"</data>
      <data key="d1">"PNPLA3 mRNA levels were increased in response to a high carbohydrate diet."&gt;</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;MALONYL-COA&quot;">
      <data key="d0">"ACC-1"</data>
      <data key="d1">"ACC-1 is involved in the formation of malonyl-CoA which modulates fatty acid synthesis."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;OLEIC ACID&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Oleic acid affects PNPLA3 levels through its impact on gene expression related to lipid accumulation. It suppresses the protein's expression leading to reduced lipid content in cells."&lt;SEP&gt;"Oleic acid is a type of nutrient that suppresses PNPLA3 gene expression and reduces lipid content in cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;HEPG2 CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"HepG2 cells are used for studying the effects of nutrients and dietary patterns on gene expression."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;INSULIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The PNPLA3 gene does not response to insulin signaling in hepatic cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;GLUCAGON&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Exercise stimulates glucagon secretion, which may affect the expression of genes like PNPLA3."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;CITRATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Citrate metabolism is downstream from glucose metabolism and influences the regulation of genes like PNPLA3."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;CITRATE METABOLISM&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Incubation with citrate increases PNPLA3 levels, indicating a relationship between citrate metabolism and gene expression related to lipid accumulation.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNPLA3&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Incubation with citrate increases PNPLA3 levels, indicating a relationship between citrate metabolism and gene expression related to lipid accumulation.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LEAFY GREENS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Leafy greens are a food source rich in folate, critical for cardiovascular health."&lt;SEP&gt;"Leafy greens are a food source rich in folate, critical for maintaining vascular function."&lt;SEP&gt;"Leafy greens are a food source rich in folate, which is critical for cardiovascular health."&lt;SEP&gt;"Leafy greens are a food source rich in folate, which is critical for cardiovascular health.")&lt;SEP&gt;"Leafy greens are food sources rich in folate, important for cardiovascular health."&lt;SEP&gt;&gt;&lt;"Leafy greens are a food source rich in folate, critical for cardiovascular health."&gt;&lt;SEP&gt;&gt;&lt;"Leafy greens are a food source rich in folate, which is critical for cardiovascular health."&gt;&lt;SEP&gt;"Leafy greens are a food source rich in folate, which influences the NOS1 gene transcript."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;FOXO1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FoxO1 is a gene involved in mediating the negative effects of stress on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HIPPOCAMPAL PROGENITOR STEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Hippocampal progenitor stem cells are involved in FoxO1-mediated regulation of neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CORTISOL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Cortisol is a stress hormone that modulates the expression and activity of genes like FoxO1."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;STRESS-INDUCED GENE UPREGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FoxO1 gene upregulation in response to cortisol exposure mediates negative effects on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEUROGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cortisol and FoxO1 signaling affect neuronal proliferation, a process central to brain function."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SERUM GLUCOCORTICOID KINASE 1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SGK-1 is a stress responsive gene that mediates negative effects of cortisol on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEUROLOGICAL DISEASE RISK FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Childhood trauma and exposure to PNS are risk factors for neurological disease, as indicated by FoxO1 upregulation.") ("entity"</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;BRDU+ CELLS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Neuronal proliferation, indicated by BrdU+ cells, is negatively affected by cortisol exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;ARID5B&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Isochorismatase Domain Containing 1 interacts with ARID5B to mediate the negative effect of stress on neurogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ISOC1&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Isochorismatase Domain Containing 1 interacts with ARID5B to mediate the negative effect of stress on neurogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EPHA4&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"EPHA4 interacts with FBXO32 to mediate cytokines signaling, TGF-β1 signaling and glucocorticoid receptor signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FBXO32&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"EPHA4 interacts with FBXO32 to mediate cytokines signaling, TGF-β1 signaling and glucocorticoid receptor signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MYO1D&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"FOXO1 mediates negative effect of stress on neurogenesis through interaction with MYO1D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PIK3C2B&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Phosphatidylinositol-4-Phosphate 3-Kinase, Catalytic Subunit Type 2 Beta interacts with Phosphatidic Acid Phosphatase Type 2A to mediate cytokines signaling, TGF-β1 signaling and glucocorticoid receptor signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PPAP2A&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Phosphatidylinositol-4-Phosphate 3-Kinase, Catalytic Subunit Type 2 Beta interacts with Phosphatidic Acid Phosphatase Type 2A to mediate cytokines signaling, TGF-β1 signaling and glucocorticoid receptor signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LRRN3&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Leucine-rich repeat neuronal protein 3 interacts with ISOC1 to mediate cytokines signaling, TGF- β1 signaling and glucocorticoid receptor signaling.)</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TGF-Β1&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Transforming Growth Factor, Beta 1 mediates negative effect of stress on neurogenesis through interaction with FOXO1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4771122&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs4771122 is associated with long term weight loss after bariatric surgery, reflecting genetic influences on physiological processes."&lt;SEP&gt;"SNP rs4771122 was associated with long term weight loss after bariatric surgery in a genome-wide association study."&lt;SEP&gt;"SNP rs4771122 was associated with long term weight loss after bariatric surgery, adjusting for pre-surgical BMI."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;81&quot;">
      <data key="d0">"DEMOGRAPHICS"</data>
      <data key="d1">"Eighty-one percent of participants were female, reflecting typical distribution of bariatric surgery patients."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;1634&quot;">
      <data key="d0">"OBESITY AND WHR GWAS SNP ASSOCIATIONS WITH LONG TERM WEIGHT LOSS AFTER BARIATRIC SURGERY"</data>
      <data key="d1">"There were 1634 weight observations in the dataset as part of obesity and WHR GWAS."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;52&quot;">
      <data key="d0">"DEMOGRAPHICS"</data>
      <data key="d1">"In addition to 95 whites, there were 52 self-identified blacks genotyped for the study."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;LONG TERM WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Long term weight loss is a physiological process influenced by genetic factors and bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;GCK VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A total of 217 individuals tested positive for a GCK variant, either through Sanger sequencing or MODY gene panel."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SANGER SEQUENCING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sanger sequencing is used to identify genetic variants in the GCK region."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MODY GENE PANEL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The MODY gene panel tests for mutations in genes associated with maturity-onset diabetes of the young (MODY)."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;UNIVERSITY OF CHICAGO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Seventy-four probands have yet to be tested, primarily conducted at the University of Chicago."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CLINICAL INFORMATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Clinical information for a subset of individuals with GCK variants is available through various research and clinical efforts at the University of Chicago."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;TABLE 2&quot;">
      <data key="d0">"DOCUMENT REFERENCE"</data>
      <data key="d1">"Additional details and novel GCK variants identified between 2008-2018 are presented in Table 2."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANT P.LYS13X&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One variant, p.Lys13X, was previously reported but is included in the professional version of HGMD and thus not further described here."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANT P.LEU185PRO&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Variant p.Leu185Pro found in one individual results in a protein with altered function potentially impacting glucose metabolism."&lt;SEP&gt;"Variant p.Leu185Pro identified could alter the activity or structure of proteins involved in glucose regulation within cells."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANT P.VAL207LEU&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Variant p.Val207Leu identified in another individual may affect the processing of proteins within cells."&lt;SEP&gt;"Variant p.Val207Leu may modify protein processing and function, potentially affecting glucose metabolism in individuals."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANT C.579+4DELA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Insertion/deletion variant c.579+4delA found in one individual could indicate a regulatory change that impacts protein expression or function without clear phenotypic effect."&lt;SEP&gt;"One insertion/deletion variant, c.579+4delA, was detected and lacks clear explanation or classification due to lack of phenotypic data in family members."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANT P.HIS317GLN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Variant p.His317Gln detected in an individual with mild fasting hyperglycemia and atypical HbA1c levels raises questions about the impact of this variant on glucose metabolism."&lt;SEP&gt;"Variant p.His317Gln identified in one individual with mild fasting hyperglycemia raises questions about variant impact and disease severity due to atypical HbA1c levels."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;TARGETED SEQUENCING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Targeted sequencing of parents’ DNA was used to identify de novo variants, such as p.Leu307Phe, in individuals without family history of diabetes."&lt;SEP&gt;"Targeted sequencing of parents’ DNA was used to identify variants such as p.Leu307Phe, which were identified in an individual without family history of diabetes."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;HBA1C LEVELS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A proband with a stable mild fasting hyperglycemia level reported an HbA1c level below the expected range for GCK-MODY.") ("entity"&lt;SEP&gt;"Normal HbA1c levels were maintained during follow-up for some patients after pancreatectomy and diazoxide treatments."&gt;15&lt;SEP&gt;18</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;INDIVIDUALS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Among the 20,986 individuals, a higher adherence to the Mediterranean Diet was observed among women, individuals with lower BMI and WC, older, physically active people."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;RMED&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"rMED stands for 'Mediterranean diet adherence' categories, ranging from low to high adherence levels."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;TAG&quot;&gt;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lower TAG concentrations were associated with greater adherence to the Mediterranean Diet, which is rich in foods known for their role in reducing cardiovascular risk factors like high TAG levels."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;HDL-C&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Higher HDL-C concentrations are linked to a higher rMED, indicating that dietary patterns associated with reduced heart disease risks promote better HDL function."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;HBA1C &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Participants with a lower rMED had significantly lower HbA1c concentrations, indicating better glucose control associated with adherence to the Mediterranean Diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The apoB:apoA-1 ratio is part of the broader metabolic pathway that includes factors like TAG and HDL, both of which were affected by dietary patterns in this study."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;GCKR&quot;&gt;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Glucokinase regulatory protein (GCPR) is a key regulator of glucose metabolism and has been studied in relation to cardiovascular risk factors like TAG levels."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;SOCIAL CLASS &quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There were significant differences observed in relation to educational level and physical activity. This suggests that factors beyond just diet influence metabolic health."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY &quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The association between physical activity and metabolic health suggests that lifestyle factors can interact with dietary patterns to influence physiological processes related to cardiovascular disease risk."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;LIFESTYLE FACTORS&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"Physical activity is an environmental factor that has been shown in this study to modulate the relationship between adherence to a Mediterranean Diet and metabolic markers like TAG concentrations.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;SMOKER V. NON-SMOKER&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">&gt;&lt;&gt;In our study, the distinct dietary patterns observed between smokers and non-smokers highlight potential gene-diet interactions that may influence triglyceride levels.&lt;/&gt;) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;GLUD1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">1</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG32夕HIS MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">2</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.SER498LEU MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ASN463ASP MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">4</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG32夕HIS HETEROZYGOTE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.SER498LEU HETEROZYGOTE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">24&lt;SEP&gt;6</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ASN463ASP HETEROZYGOTE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">25&lt;SEP&gt;7</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPOGLYCAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">8</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPERTRICHOSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">9</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">10</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;OCTREOTIDE ADMINISTRATION&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Three diazoxide-unresponsive patients were treated with octreotide but showed no improvement or required discontinuation due to side effects."&gt;7&lt;SEP&gt;11</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PANCREATECTOMY&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">13</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SUBTOTAL PANCREATECTOMY&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">14</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;INSULIN TREATMENT&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">15</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;NASOGASTRIC TUBE FEEDING&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">16</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">17</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIC PURPURA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">19</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;MULTIORGAN FAILURE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">20</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SEVERE HYPOGLYCAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">21</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;IODIDE SUPPLEMENTATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">22</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DRUG&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Interventions, including drug therapies like statins, may be used to manage disease risk."&lt;SEP&gt;"Two patients required insulin treatment for diabetes mellitus after surgery and diazoxide treatments."&gt;11</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DRUG SIDE EFFECTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Side effects such as nausea, vomiting were observed in 80% of patients during diazoxide therapy."&gt;17</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;BLOOD GLUCOSE LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regular monitoring of blood glucose levels was necessary for patients undergoing pancreatic interventions."&gt;19</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;GLUCOSE METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">26</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIETARY ADJUSTMENTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">27</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE DISCONTINUATION&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">28</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;RESPONSE TO OCTREOTIDE&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">29</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET COMPLIANCE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">30</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;NASOGASTRIC TUBE FEEDING MANAGEMENT&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">31</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PANCREATECTOMY OUTCOMES&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">32</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;INSULIN DEPENDENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">33</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;BLOOD GLUCOSE MONITORING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">34</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SEVERE HYPOGLYCAEMIA MANAGEMENT&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">35</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;MULTIORGAN FAILURE DETAILS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">36</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;IODIDE SUPPLEMENTATION PROTOCOL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">37</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PROCEDURE&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">"Pancreatectomy was performed in ten patients unresponsive to drugs, leading to varying disease outcomes."&gt;32</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;ACAC&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"AcAc is a nutrient that has been associated with changes in glucose levels and risk of diabetes."&lt;SEP&gt;"AcAc, also known as 3-hydroxybutyrate, is a metabolite associated with ketosis and energy production."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;BHB&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"BHB is a ketone body involved in energy metabolism and homeostasis."&lt;SEP&gt;"BHB is another nutrient linked to alterations in glucose metabolism and potential risk factors for diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GLUCOSE AUC&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASURE"</data>
      <data key="d1">"Glucose AUC is a continuous measure of blood sugar over time, used in the study for assessing risk factors for diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INCIDENT DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Incident diabetes refers to new cases of diabetes that were diagnosed during the follow-up period."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IFG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"IFG is defined as fasting plasma glucose levels between 5.4 and less than 7 mmol/L."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IGT&quot;">
      <data key="d0">"IMPAIRED GLUCOSE TOLERANCE"</data>
      <data key="d1">"IGT stands for impaired glucose tolerance, which is a precursor condition to type 2 diabetes where blood sugar levels are above normal but not high enough yet to be diagnosed as diabetes."&lt;SEP&gt;"People with IGT have blood glucose levels that are above normal after fasting, indicating a risk for developing T2DM in the future."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;NUTRITIONAL FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Nutritional factors such as KBs (ketone bodies) can interact with environmental factors like diet and lifestyle habits.") ("entity"</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Insulin secretion refers to the process by which the pancreas produces insulin in response to blood sugar levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;C ALLELE OF RS780094 OF GCKR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A C allele of the rs780094 locus in the GCKR gene has been associated with elevated BHB levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FADS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FADS1 gene plays a role in lipid metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ANK1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ANK1 gene is associated with various biological processes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GIPR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"GIPR protein influences glucose and insulin responses."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGA2 gene has been linked to several diseases, including cancer."&lt;SEP&gt;"HMGA2 is a gene that has been linked to measurements indexing the width of the upper region of the face and nose, also associated with increased number of teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;SLC2A2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC2A2 encodes a transmembrane protein involved in glucose transport and metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CPT1A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CPT1A is an enzyme important for the transportation of long-chain fatty acids into mitochondria."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;MATSUDA ISI&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Matsuda insulin sensitivity index measures insulin sensitivity in response to glucose challenge."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FFAS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Fasting FFAs are fats circulating in the bloodstream and play a role in metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;KBS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"KBs, including BHB and AcAc, are key components of ketone body metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CARNITINE PALMITOYLTRANSFERASE 1A (CPT1A)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CPT1A is an enzyme involved in transporting long-chain fatty acids into mitochondria for oxidation."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1 (HMGCS1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"HMGCS1 protein plays a role in lipid metabolism and is involved in ketogenesis process."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2 (HMGCS2)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Mitochondrial HMGCS2 protein contributes to the synthesis of mevalonate pathway intermediates, which are involved in various cellular processes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ADIPOSE TISSUE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adipose tissue is a body-wide component that stores energy and influences metabolic pathways such as ketogenesis."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CRP SNPS&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"CRP-associated genetic variants identified through genome-wide association studies."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;APOC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"APOC1 is a gene associated with serum CRP levels, implicated in lipid metabolism and cardiovascular health."&lt;SEP&gt;"APOC1 is a protein associated with cholesterol levels, as indicated by its association with rs6734238."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;GCKR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"GCKR is a gene involved in glucose metabolism, which has been linked to both cardiometabolic phenotypes and serum CRP levels."&lt;SEP&gt;"GCKR is a gene that plays a role in glucose metabolism, which is important for managing type 2 diabetes risk."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HNF1A is a gene associated with the regulation of blood sugar levels and lipid metabolism, affecting multiple aspects of cardiovascular health."&lt;SEP&gt;"The HNF1A gene has been linked to cardiovascular disease risk factors such as total cholesterol and coronary artery disease (p-value 1.16×10-5)."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;IL6R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL6R is a gene involved in immune response and inflammation, which has been linked to serum CRP concentrations and cardiometabolic traits."&lt;SEP&gt;"The IL6R protein is associated with inflammation biomarkers like CRP, indicated by its genetic locus rs4420638."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Four SNPs were chosen for defining the FADS1/2 haplotype, and their minor allele frequencies ranged from 25.0% to 32.9%."&gt;&lt;SEP&gt;"SNPs at IL1B and PTGS1 suggested association with ovarian cancer risk."&lt;SEP&gt;"SNPs at loci such as IL1B rs7596684 and PTGS1 rs2282169 were investigated for their association with ovarian cancer risk in the study population."&lt;SEP&gt;"Single Nucleotide Polymorphisms (SNPs) are genetic variants that have been associated with cardiometabolic risk factors such as CRP levels."&lt;SEP&gt;"SNP rs731236 and SNP rs1544410 showed a high LD, while SNP rs2228570 did not show significant association with risk of infection or development of chronic disease."&lt;SEP&gt;&gt;&lt;"A total of 672 candidate SNPs were genotyped. Ten SNPs had a Gencall score of less than 95%, 78 additional SNPs failed the minor allele frequency test, and 19 SNPs failed the Hardy–Weinberg equilibrium test."&gt;&lt;SEP&gt;"There is a strong correlation between SNPs and genetic models, as confirmed by statistical significance of the associations between polymorphisms and PBC susceptibility."&lt;SEP&gt;"Single nucleotide polymorphisms (SNPs) are common variations at a single position in the genome that can influence gene expression and other genetic traits."&gt;</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CRP GWAS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The CRP Genome-Wide Association Study (GWAS) has identified several loci linked to serum CRP concentrations and related cardiometabolic phenotypes."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC PHENOTYPES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cardiometabolic phenotypes refer to traits such as total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, fasting glucose, and other cardiovascular risk factors."&lt;SEP&gt;"The associations between pleiotropic SNPs and cardiometabolic phenotypes suggest complex relationships involving inflammation (CRP) and metabolic pathways."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;SERUM CRP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"CRP (C-Reactive Protein) is a blood test marker used to measure inflammation levels in the body, including inflammation of arteries that can lead to heart disease.") ("entity"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;INFLAMMATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Chronic inflammation in the body is associated with an increased risk of cardiovascular diseases such as atherosclerosis and coronary artery disease."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL1F10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL1F10 is a gene associated with cardiovascular health and disease."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PPP1R3B&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PPP1R3B is involved in processes related to cardiometabolic phenotypes, as indicated by its association with CRP levels."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF4A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HNF4A gene plays a role in metabolic pathways and has been associated with cardiovascular disease risk factors such as total cholesterol."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PABPC&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"BCL7B (p-value &lt; 1.1×10-4) is co-associated with PABPC, which suggests a potential role in molecular interactions important for cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HBA1C&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The association between GCKR and HbA1c indicates a relationship within the metabolic pathway of glucose regulation."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;TRIGLYCERIDES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Hypertriglyceridemia refers to high levels of triglycerides in the bloodstream."&lt;SEP&gt;"The adjustment for triglyceride levels in the model showed a decrease in effect sizes for BCL7B, suggesting mediation through lipid-related factors."&lt;SEP&gt;"There was a significant difference in TG levels among individuals with high uric acid and those without."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HDLC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Dealing with HDL cholesterol levels revealed decreased association after adjusting for CRP and showing possible mediated effects by BMI."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CRP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CRP is a biomarker used to measure inflammation and has been associated with multiple cardiometabolic phenotypes through genetic loci such as APOC1, HNF1A, IL6R, PPP1R3B, HNF4A, and IL1F10."&lt;SEP&gt;"SNPs in CRP did not show an association with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PPP3CA&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"PPP3CA may be related to metabolic pathways as it has been identified in the context of physiological processes affecting cardiometabolic phenotypes (S1 Table)."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"miR-34b/c rs4938723 is a SNP that was successfully genotyped for IA patients and controls."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"TP53 Arg72Pro is another SNP associated with decreased risk of IA in the combined genotypes of rs4938723CC and TP53 Arg72Pro CG/CC/GG."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;GENOTYPIC ASSOCIATION&quot;">
      <data key="d0">"RISK FACTOR FOR INTRACRANIAL ANEURYSM (IA)"</data>
      <data key="d1">"The CC genotype of miR-34b/c rs4938723 was significantly associated with decreased risk of IA compared to the TT genotype."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;ALLELIC ASSOCIATION&quot;">
      <data key="d0">"RISK FACTOR FOR INTRACRANIAL ANEURYSM (IA)"</data>
      <data key="d1">"No association between TP53 Arg72Pro alleles and the risk of IA in either genotypic or allelic analysis was found."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d0">"OUT OF 353/595, 344/698, 588/878 CASES/CONTROLS FOR RS3842787, RS20417 AND RS20118426 WERE NOT IN HARDY-WEINBERG EQUILIBRIUM.")</data>
      <data key="d1">"The Hardy-Weinberg equilibrium is an essential concept for understanding population genetics and maintaining genetic equilibrium over time."&lt;SEP&gt;"The genotype and allele frequencies distribution of both polymorphisms in the control group met the requirements of the Hardy-Weinberg equilibrium."&lt;SEP&gt;"The meta-analysis considered studies that showed departure from Hardy-Weinberg equilibrium, such as Cdx-2 in Japanese subgroup by Lurie et al. and Northern Sweden subgroup conducted by Clendenen et al., but did not find significant effects on the risk of ovarian cancer."&lt;SEP&gt;10</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;COMBINED GENOTYPES FREQUENCY&quot;">
      <data key="d0">"RISK FACTOR FOR INTRACRANIAL ANEURYSM (IA)"</data>
      <data key="d1">"Summary of combined genotypes frequencies is provided, showing significant associations with IA risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;SEX DISTRIBUTION&quot;">
      <data key="d0">"CLINICAL CHARACTERISTICS OF SUBJECTS"</data>
      <data key="d1">"In this study, there were more females among the cases (63.4%) than those in the controls (51.9%)."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;BMI STATUS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Body Mass Index (BMI) status is assessed to determine an individual's body composition."])(Relationship Strength: 1</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">1)&gt; ("relationship"</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;5′UTR REGION OF RPL7P3&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">19&gt; ("relationship"</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;MATK&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">1&gt; ("relationship"</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SEDENTARY BEHAVIOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">39&gt; ("relationship"</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;APOBR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The APOBR gene contains coding variants linked to obesity in extremely obese children and adolescents."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;SULT1A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SULT1A1 gene is screened for potential causative mutations which could lead to obesity; none are identified according to functional analysis (S2 Table)."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;MTOR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTOR gene is screened for potential causative mutations which could lead to obesity; one risk allele was identified suggesting potential genetic contribution to obesity (S3 Table)."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;CYP2D6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CYP2D6 gene is screened for potential causative mutations which could lead to obesity; no pathogenic or likely pathogenic variants identified according to American College of Medical Genetics guidelines (S4 Table)."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;TUFM&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The genomic variants associated with TUFM are predicted to affect transcription factor binding sites and splicing regulation, influencing gene function and expression.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;TUFM GENOMIC VARIANTS&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The genomic variants affecting TUFM may lead to alterations in protein structure or function due to their impact on gene regulation processes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;IL1B&quot;">
      <data key="d0">"INTERLEUKIN 1, BETA"</data>
      <data key="d1">"rs7596684 is a genetic variant associated with ovarian cancer risk in combination analyses."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;PTGS1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"rs2282169 is a protein-coding gene variant associated with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;ALOX15&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No association between genetic variants at ALOX15 and ovarian cancer was observed in the study."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;CCL2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No significant association between SNPs at CCL2 and ovarian cancer was found."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL18&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"No significant associations were observed between genetic variants at IL18 and ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL6&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SNPs in IL6 did not show an association with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;OVARIAN CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Ovarian cancer is a type of cancer that occurs in women and can have various risk factors, including genetic variants such as those at IL1B rs7596684."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;HISTOLOGICAL SUBTYPE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Different histological subtypes of ovarian cancer were studied separately in the research, adjusting for potential confounders."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;DISEASE RISK&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"No association between ALOX15 genetic variants and disease risk was observed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTOR&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d1">"No significant relationship found between SNPs at CCL2 and ovarian cancer risk.")&lt;SEP&gt;"The study explores risk factors such as genetic variants Cdx-2 gene rs731236, which may influence potential relationships between dietary and lifestyle patterns with ovarian cancer risk based on meta-analysis of six subgroup studies including 784 cases and 1,248 controls.") ("entity"</data>
      <data key="d0">"OVARIAN CANCER RISK FACTORS"</data>
    </node>
    <node id="&quot;CHILDHOOD ACUTE LEUKEMIA&quot;/&quot;ALL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Childhood acute leukemia (ALL) is a disease in which we investigated genetic associations."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TEXAS CHILDREN’S CANCER CENTER&quot;">
      <data key="d0">"INSTITUTION"</data>
      <data key="d1">"Texas Children's Cancer Center participated in the recruitment of childhood ALL cases."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;2003 TO 2010&quot;">
      <data key="d0">"TIME PERIOD"</data>
      <data key="d1">"The study period was from 2003 to 2010, including a total of 118 cases."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;118 CASES&quot;">
      <data key="d0">"CASE COUNT"</data>
      <data key="d1">"A total of 118 childhood ALL cases were recruited across the study period."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;65 MALES&quot;">
      <data key="d0">"GENDER RATIO"</data>
      <data key="d1">"The recruitment included 65 males and 53 females, with a gender ratio presented."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;53 FEMALES&quot;">
      <data key="d0">"GENDER RATIO"</data>
      <data key="d1">"Female participation was also accounted for in the study population of childhood ALL cases."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;85% PARTICIPATION RATE&quot;">
      <data key="d0">"PARTICIPATION RATE"</data>
      <data key="d1">"The overall participation rate among recruited families was 85%."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;36% TRIADS&quot;">
      <data key="d0">"STUDY DESIGN ELEMENT"</data>
      <data key="d1">"Approximately one-third of the recruited families were complete triads, with minimal potential for bias."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;59 NON-HISPANIC WHITES&quot;">
      <data key="d0">"DEMOGRAPHICS"</data>
      <data key="d1">"Participants included individuals from various racial/ethnic groups: 59 non-Hispanic whites and others."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;6 NON-HISPANIC BLACKS&quot;">
      <data key="d0">"DEMOGRAPHICS"</data>
      <data key="d1">"Six participants were of non-Hispanic black ethnicity."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;46 HISPANICS&quot;">
      <data key="d0">"DEMOGRAPHICS"</data>
      <data key="d1">"Forty-six cases were Hispanic in origin."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;7 OTHERS&quot;">
      <data key="d0">"DEMOGRAPHICS"</data>
      <data key="d1">"Seven individuals belonged to other racial/ethnic groups besides white and black participants."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;128 TAGGING SNPS&quot;">
      <data key="d0">"GENETIC MARKER"</data>
      <data key="d1">"We analyzed 128 tagging SNPs of folate metabolic genes in the study on childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MTHFD2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Two SNPs were identified for MTHFD2, a gene involved in folate metabolism."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Three SNPs related to BHMT2 were investigated for genetic associations with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One SNP was identified for NOS3, another gene potentially linked to childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One SNP of SLC19A1 was also analyzed in the study on genetic links with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;POSTERIOR PROBABILITY&quot;">
      <data key="d0">"GENETIC ANALYSIS TERM"</data>
      <data key="d1">"In the final analysis, only 7 SNPs passed through initial screening criteria based on posterior probabilities greater than 0.2."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BAYES FACTORS&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Out of these, two specific SNPs had Bayes factors above one in support of their association with childhood ALL risk."&lt;SEP&gt;"Out of these, two specific SNPs had Bayes factors above one in support of their association with childhood ALL risk.") ("entity"</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FOLATE METABOLIC GENES&quot;">
      <data key="d0">"GENE GROUP"</data>
      <data key="d1">"The study focused on 128 tagging SNPs in folate metabolic genes to identify associations with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANT"</data>
      <data key="d1">"The overall study included 108 participants after exclusions for lack of genotyping consent and incomplete data."&gt;</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE CHARACTERISTICS&quot;">
      <data key="d0">"HEALTHY EATING DIET GROUP AND MEDITERRANEAN DIET GROUP"</data>
      <data key="d1">"At baseline, no significant differences were observed in age, gender, BMI or serum AA, EPA, long chain n-3 fatty acids between individuals in either of the two diet groups."&gt;</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE MEASURES&quot;">
      <data key="d0">"AA CONCENTRATION PREDICTORS"</data>
      <data key="d1">"Dietary intakes were significant predictors for baseline serum long chain n-3 concentration and colonic long chain n-3 concentration, while dietary AA intake was not predictive of either serum or colon concentrations."&gt;&gt;&lt;SEP&gt;"Greater number of minor alleles was significantly associated with lower serum AA concentration."&gt;&lt;SEP&gt;"Number of Minor Alleles was a significant predictor of serum AA concentration (p &lt; 0.001), while dietary AA intakes were not a significant predictor for either serum or colon concentrations."&gt;&gt;</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET GROUP&quot;">
      <data key="d0">"DIETARY GROUP"</data>
      <data key="d1">"The Healthy Eating diet group consisted of 54 participants who followed a dietary plan designed to reduce saturated fats and increase long chain n-3 PUFA."&gt;</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET GROUP&quot;">
      <data key="d0">"DIETARY GROUP"</data>
      <data key="d1">"The Mediterranean diet group also included 54 participants, focusing on reducing dietary intakes of SFA and increasing both MUFA and long chain n-3 PUFA as part of their intervention."&gt;&gt;</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;EXCLUSIONS PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANTS WHO WERE EXCLUDED FROM THE STUDY DUE TO LACK OF CONSENT OR INCOMPLETE GENOTYPE DATA"</data>
      <data key="d1">"A total of 9 participants did not give consent for full genotyping, while an additional 3 had incomplete genotype data and therefore could not be included in the final analysis."&gt;&gt;</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;FADS1/2 GENE CLUSTER&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No significant genotype-by-diet interactions were found for AA in serum nor EPA within the FADS1/2 gene cluster."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;SERUM FATTY ACIDS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Changes in serum fatty acids are associated with dietary interventions and genetic factors."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;COLON FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Changes in colon fatty acids are influenced by both genetic factors and dietary patterns."&lt;SEP&gt;"Long chain n-3 PUFA significantly increased in both Healthy Eating and Mediterranean groups at 6 months."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Healthy Eating diet arm showed a significant increase in colon AA concentrations compared to the Mediterranean group.") ("entity"</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;GENOTYPING SUCCESS RATE&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Genotyping success rate was between 96.7% to 98.3%, indicating high rates of successful SNP identification in the study participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIET GROUPS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Baseline Characteristics"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNORING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Snoring is identified as an issue related to sleep disturbances.")</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;MALES&quot;">
      <data key="d0">"GENDER"</data>
      <data key="d1">"Males were found to have a higher prevalence of snoring than females in the study.")</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SEX-STRATIFIED GWAS&quot;">
      <data key="d0">"RESEARCH METHOD"</data>
      <data key="d1">"The study conducted sex-stratified genome-wide association studies (GWAS) on snoring risk factors.")</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;GWAS SIGNIFICANT SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"4 genome-wide significant SNPs identified for snoring in males, 25 in females based on sex-stratified GWAS.")</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SNP HERITABILITY&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Heritability of the genetic factors influencing snoring was estimated to be around 8.77% and 12.42% for males and females respectively in sex-stratified GWAS.")</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSIS BMI ADJUSTMENT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"In sensitivity analyses, adjusting for body mass index (BMI), heritability of snoring SNPs slightly decreased for both genders: 7.72% and 10.85% respectively."]</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;CROSS-SEX GENETIC CORRELATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The cross-sex genetic correlation between males and females was reported as high, indicating consistency in the effect of identified snoring SNPs across sexes."]</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;PGS FOR SNORING&quot;">
      <data key="d0">"BIOMARKER"</data>
      <data key="d1">"A PGS (polygenic score) for snoring was derived from an independent target sample and significantly associated with recent self-reported snoring incidents."]</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;AUSTRALIAN GENETICS OF DEPRESSION STUDY AGDS&quot;">
      <data key="d0">"STUDY POPULATION"</data>
      <data key="d1">"The study used data from the Australian Genetics of Depression Study (AGDS), which includes a focus on genetic factors influencing snoring in participants."]</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;VDBP POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"VDBP SNPs are genetic variants in the VDBP gene that may affect vitamin D metabolism."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Vitamin D status of mothers and neonates is measured as total 25(OH)D levels, indicating their exposure to sunlight or supplements."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL CUT-OFFS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Cut-offs for vitamin D concentrations in newborns are used to assess their vitamin D sufficiency at birth."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;UVB EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Ultraviolet B radiation is a key factor in the synthesis of vitamin D in skin, particularly relevant for pregnant women and their newborns."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL HEIGHT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Height is one of several demographic factors that were controlled during statistical analyses to adjust for potential confounding variables."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI PRE-PREGNANCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Body Mass Index pre-pregnancy was another covariate adjusted in the study, influencing maternal vitamin D status and neonatal outcomes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;WEEKS OF GESTATIONAL AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Weeks of gestation were also controlled for, to account for potential developmental differences among newborns."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI TERMINAL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Body Mass Index terminal was used as another covariate in the study to control for weight changes during pregnancy that may affect maternal and neonatal vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;ANCOVA&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"ANOVA stands for Analysis of Covariance, a statistical method employed to compare groups on the basis of continuous variables while controlling for potential confounding effects such as age or BMI."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;COVARIATES&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Covariates are used in statistical models to adjust for factors that could influence the outcome variable and potentially confound the results."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;P VALUES&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"P values were adjusted for several covariates including maternal height, BMI pre-pregnancy, BMI terminal, UVB exposure, and weeks of gestation."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D EQUILIBRIUM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"No significant differences in the distribution or concentrations of maternal vitamin D equilibrium were observed among different genotype profiles of VDBP."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D EQUILIBRIUM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"There were no significant differences between neonatal vitamin D states, indicating similar sufficiency levels across various genetic groups.") ("entity"</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D SUFFICIENCY&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Neonatal vitamin D sufficiency at birth is assessed by measuring total 25(OH)D in newborns' blood samples."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VITAMIN D SUPPLEMENTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of vitamin supplements, particularly vitamin D, may influence the levels of maternal and neonatal vitamin D sufficiency."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;UVB SYNTHESIS OF VITAMIN D&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Ultraviolet B radiation is crucial for the synthesis of vitamin D in skin, a key factor influencing vitamin D status in both mothers and newborns."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;RS3025020&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"MAF of rs3025020 (-583T&gt;C) was higher in women with PCOS than control women (0.34 vs. 0.29; P = 9.0 × 10−4)."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;MAFS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"MAFs refer to minor allele frequencies, a measure of genetic variation in populations."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;HS-CRP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There was a positive association between carriage of the minor C allele at rs3025020 and hs-CRP, suggesting a link to inflammation in women with PCOS."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;ERYTHROCYTE SEDIMENTATION RATE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There was a negative association between presence of the minor C allele at rs2010963 and erythrocyte sedimentation rate (ESR), indicating possible differences in immune response."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FASTING INSULIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Significant increases were observed in fasting insulin levels among women carrying the rs3025020 genotypes."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;BIOACTIVE TESTOSTERONE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Increased bioactive testosterone was noted in individuals with specific VEGFA genotypes, which may impact pathways related to hormonal regulation."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;ANTI-INFLAMMATORY IL-10&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Levels of anti-inflammatory cytokine IL-10 were not correlated with the VEGFA SNPs in our study population.")</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;STRESS CONDITION VS. NO-STRESS CONDITION&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"In the Stress condition, molecular interactions such as CRHR1 SNPs contribute to reduced response bias compared to no-stress conditions for val carriers and iso homozygotes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;DIETARY PATTERN VS. FOLATE METABOLISM&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Dietary patterns influence both the intake and subsequent metabolism of key nutrients like folate, affecting physiological processes related to cardiovascular health.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;KCNJ160&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"KCNJ160 is a gene that plays a role in age at first tooth, associated with measurements indexing the width of the upper region of the face and nose."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS2520397&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs2520397 is a genomic variant associated with increased risk of hypertension."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;FAM155E–EDA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FAM155E-EDA is a gene implicated in the genetic determinants of craniofacial shape and size, recorded in ALSPAC studies."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;BMP4&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"BMP4 is a genomic variant linked to measures indexing the width of the nose and increased face width."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1951867&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs1951867 is a genomic variant associated with height at 31 years in NFBC1966 participants."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS8069452&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs8069452 is a genomic variant associated with IGF2BP1 involved in craniofacial development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;IGF2BP1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IGF2BP1 is a protein involved in the genetic determinants of age at first tooth and number of teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;MSRB3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs1976274 is associated with MSRB3, linked to craniofacial measures including nose width."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS9894411&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs9894411 is a genomic variant that shows an increase in height and prominence of the mid-brow."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1472259&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs1472259 is a genomic variant associated with BMP4, linked to craniofacial measures including nose width and number of teeth.") ("entity"</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;NFBC1966&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"NFBC1966 is a population from which height was measured at 31 years of age for genetic association studies."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS17563&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs17563 is a SNP that is located within the BMP4 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of BMP4 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"The SNP rs8178974 is a genetic variant within the GPX4 gene, associated with colorectal cancer risk."&lt;SEP&gt;"rs17563 is a SNP that is located within the BMP4 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of BMP4 expression.")</data>
      <data key="d0">"RS8178974"</data>
    </node>
    <node id="&quot;RS10740993&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs10740993 is a SNP located in the CACNB2 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of CACNB2 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4937076&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs4937076 is a SNP located in the CDON gene, which has been associated with 'number of teeth' and may influence this trait through its regulation of CDON expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1799922&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs1799922 is a SNP located in the CALU/OPN1SW gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of CALU/OPN1SW expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS997154&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs997154 is a SNP located in the AJUBA/C14orf93 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of AJUBA/C14orf93 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7924176&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs7924176 is a SNP located in the ADK gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of ADK expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS412000&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs412000 is a SNP located in the TEX14/RAD51C gene, which has been associated with 'number of teeth' and may influence this trait through its regulation of TEX14/RAD51C expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9316505&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs2804391 in the IGF2BP1 gene has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the IGF2BP1 gene.")&lt;SEP&gt;"rs9316505 is a SNP located in the DLEU7 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of DLEU7 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS17101923&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs17101923 is a SNP located in the HMGA2 region, which has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the HMGA2 region.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10932688&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs10932688 is a SNP located in the 2q35 region, which has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the 2q35 region.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS6568401&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs6568401 is a SNP located in the 6q21 region, which has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the 6q21 region.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RAD51L1&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs17105278 in the RAD51L1 locus has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the RAD51L1 locus.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9788982&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs2804391 in the KCNJ2 KCNJ160 region has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the KCNJ2 KCNJ160 region.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1458991&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs2804391 in the BMP4 gene has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the BMP4 gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2804391&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs2804391 in the FAM155E–EDA gene has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the FAM155E–EDA gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10RΑ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-10Rα is a gene that encodes for the receptor involved in the signaling of interleukin-10 (IL-10) in T cells."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NAIVE CD4+CD25−CD45RBHI T CELLS&quot;">
      <data key="d0">"T CELL SUBSET"</data>
      <data key="d1">"Naive CD4+CD25−CD45RBhi T cells are a subset of T cells that were used as recipients in the study to induce colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;RAG1-/- MICE&quot;">
      <data key="d0">"GENETIC BACKGROUND"</data>
      <data key="d1">"Rag1-/- mice are genetically engineered to lack an intact immunoglobulin locus, making them suitable for gene transfer experiments."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;CD45RBHI&quot;">
      <data key="d0">"T CELL SUBSET"</data>
      <data key="d1">"CD45RBhi indicates a high expression of the CD45RB molecule on T cells, suggesting their naïve state."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colitis is an inflammatory bowel disease that was induced in mice by transferring naive T cells into Rag1-/- recipients."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;BODY WEIGHT CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PARAMETER"</data>
      <data key="d1">"Changes in body weight were monitored to track the severity of colitis in different experimental groups."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;COLONIC HISTOPATHOLOGY&quot;">
      <data key="d0">"PHYSIOLOGICAL PARAMETER"</data>
      <data key="d1">"Changes in colon length and histopathological appearance assessed the physical damage caused by colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;T CELL INFILTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PARAMETER"</data>
      <data key="d1">"Increased T cell infiltration indicates an inflammatory response associated with colitis severity."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;CLINICAL DISEASE SEVERITY&quot;">
      <data key="d0">"DISEASE OUTCOME MEASURE"</data>
      <data key="d1">"Clinical disease severity was assessed by monitoring changes in body weight and the presence of rectal prolapse."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;SPONTANEOUS COLITIS&quot;">
      <data key="d0">"DISEASE TYPE"</data>
      <data key="d1">"Spontaneous colitis is a type of inflammatory bowel disease that occurs naturally, as observed in some genetically engineered mice used in this study."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;6-MONTH AGED MICE&quot;">
      <data key="d0">"AGING PARAMETER"</data>
      <data key="d1">"The aging and assessment of the two control groups (IL-10RαMdelRag1+/+ and IL-10Rαfl/flRag1−/−) for spontaneous colitis did not show evidence at 6 months."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NEUTROPHILS DEPLETION&quot;">
      <data key="d0">"EXPERIMENTAL TECHNIQUE"</data>
      <data key="d1">"Neutrophils were depleted using specific Abs to assess the potential impact of these cells on colitis severity.") ("entity"</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;MACROPHAGES (MΦS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Macrophages are cells that play a role in immune response and can be selectively depleted to assess the impact of IL-10 signaling on disease severity."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;MYELOID CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Myeloid cells, including macrophages and dendritic cells (DCs), have been implicated as regulators of colitis severity in T cell transfer models."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;DENDRITIC CELLS (DC)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Dendritic cells are another type of myeloid cell that can selectively be depleted to assess their role in colitis, particularly when compared with macrophages like Mϕs."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NOS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NOS1 is a gene that plays a critical role in cardiovascular health by regulating nitric oxide production."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;REGULATORY T CELL PRESENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The presence of regulatory T cells is critical for modulating inflammatory responses in cardiovascular health."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-23&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Elevated levels of IL-23 suggest that dietary factors modulate its production in response to inflammatory pathways."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;RAG1&quot;">
      <data key="d0">"GENOMIC BACKGROUND"</data>
      <data key="d1">"RAG1 is a genomic background that serves as a control for genetic variants associated with increased disease risk."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;NOS1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The NOS1 protein interacts with folate metabolism to maintain vascular function."&lt;SEP&gt;"The NOS1 protein interacts with folate metabolism to maintain vascular function."&lt;SEP&gt;"The NOS1 protein is involved in vascular function and interacts with folate metabolism for nitric oxide production."&lt;SEP&gt;3</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TH17 CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">4</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;RAG1 LOCUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6 RECEPTOR ALPHA&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">8</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;MACROPHAGES (MΦ)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">9</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6RΑ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-6 receptor alpha plays a critical role in disease protection, particularly in Rag1−/− colitis."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MΦS&quot;">
      <data key="d0">"MΦS"</data>
      <data key="d1">"IL-10Rα is expressed in Rag1−/− Mϕs, which are used to test the effects of IL-10 and anti-IL-10R antibody on pro-IL-β and mature IL-1β levels."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;PRO-IL-Β&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Pro-IL-β is a precursor protein that serves as an indicator of caspase-1 activation in Mϕs, particularly those from IL-10RαMdel RAG1−/− derived cells."&lt;SEP&gt;"Pro-IL-β is a precursor protein that serves as an indicator of caspase-1 activation in Mϕs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;MATURE IL-1Β&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Mature IL-1β is the active form of IL-1 and was undetectable in Rag1−/− cultures but elevated with anti-IL-10R Ab treatment, indicating suppression by IL-10."&lt;SEP&gt;"Mature IL-1β is the active form of IL-1 and was undetectable in Rag1−/− cultures but elevated with anti-IL-10R antibody treatment."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;CASPASE-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Caspase-1 is cleaved into its activated form (p20) upon maturation of IL-1β, used to assess caspase-1 activation in Mϕs."&lt;SEP&gt;"Caspase-1 is cleaved into its activated form (p20) upon maturation of IL-1β. Its activation in Mϕs from IL-10RαMdel RAG1−/− cells was assessed to test the effects of IL-10 and anti-IL-10R Ab treatment."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10RΑMDEL RAG1−//-DERIVED MΦS&quot;">
      <data key="d0">"MΦS"</data>
      <data key="d1">"IL-10Rα is expressed in IL-10RαMdel RAG1−/− derived Mϕs, used to test the effects of IL-10 and anti-IL-10R antibody on pro-IL-β and mature IL-1β levels."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ACTIVATED CASPASE-1 (P20)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Activated Caspase-1, specifically p20 form, is an indicator of caspase-1 activation in Mϕs. It was induced by LPS and ATP stimulation of Rag1−/− Mϕs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10RΑMDEL RAG1&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"IL-10RαMdel RAG1 plays a critical role in maintaining vascular function and is influenced by dietary patterns, particularly folate intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY T CELLS PRESENCE&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"IL-10RαMdel RAG1 plays a critical role in maintaining vascular function and is influenced by dietary patterns, particularly folate intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T CELL TRANSFER COLITIS&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"T cell transfer colitis is associated with an increased Th17 response and involves complex interactions between the immune system and dietary factors.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;RAG1 GENOMIC BACKGROUND&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"The presence of regulatory T cells in RAG1 genomic background suggests an essential role in modulating inflammatory responses and vascular health.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASED IL-10RΑMDEL RAG1−/− AND CONTROL RAG1−/− MICE">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Th17 Cell Differentiation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LP MΦS&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Th17 Cell Differentiation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Nutrient metabolism is a physiological process that interacts with the NOS1 protein to maintain vascular function."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ETHNIC BACKGROUND&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Ethnic background contributes to the diversity of microbiome composition across cohorts."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;GENETIC PROTOCOLS&quot;">
      <data key="d0">"TECHNICAL PROTOCOL"</data>
      <data key="d1">"Different genetic protocols were used across cohorts, contributing to the microbiome variation."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;DNA EXTRACTION METHOD&quot;">
      <data key="d0">"TECHNICAL PROTOCOL"</data>
      <data key="d1">"The DNA extraction method is a principal contributor to the high heterogeneity of microbial composition in different cohorts."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;SHANNON DIVERSITY INDEX&quot;">
      <data key="d0">"ALPHA DIVERSITY METRIC"</data>
      <data key="d1">"Cohort with highest Shannon diversity uses specific DNA extraction kits that are not used by other studies, potentially contributing to their outlying alpha diversities."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MICROBIOME COMPOSITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Diet is an environmental factor that influences microbiome composition across different cohorts.") (Sorry, but as a text-based AI model I cannot perform actions or access information from external databases to add missing entities.</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM&quot;">
      <data key="d0">"MICROBIOTA ABUNDANCE"</data>
      <data key="d1">"Bifidobacterium, a bacterial species regulated by the LCT gene, plays a role in gut microbiota abundance and composition.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GENETIC VARIANT&quot;">
      <data key="d0">"HERITABILITY OF MICROBIAL ABUNDANCE"</data>
      <data key="d1">"A genomic variant associated with gut microbes shows significant heritability across tested taxa.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GWAS ASSOCIATION&quot;">
      <data key="d0">"MBBTL MAPPING OF MICROBIAL PRESENCE/ABSENCE"</data>
      <data key="d1">"Ten loci were found to be associated with presence or absence of bacterial taxa through mbBTL mapping, including one taxon showing two independent mbBTLs.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GWAS META-ANALYSIS EFFECTIVENESS&quot;">
      <data key="d0">"BIFIDOBACTERIUM ABUNDANCE AND GWAS META-ANALYSIS EFFECTIVENESS"&gt;</data>
      <data key="d1">"The remaining loci in the Bifidobacterium abundance study show functionally relevant variants that support earlier studies, with overall concordance showing strong heritability across microbial taxa.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MBQTL MAPPING ANALYSIS&quot;">
      <data key="d0">"MBQTL MAPPING ANALYSIS DETAILS AND ITS ROLE IN MICROBIAL ABUNDANCE STUDY"&gt;</data>
      <data key="d1">"The mbQTL mapping analysis included 18,340 samples and identified genetic variants that mapped to 20 distinct loci associated with the abundance of bacterial taxa within gut microbiota.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MBBTL MAPPING RESULTS&quot;">
      <data key="d0">"MBBTL MAPPING FOR MICROBIAL PRESENCE/ABSENCE STUDY DETAILS"&gt;</data>
      <data key="d1">"The mbBTL mapping covered 177 taxa and identified 10 loci related to presence or absence of bacteria in the gut microbiota, including one taxon showing two independent mbBTLs.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GENETIC LOCUS FOR BIFIDOBACTERIUM ABUNDANCE MODIFIER GENE&quot;&gt;">
      <data key="d0">"LCT AS A GENETIC LOCUS RELATED TO MICROBIAL ABUNDANCE AND ITS IMPACT ON DIETARY PATTERNS"&gt;</data>
      <data key="d1">"The genetic locus at 2q21.3, including the LCT gene which was previously associated with milk products intake in individuals homozygous for the low-function LCT haplotype, may be a modifier of Bifidobacterium abundance based on its genome-wide significant mbTLs.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Personalized therapies are being explored for their role in managing cardiovascular health, including the NOS1 gene and dietary patterns.") ("entity"</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;DIETARY PREFERENCES&quot;">
      <data key="d0">"NUTRIENT PHENOTYPES"</data>
      <data key="d1">"No impact of genetic variants on microbial taxa variability was identified in relation to dietary preferences and nutrient phenotypes."&gt;8) ("entity"</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;LCT GENE&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The LCT gene, found on chromosome 2 near other protein-coding genes, is associated with regulating the abundance of Bifidobacterium in the gut microbiota.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MILK PRODUCTS INTAKE&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"Individuals homozygous for the low-function LCT haplotype show positive correlation with milk products intake, suggesting gene-diet interaction regulates Bifidobacterium abundance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HERITABILITY CORRELATION&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"A significant correlation between SNP-based meta-analysis results shows strong heritability across tested taxa, with some loci showing significant correlations (R=0.244).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANT CORRELATION ACROSS TESTED TAXA AND HERITABILITY SIGNIFICANCE&quot;&gt;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"A significant correlation between SNP-based meta-analysis results shows strong heritability across tested taxa, with some loci showing significant correlations (R=0.244).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ETHNICITY AND AGE HETEROGENEITY&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The strongest association signal for variants located at 2q21.3 shows evidence of ethnicity and age heterogeneity across cohorts, particularly among children contributing to detected heterogeneity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIANTS LOCATED AT 2Q21.3 SHOW ETHNICITY AND AGE HETEROGENEITY IN BIFIDOBACTERIUM ABUNDANCE&quot;&gt;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The strongest association signal for variants located at 2q21.3 shows evidence of ethnicity and age heterogeneity across cohorts, particularly among children contributing to detected heterogeneity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fetal Alcohol Syndrome is a disease related to prenatal exposure to alcohol."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PFAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"PFC-related disorders, also known as PFAS, are diseases linked to prenatal exposure to polychlorinated fluorinated compounds."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;FASD DIAGNOSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Diagnoses of Fetal Alcohol Spectrum Disorders (FASDs) were made in infants across both the FAS and PFAS groups."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE ARM&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Infants included in the choline arm had higher rates of FAS and PFAS diagnoses compared to those in the placebo arm."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PLACEBO ARM&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Infants in the placebo arm showed a lower rate of FAS and PFAS diagnoses than those in the choline arm."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;Χ² TEST RESULT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The χ² test result (p=0.393) indicates no significant difference between the rates of FAS and PFAS diagnoses among infants, supporting previous studies."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;RS12325817 VARIANT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Infants with a variant in the PEMT gene (rs12325817) had lower choline intake during pregnancy and were more likely to be diagnosed with FAS or PFAS disorders."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PEMT ENZYME&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The rs12325817 variant in the PEMT enzyme reduces endogenous choline synthesis, affecting dietary requirements for affected infants."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE SUPPLEMENTS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Three infants received choline supplements and three were given placebos; both groups showed varying levels of maternal choline intake during pregnancy."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;DIETARY CHOLINE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Only a small percentage of infants had adequate dietary choline intake, with none exceeding the UL (3.5 g/day) for choline."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;ADEQUATE DIETARY CHOLINE INTAKE CRITERIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Few mothers met the criteria for adequate dietary choline intake during pregnancy, which is critical to prevent FASDs."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;INFANT AFFECTED BY ALCOHOL OR PFAS&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"Infants affected by alcohol or PFAS during prenatal development."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;MOTHER CONSUMING ADEQUATE DIETARY CHOLINE&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"Mothers who consume adequate dietary choline are less likely to have infants with FASDs."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE UPPER LIMIT (UL)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The upper limit for choline intake is set at 3.5 g/day to prevent adverse effects."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"Maternal dietary choline status was only found in 9.7%, which is low for both treatment and placebo groups."|&gt;1) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;NFG GROUP&quot;">
      <data key="d0">"NUTRITIONAL FASTING GROUP"</data>
      <data key="d1">"The NFG group was designated as the control group in the study."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;IFG GROUP&quot;">
      <data key="d0">"IMPAIRED FASTING GLUCOSE GROUP"</data>
      <data key="d1">"IFG group showed significantly negative correlation with multiple alleles."|&lt;SEP&gt;"The IFG group is classified as dependent variables in the logistic regression analysis."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IGT GROUP&quot;">
      <data key="d0">"IMPAIRED GLUCOSE TOLERANCE GROUP"</data>
      <data key="d1">"IGT group also showed significant negative association with the multiple alleles."&lt;SEP&gt;"The IGT group is classified as dependent variables in the logistic regression analysis."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;T2DM GROUP&quot;">
      <data key="d0">"TYPE 2 DIABETES MELLITUS GROUP"</data>
      <data key="d1">"The T2DM group demonstrated a strong correlation with these multiple alleles."&lt;SEP&gt;"The T2DM group is also classified as dependent variables in the logistic regression analysis."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;ALLELIC FREQUENCIES OF (CA)16 AND (CA)17&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The allelic frequencies of (CA)16 were significantly lower than that of (CA)17, indicating a potential genetic association with glucose dysregulation in the IFG, IGT, and T2DM groups."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;(CA)N POLYMORPHISMS OF GRK5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The PIC values for the rs10886471 (CA)n alleles showed genetic polymorphism in all four groups, with an average value above 0.5 which supports the involvement of these polymorphisms in glucose dysregulation."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;CLINICAL PARAMETERS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The clinical parameters significantly differed between the four groups including waist circumference, BMI, SBP, DBP, FPG, and 2 h PG.") ("entity"</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;BODY MASS INDEX (BMI)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Increased BMI was observed in the study groups indicating overweight or obesity, which are risk factors for several chronic diseases including T2DM."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;SYSTOLIC BLOOD PRESSURE (SBP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Significant differences between groups indicated increased SBP, a marker of hypertension and cardiovascular disease risk."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;DIASTOLIC BLOOD PRESSURE (DBP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Significant differences in DBP were also observed across the study groups, indicating higher blood pressure which is linked to several adverse health outcomes."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"FPG levels increased significantly with disease progression from NFG to T2DM, consistent with impaired glucose regulation leading to prediabetes and diabetes."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;POSTPRANDIAL BLOOD GLUCOSE (2 H PG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Significant differences in 2 h PG were observed across groups indicating increased postprandial glucose levels which is a risk factor for T2DM development."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;NGF GROUP&quot;">
      <data key="d0">"CONTROL GROUP"</data>
      <data key="d1">"The NFG group serves as control and was not exposed to any abnormal glycemic conditions during the study period."&lt;SEP&gt;"The NFG group was designated as the control group in this study."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;ALLELES&quot;">
      <data key="d0">"MULTIPLE ALLELE"</data>
      <data key="d1">"All alleles without (CA)16 were classified as one multiple allele, including (CA)15, (CA)17, (CA)18, and (CA)19."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)16 ALLELE&quot;">
      <data key="d0">"REFERENCE ALLELE"</data>
      <data key="d1">"The (CA)16 allele was used as a reference in this study."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;T2DM&quot;">
      <data key="d0">"TYPE 2 DIABETES MELLITUS"</data>
      <data key="d1">"People with T2DM have a higher than normal blood glucose level, which can lead to serious health complications if left untreated."]()</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;MULTIPLE ALLELES&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"There was a significant negative correlation between the multiple alleles and IFG risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLORECTAL TUMOR RISK&quot;">
      <data key="d0">"INVERSE ASSOCIATION"</data>
      <data key="d1">"There is an inverse association between serum selenium levels and colorectal tumor risk."]</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SERUM SELENIUM LEVELS&quot;">
      <data key="d0">"COLORECTAL TUMOR RISK"</data>
      <data key="d1">"Inverse Association Between the Two Indicates Protective Effect"&gt;&gt;0.81</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLON CANCER RISK&quot;">
      <data key="d0">"RISK FACTOR ANALYSIS"</data>
      <data key="d1">"There is an association between higher serum selenium levels and reduced risk of colon cancer. This supports the protective effects of selenium against this disease."]</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;RECTAL CANCER RISK&quot;">
      <data key="d0">"RISK FACTOR ANALYSIS"</data>
      <data key="d1">"Similar to colon cancer, there are indications that higher serum selenium levels may be linked to a lower risk of rectal cancer."&gt;&gt;4</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;GPX4 GENE&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"The GPX4 gene contains a genomic variant linked to colorectal tumor risk, likely affecting selenium metabolism. This suggests a role for genetic factors in selenium's protective effects against colorectal cancer."]</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SELENIUM METABOLISM&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"The GPX4 gene contains a genomic variant linked to colorectal tumor risk, likely affecting selenium metabolism. This suggests a role for genetic factors in selenium's protective effects against colorectal cancer."]</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLORECTAL CANCER RISK REDUCTION &quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"Higher serum selenium levels are associated with a lower risk of colorectal cancer, supporting an inverse relationship between these factors."]</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9−/− MICE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Card9 deficient mice are disease models used to study IBD, linking CARD9 polymorphisms with colitis susceptibility."&lt;SEP&gt;"Card9−/− mice are more susceptible to colitis and have impaired recovery compared to wild-type mice, indicating a potential role in modulating intestinal healing processes."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;DEXTRAN SULFATE SODIUM (DSS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"DSS is a known trigger for colitis in mice, affecting gut microbiota composition and intestinal healing processes.")</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;APOPTOSIS&quot;">
      <data key="d0">"COLITIS"</data>
      <data key="d1">"Impaired recovery also involved increased apoptosis, indicating an imbalance within the cells of the intestinal tract that may contribute to colitis susceptibility in Card9−/−→GF mice."&lt;SEP&gt;"Increased apoptosis was seen in intestinal cells of Card9−/− mice compared to WT mice during DSS-induced colitis, which may contribute to impaired healing and inflammation.")</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;INTERLEUKIN 1BETA (IL1B)&quot;">
      <data key="d0">"COLITIS"</data>
      <data key="d1">"Expression of Il1b was also upregulated in Card9−/− mice during DSS-induced colitis, suggesting an involvement in the inflammatory response to gut injury.")</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL-22&quot;+ CELLS&quot;">
      <data key="d0">"COLITIS"</data>
      <data key="d1">"Decreased IL-22+ cells were observed in intestinal lamina propria of Card9−/− mice during DSS-induced colitis, suggesting a potential protective role for CARD9 and its effector IL-22 in the modulation of gut inflammation.")</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CD3−CD4−NKP46− CELLS&quot;">
      <data key="d0">"COLITIS"</data>
      <data key="d1">"Decreased CD3−CD4−NKp46− cells were observed in colonic tissues of Card9−/− mice during DSS-induced colitis, which may contribute to the overall inflammatory response and impaired recovery seen in these mice.")</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;MICROBIOTA FUNGI&quot;">
      <data key="d0">"CARD9−/− MICE"</data>
      <data key="d1">"Susceptibility to Colitis"</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;MICROBIOTA BACTERIAL&quot;">
      <data key="d0">"CARD9−/− MICE"</data>
      <data key="d1">"Susceptibility to Colitis"</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3B GENE&quot;">
      <data key="d0">"COLITIS"</data>
      <data key="d1">"Expression of Reg3b was found to be upregulated in Card9−/− mice during DSS-induced colitis, indicating its involvement in gut inflammatory responses and potential protective mechanisms against tissue injury.")</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL17A GENE&quot;">
      <data key="d0">"COLITIS"</data>
      <data key="d1">"Expression of Il17a was upregulated in Card9−/− mice during DSS-induced colitis, indicating a potential role in the inflammatory response to gut injury and impaired recovery mechanisms seen in these mice.")</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;ADLERCREUTZIA GENUS&quot;">
      <data key="d0">"MICROBIOTA FUNGI"</data>
      <data key="d1">"Card9−/− Mice"</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;ACTINOBACTERIA PHYLUM&quot;">
      <data key="d0">"MICROBIOTA BACTERIAL"</data>
      <data key="d1">"Card9−/− Mice"</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;MICROBIOTA TRANSFER&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The experiment involved colonizing germ-free mice with the microbiota of either WT or Card9−/− mice and observing their susceptibility to colitis, suggesting a direct link between microbiota transfer and gut health."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;GERM-FREE MICE&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Germ-free mice were used as experimental models in this study to assess the impact of microbiota on gut health."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DSS (DEXTRAN SODIUM SULFATE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DSS was used as a model for inducing colitis, highlighting its role as an environmental factor influencing gut health and disease development."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;EPITHELIAL CELL PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The impaired recovery in Card9−/−→GF mice is associated with decreased epithelial cell proliferation, indicative of a disrupted physiological process affecting gut homeostasis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;ADLERCREUTZIA (GENUS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Alterations were observed at baseline in Adlercreutzia, a genus associated with gut microbiota composition and dietary influences such as specific nutrients intake."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;LACTOBACILLUS REUTERI&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lactobacillus reuteri was noted to be decreased in Card9−/− mouse microbiota at baseline, potentially indicative of altered nutrient uptake or metabolism associated with gut health and disease states."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;MICROBIOTA FUNGUS LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In Card9−/− mice, a positive correlation between bacterial and fungal biodiversity was observed in the gut ecosystem, suggesting abnormal interactions possibly impacting gut homeostasis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTER-KINGDOM RELATIONSHIP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The microbiota analysis revealed an inter-kingdom relationship with potential competition or cooperation between bacteria and fungi that may influence gut homeostasis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;REG3G (GENE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Reduced expression of Reg3g was observed in Card9−/−→GF mice, indicating a possible nutrient-related response associated with the disease susceptibility seen in these mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL22 (GENE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The study identified reduced Il22 levels as one mechanism contributing to the impaired recovery of Card9−/−→GF mice during DSS-induced injury, suggesting a nutrient-related response that may underlie their increased susceptibility to colitis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL22 (PROTEIN)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The reduced Il22 levels were confirmed in the colon and mesenteric lymph nodes of Card9−/−→GF mice, indicating a specific impairment in IL-22 production as part of an innate antimicrobial response."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL-6 (PROTEIN)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"No differences in IL-6 levels were observed between WT and Card9−/−→GF mice at baseline, suggesting that the IL-22 axis is specifically impaired without a compensatory mechanism involving other cytokines."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL-17A (PROTEIN)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No differences in Il17a expression were detected between WT and Card9−/−→GF mice at different time points, suggesting that the observed defect is not related to IL-17 production."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DEFENSIN BETA 1 (PROTEIN)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"No differences in defensin beta 1 expression were found between WT and Card9−/−→GF mice at different time points, further supporting that the observed defect is specific to IL-22 production."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;NATURAL KILLER CELLS (CELLS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"IL-22 was identified as a factor in gut homeostasis and innate antimicrobial resistance, with reduced levels found in Card9−/−→GF mice indicating an impaired response associated with their disease susceptibility."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DENDRITIC CELLS (CELLS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Intestinal dendritic cells were explored for potential differences in stimulating IL-22-producing cells, but no significant variations between Card9−/−→GF and WT→GF mice were observed."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;MACROPHAGES (CELLS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Similarly, macrophages did not show any differences that could explain the specific defect in IL-22 production by intraepithelial γδ T cells as reported in Supplementary Figs. 8 and 9."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL-17 (PROTEIN)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The absence of differences in IL-17A expression between WT and Card9−/−→GF mice at different time points supports that the observed defect is not related to common inflammatory pathways involving IL-17."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL-22 (PROTEIN)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The reduced Il22 amounts found in Card9−/−→GF mice suggest a gut-limited defect specifically affecting IL-22, not related to the levels of other cytokines such as IL-6 and IFN-γ which were unchanged.") ("entity"</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;CELL TYPE&quot;">
      <data key="d0">"INTESTINAL DENDRITIC CELLS AND MACROPHAGES"</data>
      <data key="d1">"No differences were observed between Card9−/−→GF and WT→GF mice.") ("entity"&lt;SEP&gt;"Play a role in stimulating IL-22 producing cells via IL-23 production in Card9−/−→GF mice."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IL-22&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"IL-22 is required for the production of AHR ligands by the microbiota."&lt;SEP&gt;"Interleukin-22 (IL-22) is a nutrient involved in regulating AHR ligand production and colitis susceptibility."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CARD9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CARD9 is a gene associated with colitis susceptibility via impaired tryptophan metabolism and defective AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AHR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"AHR is involved in the regulation of AHR ligands by the gut microbiota."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Impaired tryptophan metabolism leads to defective AHR activation and colitis susceptibility."&lt;SEP&gt;"Tryptophan metabolism is a physiological process involved in modulating AHR ligand production and disease susceptibility."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;KYN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Increased levels of Kyn in fecal samples from patients with IBD indicate impaired tryptophan metabolism."&lt;SEP&gt;"Kyn, an increased level found in fecal samples from individuals with IBD, indicates impaired tryptophan metabolism."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IDO1&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Immunocompetent cells in the gut may use tryptophan to produce Kyn via IDO1, leading to defective AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IAA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Isovalerate (IAA) was found to be decreased in fecal samples from individuals with IBD, suggesting a broader impact on tryptophan metabolism and disease susceptibility."&lt;SEP&gt;"Levels of IAA were found to be decreased in fecal samples from individuals with IBD, suggesting impaired tryptophan metabolism."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CROHN'S DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Crohn’s disease is associated with reduced AHR activation and increased levels of Kyn."&lt;SEP&gt;"Crohn’s disease is characterized by reduced AHR activation and increased levels of Kyn."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Similar patterns were observed in ulcerative colitis, indicating a broader relevance to IBD pathogenesis."&lt;SEP&gt;"Ulcerative colitis also shows decreased AHR activation and higher levels of tryptophan metabolites like IAA."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;TRYPTOPHAN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Levels of tryptophan were found to be lower in fecal samples from individuals with IBD, suggesting impaired metabolism."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;FECAL SAMPLES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Fecal samples from healthy subjects are indicative of greater AHR activation compared to those from patients with IBD."&lt;SEP&gt;"Fecal samples from healthy subjects showed greater AHR activation compared to those from patients with IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AHR AGONIST&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"An AHR agonist can effectively counter defects in AHR activity and tryptophan metabolism."&lt;SEP&gt;"An AHR agonist is a potential intervention that may counter the defects in tryptophan metabolism and colitis susceptibility."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IDO1 ENZYME&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"IDO1 enzyme is involved in the conversion of tryptophan to Kyn, leading to defective AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;REGENERATING ISLET-DERIVED 3 GAMMA (REG3G)&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"Expression of Reg3g was increased in intestinal epithelial cells of Card9−/− mice during DSS-induced colitis, potentially playing a role in modulating gut inflammation and healing.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9 GENE&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"CARD9 modulates the expression and localization of IL-22+ cells involved in gut inflammation during DSS-induced colitis, suggesting a potential mechanism by which CARD9 influences susceptibility to inflammation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NITRIC OXIDE SYNTHASE (NOS)&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">"NOS1 Protein"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;COLITIS SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The gut microbiota of Card9−/− mice contributes to susceptibility to colitis by altering the IL-22 signaling pathway via impaired tryptophan metabolism, leading to reduced AHR activation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AHR ACTIVATION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Fecal metabolites from individuals with IBD showed lower ability to activate AHR compared to healthy subjects, indicative of impaired tryptophan metabolism and defective AHR signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FECAL METABOLITES&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Fecal metabolites from individuals with IBD showed lower ability to activate AHR compared to healthy subjects, indicative of impaired tryptophan metabolism and defective AHR signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AHR ACTIVATION BY MICROBIOTA DERIVED METABOLITES&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The risk allele associated with CARD9 was found to be linked with reduced AHR activation by microbiota-derived metabolites, suggesting a connection between genetic variation and impaired AHR signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9 RS10781499 ALLELE&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The risk allele associated with CARD9 was found to be linked with reduced AHR activation by microbiota-derived metabolites, suggesting a connection between genetic variation and impaired AHR signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9 GENE POLYMORPHISM&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The IBD-associated CARD9 SNP was associated with reduced AHR activation in vitro, indicating a potential link between genetic variants and human disease susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBD SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The IBD-associated CARD9 SNP was associated with reduced AHR activation in vitro, indicating a potential link between genetic variants and human disease susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL AGE AT DELIVERY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Maternal age at delivery is a race/ethnicity factor that influences pregnancy outcomes including folate metabolism and the risk for cardiovascular disease."&lt;SEP&gt;"Maternal age at delivery is an environmental factor that influences pregnancy outcomes, including those linked to folate metabolism and the NOS1 gene."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;FOLATE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Folate intake is a nutrient that influences folate metabolism and has been linked to risk for cardiovascular disease through interactions with the NOS1 gene."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;NON-HISPANIC WHITE MOTHERS&quot;">
      <data key="d0">"RACE/ETHNICITY"</data>
      <data key="d1">"Non-Hispanic White mothers are a race/ethnicity that has been associated with maternal age at delivery and educational level."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;FOLATE METABOLISM PHYSIOLOGICAL PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Folate metabolism is a physiological process that interacts with the NOS1 protein and contributes to cardiovascular health."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;NUTRIENT FOLATE IN FOODS FOUND IN LEAFY GREENS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Leafy greens are a food source rich in folate, which is an important nutrient for cardiovascular health interactions with the NOS1 gene."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY LEVEL OF MOTHERS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Physical activity level of mothers is a lifestyle factor that further modulates cardiovascular health, including interactions with the NOS1 gene and its related pathways."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFR SNPS&quot;">
      <data key="d0">"GENETIC VARIANT TYPE"</data>
      <data key="d1">"MTHFR is a type of genetic variant related to folate intake and risk for neural tube defects (NTDs)."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNP RS669340 CG&quot;">
      <data key="d0">"GENETIC VARIANT TYPE"</data>
      <data key="d1">"SHMT1 is a type of genetic variant associated with risk for neural tube defects (NTDs) when considering maternal factors and specific genotypes."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;TYMS SNPS RS502396 AND RS699517&quot;">
      <data key="d0">"GENETIC VARIANT TYPE"</data>
      <data key="d1">"TYMS is a type of genetic variant related to folate metabolism and risk for neural tube defects (NTDs)."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;T2D PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T2D is a disease characterized by insulin resistance and impaired glucose tolerance."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;INDIVIDUALS WITH NORMAL GLUCOSE TOLERANCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Normal glucose tolerance indicates individuals without T2D but may still be at risk for developing the condition."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;GLUCOSE TOLERANCE TEST&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The glucose tolerance test measures how well an individual's body can process glucose, indicating their risk of developing diabetes over time."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;SEX&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Sex is one of several environmental factors affecting the distribution of diseases like T2D across population groups."&lt;SEP&gt;"There are sex-based differences in alcohol consumption and associated physiological processes (genetic polymorphisms), as indicated in the study population's characteristics."&lt;SEP&gt;"The study included both males (HIV-infected individuals) and females (healthy controls), though the demographic profile did not detail how many of each were enrolled."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;INTER99 COHORT&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Inter99 cohort refers to a group of individuals studied for understanding risk factors related to diabetes, including genetics and lifestyle habits."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;STENO DIABETES CENTER&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"The Steno Diabetes Center recruits participants who are part of studies aimed at identifying genetic and environmental determinants of disease development."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;RS10399931 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs10399931 is a genomic variant that was studied for its association with T2D risk in the Inter99 cohort, showing no significant association after adjustment for environmental factors."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;RS4950928 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs4950928 is another genetic variant investigated for its relationship to T2D among individuals with normal glucose tolerance in the Steno Diabetes Center studies."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;SERUM C-PEPTIDE CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"C-peptide levels are markers of insulin production and can indicate pancreatic function, which is relevant for understanding diabetes risk factors such as T2D.") ("entity"</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Impaired glucose tolerance (IGT</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;AMD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"AMD is a disease that affects the macula and can result in vision loss."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;ARMS2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ARMS2 is a gene associated with age-related macular degeneration (AMD)."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;COMPLEMENT PATHWAY GENES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant in Complement Pathway Genes"</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;C3 GENE RS2230199&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"C3 Genomic Variant"</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;CFI GENE RS10033900&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CFI Genomic Variant"</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;HEALTHY LIFESTYLE SCORE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A healthy lifestyle score is associated with reduced odds for AMD among women in the subsample assessed."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;AMD RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Age-related macular degeneration (AMD) is influenced by genetic and environmental factors, including lifestyle scores and genotypes within genes like ARMS2 and C3/CFI."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;PARTICIPANT&quot;">
      <data key="d0">"PARTICIPANTS"</data>
      <data key="d1">"Involved as participants in a study on coffee consumption, which aimed to examine its relation with type 2 diabetes and prediabetes risk."&gt;&lt;SEP&gt;"Involved in a study on coffee consumption, which aimed to investigate its association with risk of prediabetes and type 2 diabetes. The study involved 4054 participants."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d0">"HABITUAL COFFEE CONSUMPTION"</data>
      <data key="d1">"Examined the association between genetic polymorphisms and habitual coffee consumption in a study population of 4054 participants."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;CAFFEINE INTAKE&quot;">
      <data key="d0">"HABITUAL COFFEE CONSUMPTION"</data>
      <data key="d1">"Conducted a GWAS for continuous caffeine intake alongside habitual coffee consumption. Identified 18 significant SNPs associated with both forms of coffee consumption."&gt;</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;TABLE 1, TABLE 3 &amp; TABLE 4&quot;">
      <data key="d0">"BASELINE CHARACTERISTICS OF STUDY POPULATION"</data>
      <data key="d1">"Tables used in the analysis to present baseline characteristics of participants involved in the study regarding demographic and lifestyle factors. These tables provide context for understanding how different groups may influence subsequent results."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;STUDY POPULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Consisted of the total number of people who took part in the research analyzing habitual coffee consumption's impact on health outcomes like type 2 diabetes and prediabetes."&gt;&lt;SEP&gt;"This study included a total of 1026 individuals, including 699 males and 507 females, from an elderly Beijing community-dwelling population."&lt;SEP&gt;"The population studied consisted of 322 ovarian cancer patients treated with paclitaxel-carboplatin combination therapy or carboplatin mono-therapy."|</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;SENP1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SENP1 gene is involved in inflammation and diabetes, with a specific focus on its function within adipocytes. "&gt;1</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC DELETION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the SENP1 gene was linked to increased risk of hypertension."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SENP1 protein is involved in inflammation and diabetes, with specific focus on its function within adipocytes."&gt;3</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOQ GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the Adipoq gene has been linked to increased risk of hypertension."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PDGFRΑ PROMOTER&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the PdgfRα gene is involved in inflammation and diabetes, specifically within adipocytes."&gt;4</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPONECTIN GENE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Adiponectin is an environmental factor that influences inflammation and diabetes, particularly in relation to the SENP1 protein in adipocytes."&gt;5</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SENP1 is a gene involved in regulating inflammation and insulin resistance, playing a critical role in diabetes progression."&lt;SEP&gt;"SENP1 is a gene involved in regulating the activation of NF-κB and cytokine production in adipocytes. It has been found to deSUMOylate NEMO, which plays a critical role in activating the IKK-NF-κB signaling pathway."&lt;SEP&gt;"SENP1 is a gene that plays a role in type-1-like diabetic phenotypes."&lt;SEP&gt;3</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;ADIPOQKO&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"AdipoqKO mice are involved in the development of insulin-dependent diabetes mellitus due to immune cell invasion."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;PDGFRKO&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PdgfRKO proteins are associated with the disruption of pancreatic islet structures in SENP1-deficient mice."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;AP2KO&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"aP2KO mice demonstrate autoimmune mediated damages to insulin-producing β cells."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;INSULIN-DEPENDENT DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Insulin-dependent diabetes mellitus is caused by T-cell-mediated destruction of pancreatic islet β cells."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;PANCREATIC ISLETS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The structures of pancreatic islets are disrupted in SENP1-deficient mice due to autoimmune responses."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;HYPERGLYCAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"SENP1-deficient mice show increased levels of CRP and β-hydroxybutyrate, indicative of diabetes onset."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;KETONES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Beta-hydroxybutyrate is a ketone produced in the body when glucose absorption is lost."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CRP (C-REACTIVE PROTEIN)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CRP levels are higher in individuals with diabetes, aiding diagnosis and monitoring of disease progression."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;IAA (INSULIN AUTOANTIBODY)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"SENP1-deficient mice have increased levels of IAA, a marker for autoimmune mediated damage to β cells."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;MHCII+CD11B+CD11C− MACROPHAGES&quot;">
      <data key="d0">"IMMUNE CELL POPULATION"</data>
      <data key="d1">"Macrophages are markedly increased in the pancreases of SENP1-aP2KO mice, indicating an inflammatory response."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;REGULATORY T-CELL SUBSET (CD4+CD25+FOXP3+)&quot;">
      <data key="d0">"IMMUNE CELL POPULATION"</data>
      <data key="d1">"In SENP1-aP2KO mice, the regulatory T-cell subset decreases while effector T-cell subsets expand concomitantly."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;DENDRITIC CELLS&quot;">
      <data key="d0">"IMMUNE CELL POPULATION"</data>
      <data key="d1">"Activated dendritic cells are observed in the lymph nodes of pancreases, indicating an ongoing inflammatory response."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;NPV7+ CD8+ T CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"NPV7+ CD8+ T cells target islet-specific antigens in SENP1-deficient mice."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;NAPRO-V7 PEPTIDE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"NaPro-V7 peptide, targeted by NPV7+ CD8+ T cells, suggests an autoimmune response involving specific antigen recognition."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;SENP1-ADIPOQKO&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"AdipoqKO and SENP1-deficient mice are involved in autoimmune mediated damages to insulin-producing β cells."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;SENP1-PDGFRKO&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PdgfRKO proteins are associated with the severe disruption of pancreatic islet structures in SENP1-aP2KO, AdipoqKO and PdgfROKO mice."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;NRP-V7-POSITIVE CD8+ T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">1</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PEPTIDE&quot;">
      <data key="d0">"PEPTIDE"</data>
      <data key="d1">2</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;AP2 KNOCKOUT (AP2KO)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">4</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PEPTIDE (PAT)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;IL-6&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">6</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TNF-Α&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Tumor necrosis factor-alpha (TNF-α) is another proinflammatory cytokine that was found to be significantly higher in adipocytes with SENP1 knockdown."&lt;SEP&gt;7</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IL-1Β&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">8</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;IFN-Γ&quot;">
      <data key="d0">"INTERFERON-GAMMA"</data>
      <data key="d1">"IFN-γ is a gene involved in T-cell proliferation and immune response."&lt;SEP&gt;"Interferon-gamma is a cytokine that was not detected in proinflammatory cytokines from adipocytes with SENP1 knockdown, indicating differences in inflammatory responses."&lt;SEP&gt;9&lt;SEP&gt;"The average relative gene expression of IFN-γ in CD subjects with certain alleles was significantly higher than those without similar SNPs."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE (CVD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">10</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;INSULIN DEFICIENCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">11</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC Β CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">12</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISEASE&quot;">
      <data key="d0">"DISEASE TERM"</data>
      <data key="d1">13</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;T1DM (TYPE 1 DIABETES MELLITUS)&quot;">
      <data key="d0">"DISEASE TERM"</data>
      <data key="d1">14</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES (IL-6, TNF-Α, IL-1Β)&quot;">
      <data key="d0">"CYTOKINE TERM"</data>
      <data key="d1">15</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLET MACROPHAGES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">16</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ADIPOSE TISSUE (PATS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">17</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCR5 LIGAND (CCL5)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">18</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCL2, CCL21, CXCL19, CXCL10&quot;">
      <data key="d0">"CHEMOKINE TERM"</data>
      <data key="d1">19</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CARDIAC MYOCARDITIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">20</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCL5 EXPRESSION IN ISLETS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">21</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLET Β CELLS (INSULIN-PRODUCING CELLS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">22</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CHEMOKINE EXPRESSION (CCL5, CCL2, CCL21, CXCL19, CXCL10)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">23) ("entity"</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;SPLEEN (BODY OF SPLEEN)&quot;">
      <data key="d0">"ORGAN SITE"</data>
      <data key="d1">25</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLETS OF LANGERHANS (PANCREATIC ISLETS)&quot;">
      <data key="d0">"ORGAN SITE"</data>
      <data key="d1">26</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CARDIAC FUNCTION (HEART FUNCTION)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">27</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;VASCULAR REACTIVITY (BLOOD VESSEL REACTIVITY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">28</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CYTOKINE SECRETION (CYTOKINES IN BODY FLUIDS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">29</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CHEMOKINE SECRETION FROM ADIPOSE TISSUE (PATS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">30</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLET MACROPHAGES FUNCTION (MACROPHAGE FUNCTION IN ISLETS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">31</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CHEMOKINE RECRUITMENT OF IMMUNE CELLS TO INFLAMMATION SITES OR AUTOIMMUNE TARGETS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">32</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;NEMO&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NEMO is an IKK subunit that can be SUMOylated at K277 and K309, critical for activating the IKK-NF-κB signaling pathway."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NF-ΚB P65/RELA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NF-κB p65/RelA is a protein that can be phosphorylated in response to stress responses such as oxidative stress, inflammatory stimuli and DNA damage."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IΚBΑ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IκBα is an inhibitor of NF-κB that becomes degraded when the IKK-NF-κB signaling pathway is activated, allowing for nuclear translocation of NF-κB p65/RelA."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SENP2 is another gene involved in regulating NF-κB activation and cytokine production. It can efficiently deSUMOylate NEMO, as reported in a 293T overexpression system."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NF-ΚB SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The NF-κB signaling pathway is involved in stress responses such as oxidative stress, inflammatory stimuli and DNA damage."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SUMOYLATED NEMO&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"SUMOylated NEMO plays a critical role in activating the IKK-NF-κB signaling pathway. It has been found that SENP1 can deSUMOylate NEMO, enhancing NF-κB activation and cytokine production."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;ADIPOCYTES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Adipocytes are cells found in fat tissue that play a key role in energy storage and inflammation in the context of diabetes."&lt;SEP&gt;"Adipocytes are cells in adipose tissue involved in the regulation of inflammatory responses through the NF-κB signaling pathway."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;INFLAMMATORY CYTOKINES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Proinflammatory cytokines such as IL-6, TNF-α and IL-1 β are involved in inflammation and have been found to be significantly higher in adipocytes with SENP1 knockdown (SENP1-AdipoqKO)."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP1-AP2KO MICE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The gene expression of proinflammatory cytokines (IL-6, TNF-α and IL-1 β) was significantly higher in SENP1 knockdown cells from SENP1-aP2KO mice."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP1-ADIPOQKO MICE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The gene expression of proinflammatory cytokines (IL-6, TNF-α and IL-1 β) was significantly higher in adipocytes isolated from SENP1-AdipoqKO mice."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP1-KO ADIPOCYTES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"In SENP1 knockdown cells, including those from SENP1-aP2KO and SENP1-AdipoqKO mice, there was increased NEMO SUMOylation and enhanced NF-κB activation."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP1 DELETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"SENP1 deletion in adipocytes enhances both basal and stress-induced IKK and p65/RelA activation, suggesting a role for SENP1 in regulating inflammatory responses via the NF-κB signaling pathway."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IL-1 Β&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Interleukin-1 beta (IL-1 β) is a proinflammatory cytokine involved in inflammation and was detected at high levels in adipocytes with SENP1 knockdown."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;ETOPOSIDE VP16&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Etoposide VP16 is an environmental factor that has been used as a DNA damage agent to induce phosphorylation of IKK and p65/RelA in adipocytes. SENP1 deletion enhances both basal and stress-induced activation in response to this environmental factor."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SENP7 is another gene involved in regulating NF-κB signaling, similar to SENP1 and SENP2. It prefers SUMO2/3 as substrates, indicating a broader family of genes involved in this pathway."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NON-OBESE DIABETIC (NOD) MOUSE&quot;">
      <data key="d0">"SPECIES"</data>
      <data key="d1">"The NOD mouse is used as a model for type 1 diabetes due to its late onset at 14 weeks of age, which allows investigation into gene-disease correlation over time."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HUMAN T1DM PATIENTS&quot;">
      <data key="d0">"PATIENT GROUP"</data>
      <data key="d1">"Humans with diagnosed Type 1 Diabetes Mellitus (T1DM) serve as a comparison group for understanding the genetic basis and disease progression in animals like the NOD mouse."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Proinflammatory cytokines are increased in human Type 1 Diabetes Mellitus patients compared to healthy cohorts."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;JSH-23&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"JSH-23 is an NF-κB inhibitor used to test the causal link between SENP1 and T1DM. It showed efficacy in reducing diabetes progression without affecting body weight or lipid profile in mice.") ("entity"</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PATS (PANCREATIC ADENOPATHY TISSUES)">
      <data key="d0">"CELL TYPE"/"SPECIES"</data>
      <data key="d1">"PATs are tissues within the pancreas of the NOD mouse that have been studied for their correlation with diabetes onset and progression, providing insights into the genetic aspects of disease."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;SENP1-AP2KO MICE">
      <data key="d0">"SPECIES"/"DISEASE MODEL"</data>
      <data key="d1">"These mice are deficient in SENP1 specifically within adipocytes. They serve as a model to study how lack of this gene affects diabetes progression and inflammatory responses."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPOGENESIS (ADIPOCYTE DIFFERENTIATION)">
      <data key="d0">"PHYSIOLOGICAL PROCESS</data>
      <data key="d1">"Adipogenesis refers to the process by which fat cells, or adipocytes, differentiate from pre-adipocytes under specific conditions. This process has been observed in SENP1-deficient mice under high-fat diet conditions."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;CCL5 (C-C MOTIF CHEMOKINE LIGAND 5)">
      <data key="d0">"NUTRIENT"/"PHYSIOLOGICAL PROCESS</data>
      <data key="d1">"CCL5 is a chemokine involved in the recruitment of immune cells to adipose tissue, particularly observed at higher levels under high-fat diet conditions and SENP1 deficiency."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;INSULIN (PRE)PROINSULIN">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Insulin serves as a target for immune cells attacking pancreatic islets in models like the NOD mouse. It has been hypothesized that short-term subcutaneous insulin administration can protect β-cells by inducing 'β-cell rest,' which could be relevant to SENP1-deficient mice."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;POPULATION GROUP&quot;">
      <data key="d0">"AFRICAN AMERICANS"</data>
      <data key="d1">"In subgroups restricted to Caucasian populations, the meta-analysis investigated Cdx-2 gene variant rs731236 and TaqI alleles with a pooled OR of 1.19 suggesting no significant association under dominant genetic model."&lt;SEP&gt;"The Northern Sweden subgroup conducted by Clendenen et al. departed from Hardy-Weinberg equilibrium, yet no significant association with ovarian cancer was found for the TaqI gene variant under a null hypothesis of dominant genetic model."&lt;SEP&gt;"This study excluded a subset conducted in the African American population by Grant et al., which contributed most to heterogeneity between other studies. No significant association was found with pooled OR of 1.09 under dominant genetic model for ovarian cancer risk."&lt;SEP&gt;"This study excluded the subgroup conducted in Japanese population by Lurie et al., which showed departure from Hardy-Weinberg equilibrium, as it did not affect our overall findings regarding Cdx-2 gene variant rs11568820 and ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;PUBLICATION BIAS&quot;">
      <data key="d0">"EGGER'S REGRESSION AND BEGG'S FUNNEL PLOT"</data>
      <data key="d1">"No publication bias was identified in this research through Egger's regression and Begg's funnel plot."&lt;SEP&gt;"Publication bias involves the selective reporting of research findings that support a particular hypothesis, which can influence medical practice and guidelines."&lt;SEP&gt;"The Egger’s test found no publication bias for Cdx-2 gene variant rs11568820 and TaqI alleles in relation to ovarian cancer, supporting the robustness of our findings across different studies."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;FOOD&quot;">
      <data key="d0">"LEAFY GREENS (A FOOD SOURCE RICH IN FOLATE)"</data>
      <data key="d1">16</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;B12 LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Maternal B12 levels are a nutrient that influence cardiovascular health through nitric oxide production."&gt;</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;B12&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"B12 is a nutrient that is unlikely to mediate the relationship between maternal folate levels and offspring birthweight."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;BIRTHWEIGHT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There is no causal effect of either maternal or fetal B12 or folate levels on gestational duration, indicating a lack of mediation by these nutrients in this context."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MATERNAL B12&quot;">
      <data key="d0">"OFFSPRING BIRTHWEIGHT"</data>
      <data key="d1">"No evidence exists that maternal B12 levels influence offspring birthweight; thus, they do not mediate the relationship between maternal folate and offspring birthweight."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;FETAL B12&quot;">
      <data key="d0">"BIRTHWEIGHT"</data>
      <data key="d1">"There is no causal effect of fetal B12 on gestational duration or any evidence suggesting mediation in this context."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;GESTATIONAL DURATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Dietary patterns including nutrient intake do not influence gestational duration. This suggests a lack of mediation by these factors in this context."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;DIRECTIONAL PLEIOTROPY&quot;">
      <data key="d0">"DISEASE RISK FACTORS"</data>
      <data key="d1">"There is no directional pleiotropy detected between SNPs and the relationship between B12 and folate levels, indicating that genetic influences do not mediate the effect of nutrients on birth outcomes."&lt;SEP&gt;"There was no evidence found for directional pleiotropy between maternal or fetal SNPs and disease risk factors through lifestyle behaviors such as physical activity during pregnancy."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;I2GX SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The low I2GX score of 0.83 suggests potential measurement error or weak instrument bias affecting folate MR Egger results but does not seem to be a concern for B12 given the high I2GX at 0.98."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MR EGGER ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Folate and B12 MR Egger analyses may have been influenced by measurement error or weak instruments, particularly concerning folate levels due to its low I2GX score of 0.83, though this is less likely for B12 at a high I2GX score of 0.98."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;WEAK INSTRUMENT BIAS&quot;">
      <data key="d0">"DISEASE RISK FACTORS"</data>
      <data key="d1">"The lack of mediation by maternal B12 levels in offspring birthweight and folate in gestational duration suggests that weak instrument bias does not play a significant role in the relationship between these nutrients and childbirth outcomes."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;GENE INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"No direct genetic influences were found to mediate the relationship between nutrient levels and childbirth outcomes through gene-gene interactions in MR Egger analysis."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The lack of directional pleiotropy from SNP analyses supports that genetic factors do not mediate the effect of B12 and folate on childbirth outcomes, at least in this study."&lt;SEP&gt;&gt;&lt;"A total of 672 candidate SNPs were genotyped. Ten SNPs had a Gencall score of less than 95%, 78 additional SNPs failed the minor allele frequency test, and 19 SNPs failed the Hardy–Weinberg equilibrium test."&gt;</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;MTHFR C677T&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTHFR gene has a variant at position C677 resulting in the CT and TT genotypes."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;MTHFR A1298C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genetic variant is found at position A1298 in the MTHFR gene, resulting in heterozygous AC or homozygous CC genotypes."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PAI-1 -675 4G/5G&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"In relation to PAI-1, a variant at the -675 position influences the polymorphic 4G/5G state of the protein product."&lt;SEP&gt;"The PAI-1 gene has a variant at position -675 influencing the 4G/5G polymorphism in the protein product."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"In the Prothrombin gene, a variant at position G20210 results in heterozygous GA and no homozygous AA genotypes."&lt;SEP&gt;"The Prothrombin gene has a specific genomic variant at the position G20210, leading to different genotypes such as GA and AA among individuals."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;FACTOR V G1691A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Factor V gene has a variant at position G1691 influencing the GA genotype distribution among LV patients."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PAI-1 A844G&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Another genetic variant in the PAI-1 gene is found at position A844, resulting in a different allele that may influence nutrient regulation."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;MTHFR C677T OR A1298C&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"There is no direct relationship identified between PAI-1 -675 4G/5G and MTHFR C677T or A1298C in the reviewed literature.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PAI-1 -675 4G/5G OR A844G&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"No direct relationship between MTHFR C677T, A1298C, PAI-1 -675 4G/5G, and PAI-1 A844G is identified in the literature.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR C677T, A1298C, OR PAI-1 -675 4G/5G AND PAI-1 A844G&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"No direct relationship between these SNPs is identified in the literature.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGIONAL DISTRIBUTION OF LV PATIENTS ACROSS DIFFERENT ETHNIC GROUPS AND COUNTRIES WITHOUT DETAILED RACIAL INFORMATION IN STUDIES&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">"No direct relationship between these SNPs is suggested due to lack of detailed regional information.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO DIRECT RELATIONSHIP BETWEEN THESE SNPS IS IDENTIFIED IN THE LITERATURE.&quot;)">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">17) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PAI-1 -675 4G/5G OR A844G, MTHFR C677T, A1298C, PAI-1 -675 4G/5G AND PAI-1 A844G&quot;">
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d1">17) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BLOOD CLOTTING&quot;">
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d1">"The Factor V G1691A protein plays a role in blood clotting processes that may be affected by the variant's influence on nitric oxide synthesis and regulation."|&lt;&gt;4) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FERTILE CONTROLS&quot;">
      <data key="d0">"DEMOGRAPHIC CHARACTERISTICS"</data>
      <data key="d1">"Fertile controls had significantly more education and shorter abstinence periods compared to infertile cases."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;B12 TRANSCOBALAMIN RECEPTOR GENE&quot;">
      <data key="d0">"GENE ASSOCIATIONS"</data>
      <data key="d1">"B12 transcobalamin receptor gene TCblR variant rs173665 in heterozygous subjects had a negative association with male infertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;B12 CONCENTRATION&quot;">
      <data key="d0">"GENE ASSOCIATIONS"</data>
      <data key="d1">"Lower B12 concentrations were observed in the infertile group compared to fertile controls, although these differences were not statistically significant."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;FOLATE SUPPLEMENTS&quot;">
      <data key="d0">"SEMEN QUALITY"</data>
      <data key="d1">"Among non-users of vitamins, serum folate and RCF concentrations were significantly lower in the infertile than the fertile group (P = 0.0063 and P = 0.044)."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;HEALTH EDUCATION&quot;">
      <data key="d0">"EDUCATION LEVEL"</data>
      <data key="d1">"Folic acid users reported higher education levels compared to non-users."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;VITAMIN SUPPLEMENTS&quot;">
      <data key="d0">"HEALTH STATUS"</data>
      <data key="d1">"All differences between users and non-users of supplements, including folate, B12, tHcy concentrations, were statistically significant (P&lt;0.05)."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SERINE HIDROXIMETIL TRANSFERASE 1 GENE (SHMT1)&quot;">
      <data key="d0">("ENZYME"</data>
      <data key="d1">("Catalyzes the reversible conversion of serine to glycine, transferring methyl groups to tetrahydrofolate (THF)."))</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1 GENE (MTHFD1)&quot;">
      <data key="d0">("PROTEIN"</data>
      <data key="d1">("Encodes a protein with three distinct enzyme activities: 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methylenetetrahydrofolate cyclohydrolase, and 10-formyltetrahydrofolate synthetase."))</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;GLUTATHIONE S-TRANSFERASE MU 1 GENE (GSTM1)&quot;">
      <data key="d0">("PROTEIN"</data>
      <data key="d1">("Encodes mu-class glutathione S-transferase for detoxification of electrophilic compounds, including carcinogens and products of oxidative stress."))</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;METHIONINE SYNTHASE REDUCTASE GENE (MTRR)&quot;">
      <data key="d0">("GENE"</data>
      <data key="d1">("Responsible for the regeneration of Methionine Synthase by reductive methylation using SAM as a methyl donor."))</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;D4 RECEPTOR OF DOPAMINE GENE (DRD4)&quot;">
      <data key="d0">("PROTEIN"</data>
      <data key="d1">("Encodes third intracellular receptor loop, with polymorphism DRD4-48bptr in exon 3 affecting between 2 to 11 repeats."))) ("entity"</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;CDC MBA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CDC MBA is a method used to measure serum folate and was compared with the CDC HPLC-MS/MS."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC HPLC-MS/MS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CDC HPLC-MS/MS is another method used for measuring serum folate, which showed high correlation with the CDC MBA."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;SERUM FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum folate levels were measured using both the CDC MBA and the CDC HPLC-MS/MS methods in this study."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;PEARSON CORRELATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Pearson correlation between the 2 methods was very high, indicating a strong relationship."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;5-METHYLTHF&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"5-methylTHF is used as a folate calibrator in some laboratories for measuring serum folate levels.")&gt;1</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;FOLIC ACID&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Folic acid, another nutrient involved in measuring serum folate levels, was also considered."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;WHOLE-BLOOD HEMOLYSATE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Samples were analyzed as whole-blood hemolysates for some laboratories.")&gt;2</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;L. RHAMNOSUS (ATCC 7469)&quot;">
      <data key="d0">"MICROORGANISM"</data>
      <data key="d1">"Laboratory #3 used the wild-type strain of L. rhamnosus, ATCC 7469, in their assay procedure."&gt;3</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;IH-CAL &amp; IH-MO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Laboratories using IH reagents and conditions were considered under an 'Environmental Factor' due to the varied procedures between laboratories.")&gt;4</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC-CAL &amp; CDC-MO&quot;">
      <data key="d0">"BIOLOGICAL REAGENT"</data>
      <data key="d1">"Both CDC-CAL (control agents for measuring serum folate levels) and CDC-MO (microorganism used in assays involving L. rhamnosus) were considered under 'Biological Reagents' category."&gt;5</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;FOLIC ACID CASEI MEDIUM&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The culture medium used for all laboratories was classified as a dietary pattern impacting microbial growth and assay conditions."&gt;6) ("entity"</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC-MO (MICROORGANISM)&quot;">
      <data key="d0">"BIOLOGICAL REAGENT"</data>
      <data key="d1">"CDC-MO is a microorganism strain used in assays involving L. rhamnosus and was considered under 'Environmental Factor' due to the varied procedures between laboratories."&gt;8</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC MBA TARGET VALUE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The CDC MBA target value is used as the reference in laboratory measurements.")</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;S-FOL&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"S-FOL is a protein involved in folate metabolism, as indicated by the study.")</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;WB-FOL&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"WB-FOL is another gene related to folate metabolism, as identified in the study.")&lt;SEP&gt;"WB-FOL is another protein related to folate metabolism and used in this study.")</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORIES #6 AND #9&quot;">
      <data key="d0">"LAB"</data>
      <data key="d1">"These specific laboratories showed a lack of agreement in results, which could be due to different conditions or reagents used.")</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;FOLIC ACID CALIBRATOR&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Folic acid calibrators are part of the laboratory setup for accurate measurement of folate levels.")</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;IH REAGENTS&quot;">
      <data key="d0">"PHYSICOCHEMICALS"</data>
      <data key="d1">"IH reagents were used in one group of laboratories to measure folate levels, affecting results.")</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC REAGENTS&quot;">
      <data key="d0">"PHYSICOCHEMICALS"</data>
      <data key="d1">"CDC reagents were the other set used by some labs, harmonized for more accurate measurements.")</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;MICROORGANISM AND CALIBRATOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The CDC round-robin kit includes microorganisms and calibrators provided in different matrices.")</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;RS1695 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism rs1695 in GSTP1 gene shows different allele frequencies among cases and controls, suggesting a potential impact on breast cancer risk."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;RS1138272 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism rs1138272 in GSTP1 gene shows no significant association with breast cancer risk based on genotype and allele frequencies."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GENOTYPES DISTRIBUTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Distribution of genotypes among cases and controls was analyzed under Hardy-Weinberg equilibrium conditions."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;OR VALUE (ODDS RATIO)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Statistical analysis provides odds ratios for genotypes associated with breast cancer risk, indicating relative risks compared to non-associated genotypes."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ALLELE T (RS1138272)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Allele T of rs1138272 shows no significant association with breast cancer risk in our study, suggesting a lack of genetic influence on this variant."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;SNPEFFECTS ONLINE SOFTWARE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Software SNPeffects analyzes the effects of Ile105Val polymorphism on GSTP1 function by predicting changes in protein properties such as aggregation and chaperone binding."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;DWALTZ (CHANGE IN AMYLOID PROPENSITY)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The dWALTZ score indicates how much the amyloid propensity of GSTP1 is affected by the Ile105Val mutation, with -228 suggesting reduced amyloid formation."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;AMYLOID PROPENSITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Amyloid propensity is evaluated using the WALTZ algorithm in GSTP1 enzyme with specific SNPs such as Ile105Val affecting this process."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;LIMBO ANALYSIS (SOFTWARE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"LIMBO software assesses how specific SNPs influence the chaperone-binding tendency of GSTP1, such as with rs1695 showing no significant impact."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GSTP1 PROMOTER METHYLATION STATUS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis of DNA methylation at the GSTP1 promoter region is crucial for understanding transcriptional regulation, which may influence gene expression in response to genetic variants."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;CHROMATIN REMODELING (GENOMIC)&quot;">
      <data key="d0">"REGULATORY PROCESS"</data>
      <data key="d1">"The remodeling of chromatin structure at the GSTP1 locus is hypothesized to facilitate changes in gene expression related to risk, possibly through interactions with regulatory elements like miR-34a or other non-coding RNAs."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;3' UTR SEQUENCES (AKT PATHWAY)&quot;">
      <data key="d0">"REGULATORY PROCESS"</data>
      <data key="d1">"The impact of 3' untranslated regions within mRNA transcripts like those of AKT pathway proteins on post-transcriptional regulation is a focus for studies investigating gene expression in relation to breast cancer risk."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;HER2/NEU PROTEIN EXPRESSION POLYMORPHISM&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"Variations in HER2/Neu protein expression can impact signaling pathways critical for cell survival and growth that may be relevant to breast cancer risk."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ILE105VAL SNP (GSTP1)&quot;">
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d1">"Amyloid Propensity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NORMAL GSTP1 PROTEIN (LIMBO ANALYSIS)&quot;">
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d1">"Amyloid Propensity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.R778L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant p.R778L is found to associate with three haplogroups A, B, C and subdivided into specific haplotype variants."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP A&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Haplogroup A was overwhelmingly common on WD chromosomes (97/100), indicating it represents most of the genetic information for p.R778L."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;CONTROL ONES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Contrary to p.P992L, control ones showed a lower prevalence compared to haplogroup A (WD chromosomes: 9.6% vs. 97.0%)."&lt;SEP&gt;"Control ones represent samples outside the main study population (non-WD chromosomes), providing a control group against which to compare genetic variation."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOTYPE VARIANTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Variant A1 (10-7-7) accounted for the largest proportion (57.0%) of haplogroup A on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP B&quot;">
      <data key="d0">"DISEASE RISK FACTORS"</data>
      <data key="d1">"Haplogroup B was found to be relatively scarce, present in 1% of samples compared to haplogroup A."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP C&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Haplogroup C appeared sporadically (2.0%), suggesting it may represent a smaller portion of the genetic information for p.R778L."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;VARIANT E1&quot;">
      <data key="d0">"DISEASE RISK FACTORS"</data>
      <data key="d1">"Variant E1 accounted for 69% of haplogroup A on WD chromosomes, dominating within this group."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP D&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Haplogroup D appeared sporadically (3.4%) in samples compared to haplogroup A."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP F&quot;">
      <data key="d0">"DISEASE RISK FACTORS"</data>
      <data key="d1">"Haplogroup F was found sporadically at a rate of 6.9% among control ones."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP G&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Haplogroup G appeared sporadically (3.4%) in samples compared to haplogroup A."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP H&quot;">
      <data key="d0">"DISEASE RISK FACTORS"</data>
      <data key="d1">"Haplogroup H appeared sporadically at rates of 10.3% and 12-5-5 within control ones, suggesting a smaller contribution than in haplogroup A."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP I&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Haplogroup I appeared sporadically (3.4%) among control ones compared to haplogroup A."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;VARIANT J1&quot;">
      <data key="d0">"DISEASE RISK FACTORS"</data>
      <data key="d1">"Variant J1 was more common at 78.6%, representing a significant difference from controls (p &lt; 0.01).") ("entity"</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;CYP2C9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CYP2C9 gene is involved in the production of warfarin, a medication used to prevent blood clots.")</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;WARFARIN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Warfarin is a drug that requires dietary monitoring as it interacts with certain foods and can affect clotting factors.")</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;DVT/PE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients with DVT or PE may be prescribed warfarin to prevent further clotting events.")</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;MEDICATION PREDICTIVE ACCURACY&quot;">
      <data key="d0">"DRUG THERAPY"</data>
      <data key="d1">"Predictive accuracy in medication dosing is crucial for individualizing patient care and optimizing treatment outcomes.")</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9*3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CYP2C9*3 is another genetic variant associated with reduced CYP2C9 function, impacting warfarin therapy.")</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9*5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CYP2C9*5 represents additional variants in the CYP2C9 gene that can decrease enzyme activity and alter warfarin dosing.")</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;AA ALGORITHM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The AA Algorithm is a gene that significantly outperforms the IWPC pharmacogenomics and clinical algorithms in dose prediction."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IWPC pharmacogenomics algorithm is related to the genes used for predicting drug doses based on genetic background."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;CLINICAL ALGORITHM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Clinical Algorithm represents a physiological process in which dose prediction algorithms are applied to clinical practice decisions."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NNG&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"NNG is an indicator of precision, representing the number of patients that need to be genotyped to prevent one predicted dose from being outside of the therapeutic range."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;DOSE PREDICTION ALGORITHMS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Predicting drug doses based on genetic background and other factors represents a dietary pattern in clinical practice for pharmacogenomics applications."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;TARGET PREDICTIVE DOSE&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The target therapeutic dose for warfarin is within a specific range determined by clinical trials.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY FACTORS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Dietary factors can influence the amount of warfarin required to achieve an effective dosage.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERAPEUTIC WARFARIN DOSE&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Dietary factors can influence the amount of warfarin required to achieve an effective dosage.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREDICTED DOSE REQUIREMENTS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Warfarin"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP2C9 STAR VARIANT GROUP&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The CYP2C9 star variant group is linked to an increased risk of cardiovascular diseases due to its impact on warfarin metabolism and dosage requirements.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERCENT ADMIXTURE&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"A strong inverse correlation between percent WAA and predicted dose within the 20% therapeutic range indicates an association with higher doses required by patients requiring doses of ≥60 mg/week.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRECISION IN DOSE PREDICTION&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"The NNG reflects precision, indicating how many patients need to be genotyped versus using the IWPC clinical algorithm for dose prediction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POPULATION-SPECIFIC VARIABLES&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"Our novel AA algorithm does not show association because population-specific variables are incorporated and therefore may account for WAA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP24A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP24A1 is a gene that plays a role in vitamin D metabolism and calcium homeostasis."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"c.428_430delAAG variant" |&gt;"Genomic Variant"</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;SAMPLE&quot;">
      <data key="d0">"DNA SAMPLE"</data>
      <data key="d1">"Two samples were used as positive controls with known CYP24A1 status."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;CONTROL&quot;">
      <data key="d0">"DNA CONTROL"</data>
      <data key="d1">"Two wt control samples had no CYP24A1 variants and showed specific melting behavior."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS SAMPLE&quot;">
      <data key="d0">"DNA SAMPLE"</data>
      <data key="d1">"One compound heterozygous sample carried both variants tested, showing distinct genotyping curves."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DENVER DEVELOPMENTAL SCREENING TEST II&quot;">
      <data key="d0">"TEST"</data>
      <data key="d1">"The Denver Developmental Screening Test II assessed developmental skill levels at 20 months of age, including gross motor, fine motor, language, and personal-social skills.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;GROSS MOTOR SKILLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gross motor abilities were assessed as being below average at 5 months.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;FINE MOTOR SKILLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fine motor skills were assessed as being behind average by 7 months.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;LANGUAGE SKILLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Language abilities were assessed as behind at 7 months.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;PERSONAL-SOCIAL SKILLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Personal-social skills were assessed as being below average at 11 months.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BRAIN MRI&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A brain MRI showed atrophy and delayed myelination, indicating potential environmental factors affecting development.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CLINICAL NEUROPHYSIOLOGY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Clinical neurophysiology studies were normal in the patient, suggesting normal physiological processes despite developmental delays.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;SERUM COPPER LEVEL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The patient’s serum copper level was within the normal range, indicating no deficiency or overload related to copper levels.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;URINE B2-MICROGLOBULIN&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Normal urine b2-microglobulin levels suggest absence of renal injury due to copper overload.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;PLASMA CATECHOLAMINE RATIOS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Deficient activity of dopamine-beta-hydroxylase reflected in normal plasma catecholamine ratios, suggesting lack of Menkes disease.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CEREBROSPINAL FLUID COPPER AND CATECHOLAMINE RATIOS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Higher cerebrospinal fluid copper and catecholamine ratios indicate classical Menkes disease.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MOSAICISM FOR P1001L MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The patient showed mosaicism for the P1001L mutation, indicating a genetic variant affecting development.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;WILD TYPE ALLELE AND MUTANT ALLELE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Different levels of wild type and mutant alleles were detected in different tissues, suggesting complex interactions within the body.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;QUANTITATIVE REAL-TIME PCR (Q-RT-PCR)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Used to compare mosaicism between tissues, indicating involvement of multiple metabolic pathways affecting development.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;INFANT PATIENT&quot;">
      <data key="d0">"ENTITY TYPE"</data>
      <data key="d1">"A patient at 20 months of age was the focus of the developmental assessment.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BRAIN ATROPHY AND DELAYED MYELINATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"MRI findings indicated atrophy and delayed myelination, suggesting a physiological process affecting development.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS&quot;">
      <data key="d0">"CLINICAL NEUROPHYSIOLOGY STUDY"</data>
      <data key="d1">"Measured values were within normal range for the L wrist and elbow in clinical neurophysiology studies.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE SENSORY ACTION POTENTIAL&quot;">
      <data key="d0">"CLINICAL NEUROPHYSIOLOGY STUDY"</data>
      <data key="d1">"Values measured were also within normal ranges, indicating normal sensory function.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Conduction velocity was assessed as slightly below average at 50 m/s, suggesting a physiological process related to motor and sensory functions.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;DOPAMINE-BETA-HYDROXYLASE ACTIVITY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Plasma catecholamine ratios indicated deficient activity of dopamine-beta-hydroxylase, reflecting a metabolic pathway issue.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MENKES DISEASE RISK FACTOR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"P1001L mutation mosaicism is consistent with Menkes disease risk factors but does not confirm the diagnosis.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;PRIMARY FIBROBLAST CULTURE&quot;">
      <data key="d0">"BIOLOGICAL SAMPLE"</data>
      <data key="d1">"A primary fibroblast culture from skin biopsy showed less abundant wild type alleles, indicating a focus on copper handling and activity in this tissue.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;NORMAL CONTROL DNA&quot;">
      <data key="d0">"BIOLOGICAL SAMPLE"</data>
      <data key="d1">"DNA comparison with normal control indicated higher abundance of the wild type allele in patient's blood compared to fibroblast culture sample, suggesting different physiological conditions between tissues.")</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;GPX4 3′UTR&quot;">
      <data key="d0">"PROTEIN EXPRESSION LEVELS"</data>
      <data key="d1">"The GPX4 3′UTR influences protein levels, particularly for GPx activity and selenoproteins."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;OXIDATIVE CHALLENGE&quot;">
      <data key="d0">"CELL VIABILITY"</data>
      <data key="d1">"Oxidative challenge, such as tert-butylhydroperoxide, affects cell viability and expression of IDI transcripts."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 ANTIOXIDANT PROTEIN&quot;">
      <data key="d0">"TR1 PROTEIN"</data>
      <data key="d1">"GPX4 is involved in producing TR1 protein, a key enzyme for cellular defense against oxidative stress."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX1 ENZYME&quot;">
      <data key="d0">"GPX4 REGULATION"</data>
      <data key="d1">"GPX1 and GPX4 enzymes regulate antioxidant pathways within Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;IDI-C CELLS&quot;">
      <data key="d0">"CELL LINE OR CELL TYPE"</data>
      <data key="d1">"IDI-C cells are distinct from IDI-T cells with respect to selenoprotein expression and sensitivity to oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-T CELLS&quot;">
      <data key="d0">"CELL LINE OR CELL TYPE"</data>
      <data key="d1">"IDI-T cells show different responses to oxidative stress compared to IDI-C cells, particularly in their ability to withstand tert-butylhydroperoxide treatment."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"GPx4 is an enzyme that is sensitive to changes in selenoprotein expression and may play a role in oxidative stress response."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TR1, GPX1, GPX4 MRNAS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The levels of TR1, GPx1, and GPx4 mRNAs are similar between IDI-T and IDI-C cells grown under various conditions but differ in selenoprotein expression."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENOPROTEIN H MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The expression of the selenoprotein H mRNA is lower in IDI-C cells compared to IDI-T cells, regardless of Se supply."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX1 ACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"There is a significant difference in GPx1 activity between clones expressing similar levels of the transgene but differing expression of the IDI transcript and varying sensitivity to oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;ROS LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Oxidative stress, as measured by ROS levels, shows greater increase in IDI-C cells compared to IDI-T cells when exposed to tert-butylhydroperoxide."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Ter-butylhydroperoxide is used as a challenge agent to assess oxidative stress and cell viability under various Se conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;MEAN GPX ACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"There is a significant difference in mean GPx activity between IDI-C cells grown in depleted vs. supplemented medium, with higher expression of selenoproteins leading to greater oxidative stress resistance."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI TRANSCRIPT LEVELS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Different levels of the IDI transcript are associated with varying responses to oxidative challenge and changes in GPx activity between clones."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;CELL VIABILITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cell viability is influenced by both Se supply and expression of the IDI transgene, as demonstrated through experiments with tert-butylhydroperoxide exposure.") ("entity"</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX1 EXPRESSION&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"GPx1 expression is associated with differences in GPx activity between IDI-T and IDI-C clones under varying conditions of Se supply."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENOPROTEINS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenoproteins, including GPx4, are critical for the cell's ability to withstand oxidative stress induced by environmental factors such as tert-butylhydroperoxide."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI EXPRESSION DIFFERENCES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression differences between IDI transcripts in IDI-T and IDI-C cells influence their response to oxidative challenge, particularly in terms of GPx activity and cell viability."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;EXPRESSION LEVELS&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"Selenoprotein H mRNA levels are lower in cells expressing the IDI-C variant compared to those expressing the IDI-T variant.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SELENOPROTEIN H&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"Selenoprotein H mRNA levels are lower in cells expressing the IDI-C variant compared to those expressing the IDI-T variant.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHAT GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CHAT is a gene associated with neurological function as it encodes for acetylcholinesterase, critical for synaptic transmission."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.THR553ASN MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"p.Thr553Asn is a genomic variant in the CHAT gene that alters enzyme function and affects neurological function."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.SER704PRO MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"p.Ser704Pro is another genomic variant in the CHAT gene, functionally characterized by others but not explicitly mentioned here."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.ALA557THR MUTATION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"p.Ala557Thr mutation results in a significant reduction of ChAT transcript expression and affects neurological function."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;CHAT CDNA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The CHAT gene encodes for acetylcholinesterase, the protein targeted by genetic variants investigated here."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;BOSC 23 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Mutant CHAT proteins were expressed in Bosc 23 cells to examine their expression at the protein level."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;SPINAL CORD CHAT TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The spinal cord ChAT transcript has two alternative start sites, yielding different molecular weight proteins."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;E. COLI EXPRESSION VECTOR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CHAT cDNA was transformed into E. coli to produce histidine-tagged CHAT for kinetic property and thermal stability analysis."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;NI-NTA COLUMN">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Histidine-tagged CHAT proteins were purified using a Ni-NTA column followed by fast protein liquid chromatography for detailed molecular interaction studies.") ("entity"</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;SYNAPTIC TRANSMISSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Synaptic transmission is the process mediated by neurotransmitters like those encoded by the CHAT gene, crucial for communication between neurons."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;ACETYLCHOLINESTERASE FUNCTION&quot;">
      <data key="d0">"PROTEIN FUNCTION"</data>
      <data key="d1">"Acetylcholinesterase plays a critical role in synaptic function and degradation of acetylcholine after nerve impulses."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;NEUROLOGICAL DISORDER">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mutations affecting CHAT gene are associated with neurological disorders, impacting synaptic transmission due to altered enzyme activity."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;SPINAL CORD CHAT TRANSCRIPT VARIATION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The variation in the spinal cord ChAT transcript affects protein expression and function through alternative start sites."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;TGSH&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"TGSH is an important antioxidant and its levels indicate the oxidative state of an individual.")&lt;SEP&gt;"TGSH is an important antioxidant involved in maintaining cellular redox balance.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GSH&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"GSH is another important antioxidant that helps to protect cells against oxidative stress.")&lt;SEP&gt;"GSH is another important antioxidant, involved in reducing oxidative stress.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GSSG&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"GSSG is a marker of oxidative stress and its levels can indicate the presence of oxidative damage.")&lt;SEP&gt;"GSSG represents the oxidized form of glutathione and serves as a biomarker for assessing levels of oxidative stress in tissues.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;HCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Homocysteine"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;OXLDL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"OxLDL is a marker of lipid peroxidation in the bloodstream indicating potential oxidative damage to LDL cholesterol particles.")&lt;SEP&gt;"OxLDL is a marker of lipid-related oxidative stress; its presence indicates damage or potential damage to LDL particles.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"CD measures products of lipid peroxidation and reflects the extent of LDL oxidation in individuals.")&lt;SEP&gt;"CD measures products of lipid peroxidation, providing insight into the extent and type of oxidative stress present in an individual's plasma.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;BCD-LDL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"BCD-LDL is a marker for further oxidative modification of LDL particles, indicating higher levels of ongoing oxidative stress.")&lt;SEP&gt;"BCD-LDL reflects additional oxidation of LDL particles beyond what is measured by CD, indicating a more severe form of oxidative damage to lipoproteins.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;SEMA6A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SEMA6A is a protein with anti-angiogenic function that is associated with lipid peroxidation products.")&lt;SEP&gt;"SEMA6A plays an anti-angiogenic role in the vascular system and its expression is linked with markers of lipid peroxidation such as oxLDL.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;TAPBP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TAPBP is an enzyme involved in the processing of LDL particles, whose methylation levels are linked to oxidative stress markers CD and BCD-LDL.")&lt;SEP&gt;"TAPBP is involved in the immune complex processing of LDL particles, with associations found between methylation at specific CpG sites and oxidative stress biomarkers like BCD-LDL.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CKAP5&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CKAP5 is a cytoskeleton associated protein that has its expression regulated by CpG sites within the promoter region, which also show associations with lipid peroxidation markers.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FOSL2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FOSL2 is an antigen related to FOS family of proteins and it shows a strong association with DNA methylation at specific CpG sites.")</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CPGS ASSOCIATED WITH OXIDATIVE MARKERS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">1&lt;SEP&gt;7</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;OXIDATIVE MARKERS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">2</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PROMOTERS OF GENES&quot;">
      <data key="d0">"FUNCTIONAL REGULATORY ELEMENT"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;FDR&lt;0.05, NOMINAL P-VALUE&lt;2.07E-4&quot;">
      <data key="d0">"REGULOMEDB SCORE 1A-2C"</data>
      <data key="d1">4</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PROMOTER OF A GENE&quot;">
      <data key="d0">"CPG ISLAND SHORES"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;FUNCTIONAL REGULATORY REGION&quot;">
      <data key="d0">"REGULOMEDB SCORE 1A-2C"</data>
      <data key="d1">6</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;E2F1 GENE/PROTEIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">11&lt;SEP&gt;15</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;JASPAR DATABASE TF BINDING SITE&quot;">
      <data key="d0">"TF BINDING SITE"</data>
      <data key="d1">13</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;ATHEROSCLEROSIS AND CORONARY HEART DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">17</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;AMDHD1 GENE/PROTEIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">20</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;OPRM1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The OPRM1 gene is a gene associated with alcohol craving and subjective response to alcohol.")</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALDH2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ALDHj2 genotype is a genomic variant linked to the risk of cardiovascular disease.")</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ADH1B&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ADH1B genotype is a genomic variant associated with alcohol metabolism and risk of cardiovascular disease.")</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALCOHOL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Alcohol is a nutrient related to its consumption and the measurement of AUDIT scores in individuals with varying OPRM1 genotypes and ALDH2/ADH1B genetic variants.")&gt;5</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DRINKING DAYS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The number of drinking days per week is a dietary pattern variable that affects alcohol consumption among different demographic groups.")</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The number of drinks consumed per day during the past 30 days is another dietary pattern variable related to AUDIT score and drinking behavior.")&gt;7</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ALDH2 genotypes are significant covariates in alcohol consumption and self-administration."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;BASELINE STIMULUS VALUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline stimulus values influence the number of drinks consumed, which is a physiological process related to alcohol self-administration."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;MEDICATION NALTREXONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Naltrexone is one medication that affects drinking behavior in participants with different genotypes and baseline stimulus levels."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;PLACEBO&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Placebo serves as a control group for the study, influencing the number of drinks consumed among participants with specific ALDH2 genotypes."&lt;SEP&gt;"The placebo used in this study was inert and did not contain any active pharmacological ingredient.")</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6&lt;SEP&gt;chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;ALDH2 ASP40 CARRIERS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"ALDH2 carriers consume fewer drinks in comparison to Asn40 homozygotes, which indicates a relationship between this genetic factor and nutrient intake (alcohol consumption)."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ASN40 HOMOZYGOTES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Asn40 homozygous individuals consume more alcohol than ALDH2 carriers or the placebo group."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NALTREXONE MEAN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Mean values of Naltrexone suggest a neutral effect on drink consumption, while placebo shows greater drinking behavior."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;PLACEBO MEAN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The higher mean number of drinks consumed by those taking placebo aligns with the findings in non-NS group participants."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;SMOKING STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Non-smokers consume a lower number of drinks compared to smokers, which indicates an effect of smoking status on self-administration behavior."&lt;SEP&gt;"Smoking status was also considered an environmental factor in the multivariate linear regression models."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;MEDICATION GROUP NON-SMOKERS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Participants who do not smoke show less drinking behavior, suggesting that environmental factors can impact alcohol consumption."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;MEDICATION GROUP SMOKERS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Smoking status does not significantly influence medication or genotype effects on self-administration or latency to drink."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPES AND DRINKING BEHAVIOR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alcohol consumption is influenced by specific genetic variants such as ALDH2 genotypes, which are related to the pharmacogenetic results reported in this study. These relationships highlight how genetics can affect nutrient intake (alcohol) through physiological processes."&lt;SEP&gt;"The relationship between ALDH2 genotypes and drinking behavior in individuals highlights physiological processes such as alcohol metabolism by enzymes like ALDH2."&lt;SEP&gt;"These physiological processes involving ALDH2 genotypes highlight metabolic pathways that are influenced by dietary patterns and other demographic details like smoking status."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;LATENCY TO FIRST DRINK&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Individuals with shorter latency to drink have a higher chance of consuming alcohol, which is directly related to the pharmacogenetic results and their implications for drinking behavior."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALDH2 CARRIERS'">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Alcohol consumption is influenced by dietary patterns involving specific genetic variants such as ALDH2 carriers. These individuals are part of a larger population that interacts with environmental factors like smoking status in determining alcohol intake."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;OPRM1 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"OPRM1 genotype is another genetic factor that does not significantly alter pharmacogenetic results but remains part of the study's demographic details."&lt;SEP&gt;"OPRM1 genotypes are among the demographic details of participants that do not significantly affect pharmacogenetic results but influence other aspects of study data."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;BRAC POST-HOC ANALYSIS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The study examines post-hoc the effects of BrAC (brac contents) on various physiological processes including NOS1 transcript expression."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALDH2 ASP40 CARRIERS'">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These individuals exhibit reduced alcohol consumption due to genetic variations that alter ALDH2 enzyme activity and protein interactions related to metabolism of ethanol."&lt;SEP&gt;"These individuals have lower intake of alcohol due to genetic factors that influence their metabolic response, suggesting a relationship with dietary patterns involving folate and other nutrients."&lt;SEP&gt;"These individuals' reduced drinking patterns suggest a response to environmental factors that also influence physiological processes like alcohol metabolism, as described in the study data."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;BRAC AND FOLATE METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Alcohol consumption is influenced by dietary patterns that affect folate metabolism, which in turn modulates vascular function through related metabolic pathways."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPES AND BASELINE STIMULUS VALUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These baseline stimulus values influence drinking behavior, a key physiological process studied in the context of pharmacogenetics."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;SMOKING STATUS AND SELF-ADMINISTRATION BEHAVIOR&quot;">
      <data key="d0">"RELATIONSHIP DESCRIPTION"</data>
      <data key="d1">"There is an observed relationship between smoking status and self-administration behavior among study participants. This finding suggests interrelations among environmental and physiological processes that affect drinking behaviors."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALDH2 RS671 GENOTYPES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ALDH2 rs671 genotype is a genomic variant that may influence daily alcohol consumption, as observed in the study population."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALDH2 is a gene known to be associated with alcohol metabolism and has been studied for its impact on various physiological processes including alcohol intake and cardiovascular health."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;DRINKS PER DAY&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"In men and women, there are variations in mean daily drinks according to their genetic makeup (ALDH2 rs671 genotypes)."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;CORTISOL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The pattern of cortisol levels is observed to vary by the ALDH2 rs671 genotypes, indicating a physiological process influenced by this genomic variant."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;AGE DISTRIBUTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Significant variations were observed in age distribution among different genetic groups, with GA genotype group being older than others in both sexes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hypertension and diabetes were controlled for, as they are risk factors that can influence physiological processes related to alcohol consumption and cortisol levels.") ("entity"</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GENDER DISTRIBUTION&quot;">
      <data key="d0">"DISTRIBUTION BY GENDER"</data>
      <data key="d1">"The gender distribution in the study population was balanced with 699 males (68.1%) and 507 females (49.4%)."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;HYPERTENSION PREVALENCE&quot;">
      <data key="d0">"HYPERTENSIVE PATIENTS"</data>
      <data key="d1">"Among the hypertensive patients, there was a higher prevalence compared to controls (47.7% vs 38.8%, p = 0.041)."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SYSTOLIC BLOOD PRESSURE AND DIASTOLIC BLOOD PRESSURE&quot;">
      <data key="d0">"HYPERTENSION TREATMENT"</data>
      <data key="d1">"There was no significant difference in systolic blood pressure (SBP) and diastolic blood pressure (DBP) between the HUA cases and controls, which may be related to hypertension treatment."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;DIURETICS USAGE&quot;">
      <data key="d0">"HYPERTENSIVE PATIENTS"</data>
      <data key="d1">"The ratio of diuretics was relatively low and did not reach statistical significance between the two groups."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SERUM CREATININE LEVELS&quot;">
      <data key="d0">"HUA CASES"</data>
      <data key="d1">"Individuals in the HUA group had higher levels of serum creatinine, TG, LDL, and BMI compared to controls (p &lt; 0.05)."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;HIGH DENSITY LIPOPROTEIN CHOLESTEROL&quot;">
      <data key="d0">"HUA CASES"</data>
      <data key="d1">"There was also a significant difference in HDL cholesterol levels among the participants."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;URIC ACID LEVELS&quot;">
      <data key="d0">"HUA CASES"</data>
      <data key="d1">"The prevalence of hyperuricemia was found to be 14.71%."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SERUM CREATININE&quot;">
      <data key="d0">"HUA CASES"</data>
      <data key="d1">"There were higher levels of serum creatinine among individuals with high uric acid compared to those without (p &lt; 0.05)."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"There was no significant difference in alcohol consumption between cases and controls.")&gt; ("entity"</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;RISK RATIO&quot;">
      <data key="d0">"HYPERURICEMIA"</data>
      <data key="d1">"The OR (95% CI) of HUA cases showed an increased association with each copy of the risk alleles of these three SNPs. Specifically, for SLC2A9 rs3733591 and ABCG2 rs2231142, there was a significant increase in HUA risk (p &lt; 0.05)."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;GENETIC FACTORS&quot;">
      <data key="d0">"HYPERTENSIVE PATIENTS"</data>
      <data key="d1">"Genetic factors, including polymorphisms in genes such as ABCG2 and SLC2A9, were found to be associated with both sUA levels and HUA risk."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION RISK FACTOR&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consuming alcohol was identified as a non-significant factor compared to controls in this study."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SMOKING BEHAVIOR&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There was no significant difference in tobacco smoking between cases and controls, suggesting that these factors may not play a major role in the development of hyperuricemia in this population."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;RS2228285&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant rs2228285 is associated with an increased risk of hypertension."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;RS116549037&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genomic variant, rs116549037, also linked to increased risk of hypertension."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;SUA LEVEL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum uric acid levels are a nutrient that have been associated with cardiovascular risk factors."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;HUA RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hyperuricemia is the disease state linked to increased sUA level and higher cardiovascular risk."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;T ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The T allele of the rs2231142 variant plays a role in determining dietary folate intake."&lt;SEP&gt;"The T allele, found in the CRC patients compared to the control group, showed reduced expression in relation to colorectal cancer risk."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27&lt;SEP&gt;chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d1">"Elevated sUA levels are a cardiovascular risk factor and correlate with higher HUA risk among those carrying specific genetic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2231142&quot;">
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d1">"Both genetic variants are related and contribute to increased risk of hypertension, indicating a complex relationship between different genomic loci and cardiovascular disease."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LNK4B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LNK4B gene has been associated with eGFR and is involved in kidney function across different ancestry groups."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;EGFR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"eGFR (estimated glomerular filtration rate) is a physiological process that measures the filtration of blood by the kidneys, indicating their health status."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;CKD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chronic kidney disease (CKD), including ESRD, is a disease condition characterized by impaired renal function and reduced eGFR levels."&lt;SEP&gt;"Chronic kidney disease (CKD), including ESRD, is a disease condition characterized by impaired renal function and reduced eGFR levels.") ("entity"</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;ESRD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"End-stage renal disease (ESRD) represents the final stage of chronic kidney disease where the kidneys no longer function effectively enough to maintain life."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;GENOMIC ANNOTATION&quot;">
      <data key="d0">"GENOMIC ANNOTATIONS FOR SINGLE-NUCLEOTIDE VARIANTS"</data>
      <data key="d1">"Only 5.4% of the posterior probability of driving association signals was annotated to coding variants at the 20 GWAS loci, suggesting that most are likely mediated by effects on gene regulation.")&gt;7</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;CHROMATIN STATE&quot;">
      <data key="d0">"REGULATORY CHROMATIN STATE FOR KIDNEY CELLS"</data>
      <data key="d1">"Genomic annotations of regulatory chromatin state were predictive of posterior probability of driving association signals across the 20 GWAS loci in kidney cells, suggesting a role in disease-relevant tissues.")&gt;8</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITES&quot;">
      <data key="d0">"HDAC8 BINDING SITES"</data>
      <data key="d1">"Variants overlapping transcription factor binding sites, particularly for HDAC8, are associated with increased posterior probability of driving association signals in renal cells and may have implications for kidney function and disease treatment.")&gt;9</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;DROSOPHILA MELANOGASTER&quot;">
      <data key="d0">"MODEL ORGANISM OF INTEREST - DROSOPHILA MELANOGASTER"</data>
      <data key="d1">"Drosophila melanogaster serves as a model organism to study the function of genes like NFATC1 and RGS14, which are involved in kidney physiology and salt sensitivity.")&gt;10</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;LOCO MUTANTS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The loco mutants are a set of genes involved in resistance to salt stress."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;ISOGENIC Y1W1 CONTROLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Y1W1 is a protein present in control strains, likely playing a role in baseline health and response to dietary changes."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;NACL CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"NaCl refers to salt concentration and was varied as a nutrient to test the mutants' resistance capabilities."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;SUPPLEMENTATION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The addition of varying NaCl concentrations is part of an experimental dietary pattern designed to study the gene's role in response to stress."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;SALT STRESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Salt stress is a physiological process that the loco mutants were tested for resistance, indicating a role for this gene under these conditions."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;MORTALITY RATE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Very little mortality of any genotypes indicates an environmental factor supporting baseline viability over time."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;VIABILITY&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"There was no baseline difference in viability between strains, suggesting no major dietary influences impacting their health during the test period."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;HIGH-SALT DIET&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A high-salt diet is a metabolic pathway that can affect renal function and salt sensitivity."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;GLOMERULOSCLEROSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Subtotal nephrectomy induces chronic kidney disease, referred to as glomerulosclerosis in the text."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;NFATC1 AND RGS14">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"NFATC1 and RGS14 are genes that show altered expression during high-salt exposure and CKD, suggesting a molecular interaction between these factors.") ("entity"</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CAMPYLOBACTER&quot;">
      <data key="d0">"MICROORGANISM"</data>
      <data key="d1">"Campylobacter is a genus of bacteria that can cause infections in humans."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT CAMPYLOBACTER&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"177 isolates were quinolone-resistant, associated with the presence of a specific genomic variant."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;ERYTHROMYCIN-RESISTANT CAMPYLOBACTER&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"3 isolates were erythromycin-resistant, indicating resistance to this antibiotic."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;C. COLI&quot;">
      <data key="d0">"MICROORGANISM"</data>
      <data key="d1">"152 isolates were from C. coli, a species within the Campylobacter genus."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;C. JEJUNI&quot;">
      <data key="d0">"MICROORGANISM"</data>
      <data key="d1">"526 isolates were from C. jejuni, another species within the Campylobacter genus."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE RESISTANCE IN CAMPYLOBACTER&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Quinolone resistance is a physiological process in which Campylobacter bacteria develop mechanisms to resist quinolones."&gt;</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;C. JEJUNI WITH QUINOLONE SENSITIVITY&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Domestic and foreign dietary patterns, including the consumption of fresh poultry, are factors that can influence the presence of quinolone-resistant Campylobacter strains in certain populations."&gt;)</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;ANTIMICROBIAL DRUGS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fluoroquinolone-resistant infections involve antimicrobial drugs and their resistance mechanisms.") ("entity"</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;C. COLI WITH QUINOLONE RESISTANCE&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"152 isolates were from C. coli and were found to be quinolone-resistant, indicating this strain's resistance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT C. COLI&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"152 isolates were from C. coli and were found to be quinolone-resistant, indicating this strain's resistance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QUINOLONE-SENSITIVE C. JEJUNI&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"526 isolates were from C. jejuni and showed sensitivity to quinolones, indicating they did not exhibit quinolone resistance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NITRIC OXIDE SYNTHESIS PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"IL-8 has been linked to the regulation of nitric oxide synthesis, which is critical for vascular function and asthma pathophysiology."&lt;SEP&gt;&gt;&lt;"The metabolic pathway of nitric oxide synthesis is central to this interaction, and alterations in this pathway have been observed in individuals with poor dietary patterns."&gt;</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">&gt;&lt;"Social disinhibition was the outcome studied. It's a measure of how much people tend not to think before they act or say things that are out of place, inappropriate, or socially unacceptable during everyday interactions with others."&gt;</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;PRINCIPAL COMPONENTS ANALYSIS&quot;">
      <data key="d0">"RESEARCH METHODOLOGY"</data>
      <data key="d1">&gt;&lt;"For the principal components analysis, we used N = 1132 participants and 511 SNPs which were shown to be unassociated with the social disinhibition outcome in univariate analyses at a significance level of 0.05 based on the best genetic model fit."&gt;</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;ETHNIC STRATIFICATION&quot;">
      <data key="d0">"RESEARCH CONSIDERATION"</data>
      <data key="d1">&gt;&lt;"We did not observe significant ethnic stratification in our data from the principal components analysis, indicating that ethnicity does not independently influence social disinhibition outcomes."&gt;&lt;SEP&gt;&gt;&lt;"We did not observe significant ethnic stratification in our data from the principal components analysis."&gt;</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;SNPS ASSOCIATED WITH SOCIAL DISINHIBITION&quot;">
      <data key="d0">"BIOLOGICAL FINDING"</data>
      <data key="d1">&gt;&lt;"Six of the 11 SNPs were found to be significant at α = 0.05 level in the final multivariable model, which included demographic and psychosocial characteristics as well as the three largest principal components terms."&gt;</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;LINGUISTIC ACCULTURATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">&gt;&lt;"Each 1-point increase in a participant's overall linguistic acculturation score was expected to increase their social disinhibition score by 0.30 points (95% CI = 0.20–0.41)"&gt;</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;TAS &amp; DAS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">&gt;&lt;"Each 1-unit increase in TAS or DAS score is expected to increase participants' social disinhibition score by 0.20 and 0.45 points, respectively (95% CI = 0.17–0.23) and (95% CI = 0.40–0.51), respectively."&gt;</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;GENDER &amp; PARENTAL EDUCATION&quot;">
      <data key="d0">"DISEASE RISK FACTOR"</data>
      <data key="d1">&gt;&lt;"Gender and parental education were not significantly associated with social disinhibition score, indicating that these factors do not independently increase the risk of social disinhibition."&gt;) ("entity"</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;PRINCIPAL COMPONENTS ANALYSIS (PCA)&quot;">
      <data key="d0">"STATISTICAL METHODOLOGY"</data>
      <data key="d1">&gt;&lt;"For the principal components analysis, we used N = 1132 participants to analyze the relationship between genetic variants and social disinhibition outcome."&gt;</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;TAS &amp; DAS (TOOTH A/A-ANTIBODY TEST AND DENTAL ANXIETY SCALE)&quot;">
      <data key="d0">"PSYCHOLOGICAL MEASURE"</data>
      <data key="d1">&gt;&lt;"Each unit increase in TAS or DAS scores is expected to increase participants' social disinhibition score by 0.20 points for TAS and 0.45 points for DAS, indicating that dental anxiety also plays a role in predicting social disinhibition."&gt;</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;GENDER &amp; PARENTAL EDUCATION (SOCIOECONOMIC STATUS)&quot;">
      <data key="d0">"DEMOGRAPHIC FACTORS"</data>
      <data key="d1">&gt;&lt;"We did not find significant associations between gender or parental education and social disinhibition score, suggesting these factors do not independently increase the risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS9534511&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"The minor allele of rs9534511 was positively associated with increased social disinhibition score, suggesting an increase in the risk for social disinhibition.")&gt;3</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;RS4938056&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"The minor allele of rs4938056 showed protective effects against social disinhibition, indicating a decrease in the risk for this condition."&gt;4</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;RS16116&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"Negative association between rs16116 and increased social disinhibition score was observed. This suggests protection from social disinhibition with these alleles."&gt;5</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;RS16870286&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"The minor allele of rs16870286 showed a protective effect against increased social disinhibition, indicating reduced risk for this condition."&gt;6</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;RS1003921&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"The minor allele of rs1003921 was negatively associated with the social disinhibition score, suggesting a decrease in risk for social disinhibition with these alleles."&gt;7</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;CNR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CNR1 is a gene associated with drug-seeking behavior in animals and regulates CB1 receptor levels."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;RS2023239&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2023239 is a genomic variant associated with greater reward from alcoholic beverages."&lt;SEP&gt;"rs2023239 is an alternative promoter described in the study by Zhang et al, affecting CNR1 expression."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59&lt;SEP&gt;chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CB1 RECEPTOR LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CB1 receptor levels are regulated by genetic variation at rs2023239 and influenced by dietary patterns."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;BRODMANN AREAS 9 AND 10&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Greater CB1 binding in Brodmann areas 9 and 10 indicates the presence of a functional CB1 receptor, suggesting an active physiological process."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ANOVA REVEAL SIGNIFICANT FINDINGS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The ANOVA revealed significant differences in CB1 binding between individuals with favorable and unfavorable genotypes, indicating a physiological process at play."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CB1 BINDING QUANTIFICATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Quantitative analysis of CB1 binding shows that those with the CT or CC genotype have higher levels than those with the TT genotype in Brodmann areas 9 and 10."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;BRODLANN AREAS 9 AND 10 ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Activation in areas 9 and 10 indicates a functional CB1 receptor, which modulates mesocorticolimbic neurocircuitry involved in drug-seeking behavior."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;MESOCORTICOLIMBC NEUROCIRCUITRY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The modulation of the mesocorticolimbic neurocircuitry by CB1 receptors is associated with drug-seeking behaviors and alcohol cues."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL CUES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to alcohol cues modulates brain activation in areas such as Brodmann areas 9 and 10, indicating a physiological response influenced by environmental factors."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;AUDIT SCORE CORRELATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Correlations between CB1 binding levels and AUDIT scores suggest that genetic variation at rs2023239 modulates reward and positive affect after alcohol consumption."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;PROFILE OF MOOD STATES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Profile of Mood states measures subjective effects of alcohol, indicating significant differences in reward and mood between favorable genotype groups."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;DIFFERENCE BETWEEN ALCOHOL VS PLACEBO BEVERAGE SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Significant main effect for genotype was found on the difference between alcohol and placebo beverage scores, with individuals showing greater reward after drinking."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;MEDICATION TARGETING CB1 RECEPTORS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The medication targeting CB1 receptors is likely a therapy aimed at modulating drug-seeking behavior based on genetic factors.") ("entity"</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;DRUG-SEEKING BEHAVIOR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The modulation of mesocorticolimbic neurocircuitry by CB1 receptor activation is associated with drug-seeking behavior in animals and humans."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;PFC POSTMORTEM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Quantitative analysis of postmortem human PFC shows that genetic variation at rs2023239 modulates cortisol levels, indicating a physiological process influenced by the CT genotype."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL CUE-INDUCED BRAIN ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain activation in response to alcohol cues is an active physiological process involving areas such as NAcc and VMPFC, which are modulated by genetic variation at rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;DRUG/ALCOHOL USE DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The AUDIT score measures drug or alcohol use disorders in individuals with varying genotypes, including those with the CT and TT genotypes as described in this study."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;NACC ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Greater activation of NAcc compared to inactive controls suggests a functional response at CB1 receptors, which modulates drug-seeking behavior based on individual genetic profiles."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;VMPFC ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Increased VMPFC activation in individuals with favorable genotype may influence reward and positive affect pathways related to alcohol consumption."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;OFC ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"OFC (orbitofrontal cortex) activation is associated with subjective measures of drug-seeking behavior, suggesting a physiological process influenced by individual genetic factors."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CT GENOTYPE&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"The CT genotype is linked to increased reward and positive affect after drinking alcohol."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;TT GENOTYPE&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"The TT genotype does not differ in reported rewards or positive affect compared to the CT genotype."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;MEDICATION&quot;">
      <data key="d0">"OLANZAPINE"</data>
      <data key="d1">"Olanzapine is a medication that targets the dopamine system and was used in this study."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d0">"MEDICATION"</data>
      <data key="d1">"Cyproheptadine hydrochloride is an inactive control medication, used as a comparator to olanzapine."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;DRINK&quot;">
      <data key="d0">"DRINKS PER DRINKING DAY"</data>
      <data key="d1">"Participants in the study were asked about their drinks and drinking days during a 12-week trial."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CUE ELICITED CRAVING&quot;">
      <data key="d0">"CUE ELICITED CRAVING"</data>
      <data key="d1">"Individuals with the CT genotype reported greater cue-elicited craving when treated with olanzapine vs placebo."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;POSITIVE AFFECT&quot;">
      <data key="d0">"POSITIVE AFFECT"</data>
      <data key="d1">"Positive affect was measured and found to be higher in individuals with the CT genotype compared to TT."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;REWARD&quot;">
      <data key="d0">"REWARD"</data>
      <data key="d1">"Greater reward from drinking alcohol was associated with the CT genotype.") It appears that you are asking for me to identify and add additional biomedical entities related to a specific text document. However, without the exact text provided, it is not possible for me to accurately list all relevant entities as per your requirements. The last example you provided seems to be about genetics, pharmacology, and alcohol consumption, which would include genes (genotype), medication (olanzapine</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;LPL DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"LPL deficiency is a rare autosomal recessive disorder with clinical features including hypertriglyceridemia and xanthomas."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ERUPTIVE XANTHOMAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Frequent occurrence of eruptive xanthomas on the skin's extensor surfaces due to severe hypertriglyceridemia in affected individuals."&lt;SEP&gt;"Patients with LPL deficiency can present with eruptive xanthomas and other clinical features such as abdominal pain and recurrent pancreatitis."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LPL gene encodes for lipoprotein lipase which is responsible for triglyceride hydrolysis in blood."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPEMIA RETINALIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Lipemia retinalis involves yellowing of the retina due to elevated TG levels, affecting peripheral and posterior pole vision."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HYPERVISCOSITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Elevated triglycerides can cause hyperviscosity leading to abdominal pain and gastrointestinal hemorrhage."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PANCREATITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients with severe hypertriglyceridemia often experience recurrent pancreatitis, risk increases over 1000 mg/dl TG levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DIETARY FAT RESTRICTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Dietary fat restriction is a cornerstone of treatment for LPL deficiency-induced hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;MCT (MEDIUM CHAIN TRIGLYCERIDES)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"MCT oil supplements are used due to their direct absorption into the portal vein, aiding in reducing TG levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PORTAL VEIN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Direct absorption of MCTs via the portal vein is a useful dietary strategy for managing hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GEMFIBROZIL&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Gemfibrozil, omega-3 fatty acids and orlistat are some drug therapies used to lower TG levels in LPL deficiency cases."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ORLISTAT&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Orlistat is a weight loss medication that can also be used for hypertriglyceridemia management."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DGAT1 (DIACYLGLYCEROL O-ACYLTRANSFERASE 1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Involved in triglyceride synthesis during dietary fat absorption, targeted by experimental treatments."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GAIN-OF-FUNCTION VARIANT&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A gain-of-function LPL gene variant is approved for use in Europe to manage hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;P.Q240H MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A novel p.Q240H mutation found in the LPL gene is responsible for severe hypertriglyceridemia in our patient.") ("entity"</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HETEROZYGOUS PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Heterozygote patients can present with normal or mildly elevated TG levels, indicating varying severity of LPL deficiency symptoms."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HOMOZYGOUS PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients who are homozygous for the LPL gene mutations often exhibit marked hypertriglyceridemia and potential complications like pancreatitis."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPOPROTEIN LIPASE (LPL)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LPL is a critical enzyme involved in hydrolyzing triglycerides from lipoproteins, crucial for lipid metabolism."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DIETARY FAT RESTRICTED FORMULA&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"A diet restricted in medium-chain triglycerides was used to manage the condition of an LPL deficiency patient."] ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDIUM-CHAIN TRIGLYCERIDES&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"A diet restricted in medium-chain triglycerides was used to manage the condition of an LPL deficiency patient."] ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOPIRAMATE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Topiramate is a drug used for the treatment of alcohol use disorder, indicated for patients with or at risk for relapse after previous discontinuation of other medications.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2832407 is a genetic variant that affects the response to topiramate in European-American participants, impacting their likelihood of experiencing no HDDs during treatment.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;HDDS (HEAVY DRINKING DAYS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"HDDs refer to heavy drinking days and are a measure of alcohol consumption over the past month among patients in this study.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;NNT (NUMBER NEEDED TO TREAT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"NNT is an index used to determine how many individuals need to be treated with topiramate for one individual to benefit from treatment, based on the reported rates of no HDDs.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;ADVERSE EVENTS (AE)&quot;">
      <data key="d0">"MILDNESS SEVERITY SCORE"</data>
      <data key="d1">"Most patients in this study experienced at least one adverse event during their treatment period. The severity scores indicated that while most events were mild, some were moderate or greater in severity.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;EUROPEAN-AMERICAN PARTICIPANTS (EA)&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"The study focused on European-American participants in the full sample, which includes individuals from various demographic backgrounds.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407*C-HOMOZYGOUS INDIVIDUALS&quot;">
      <data key="d0">"GENOMIC VARIANT MODIFIER"</data>
      <data key="d1">"Individuals with the rs2832407*C allele in this study are classified as C-homozygous, which affects their response to topiramate treatment.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407*A-ALLELE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT MODIFIER"</data>
      <data key="d1">"Individuals with the A allele in rs2832407 are classified as A-allele carriers, which also influence their response to topiramate treatment.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;MEDICATION GROUP X GENOTYPE INTERACTION (INTERACTION)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The interaction between the medication group and genotype groups showed that certain genetic variants can moderate the effects of medications such as topiramate on alcohol use disorder symptoms, indicating a complex interplay between genetics and pharmacology.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;ADVERSE EVENT SEVERITY SCORE (AESS)&quot;">
      <data key="d0">"MILDNESS SEVERITY SCORE"</data>
      <data key="d1">"Adverse event severity scores were used to assess the potential impact of treatment-related adverse events on patient outcomes in this study.")</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;PATIENT CHARACTERISTICS&quot;">
      <data key="d0">"PATIENT CHARACTERISTICS"</data>
      <data key="d1">"Data on patient demographics, clinical characteristics and other relevant factors were collected from a total of 120 eligible patients who consented to participate in the study."&lt;SEP&gt;"Most patients were female, white non-Hispanic individuals with an annual household income of at least $40,000 per year."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;INCLUSION CRITERIA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Inclusion criteria define the characteristics and parameters for which research papers are selected to be included in a study, such as specific gene polymorphisms being studied here."&lt;SEP&gt;"Out of 120 eligible patients approached, 107 completed the study and had their data included for analysis."&lt;SEP&gt;"The use of inclusion criteria defines the types of studies that are selected for further analysis within medical research settings."&gt;)&gt;3</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;STUDY DEMOGRAPHICS&quot;">
      <data key="d0">"PATIENT CHARACTERISTICS"</data>
      <data key="d1">"The majority (93 out of 88) of participants included in this analysis had complete self-reported and genetic data available for further examination."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;VARIABLES MEASURED&quot;">
      <data key="d0">"PATIENT CHARACTERISTICS"</data>
      <data key="d1">"Demographic and clinical characteristics of the sample including age, gender, income level, type of malignancy, disease stage, chemotherapy regimen usage and prescribed anti-emetic medications were assessed."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ANTI-EMETIC MEDICATIONS&quot;">
      <data key="d0">"PRESCRIBED ANTI-EMETIC MEDICATIONS"</data>
      <data key="d1">"The majority of participants received palonosetron (99%) and dexamethasone (98%). Additional commonly used anti-emetics included prochlorperazine (88%), ondansetron (46%), and fosaprepitant (34%)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CANCER TYPES&quot;">
      <data key="d0">"CANCER TYPES"</data>
      <data key="d1">"The majority of patients were diagnosed with gastrointestinal, thoracic or breast malignancies."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PATIENT REPORTED NAUSEA SEVERITY&quot;">
      <data key="d0">"PATIENT CHARACTERISTICS"</data>
      <data key="d1">"Mean self-reported CINV severity and CTCAE ratings were displayed in Table IV to assess patient-reported outcomes such as nausea severity and vomiting frequency. This data was collected from 107 patients who completed the study, with participants reporting on their individual experiences of acute and delayed symptoms."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PRESCRIBED ANTI-EMETIC MEDICATIONS&quot;">
      <data key="d0">"ANTI-EMETIC MEDICATIONS"</data>
      <data key="d1">"The study involved assessing prescribed anti-emetic medications such as palonosetron and dexamethasone, which were commonly used in the majority of participants. These drugs are often used to prevent chemotherapy-induced nausea and vomiting (CINV)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;DISEASE INDUCED NAUSEA AND VOMITING (CINV)&quot;">
      <data key="d0">"PATIENT CHARACTERISTICS"</data>
      <data key="d1">"The study aimed to understand risk factors associated with disease-induced nausea and vomiting, known as chemotherapy-induced nausea and vomiting or CINV. The impact of various demographic, clinical, patient-reported, and genetic variables on the severity and occurrence of acute and delayed symptoms was analyzed."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;LACTASE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Steady-state LCT mRNA levels vary significantly across individuals."&gt;3&lt;SEP&gt;"The Lactase gene (LCT) is associated with lactose tolerance in humans and mammals.")&gt;1&lt;SEP&gt;"The Lactase gene is involved in the age-related decline of intestinal lactase activity."&gt;5&lt;SEP&gt;"The Lactase gene is linked to lactose intolerance and non-persistence in humans."&gt;7</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INTESTINAL EPITHELIAL CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These cells are responsible for lactose metabolism in the small intestine."&gt;2</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Lactase non-persistence refers to individuals who lose the ability to digest lactose as they age."&gt;4</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTASE GENE REGION (C/T-13910)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C/T-13910 SNP is associated with lactase persistence and non-persistence of lactose digestion.")&gt;6</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MCM6 INTRON 13&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;NUCLEOTIDE (DNA)&quot;">
      <data key="d0">"C-13910"</data>
      <data key="d1">"Genomic Variant"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT INDIVIDUALS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE PERSISTENT (TT) INDIVIDUALS&quot;">
      <data key="d0">"REGULATORY REGIONS IN MCM6 AND LCT"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LOC100507600&quot;">
      <data key="d0">"LNCRNA"</data>
      <data key="d1">"The silencing of LOC100507600 resulted in a molecular interaction that reduced LCT mRNA expression, impacting lactase persistence."&lt;SEP&gt;("relationship"</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;SPERM SAMPLES&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;ENTEROCYTE SAMPLES&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT INDIVIDUALS (CC)&quot;">
      <data key="d0">"INDIVIDUALS BY DIETARY PATTERN"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;INTERMEDIATE (CT) INDIVIDUALS&quot;">
      <data key="d0">"INDIVIDUALS BY DIETARY PATTERN"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;MCM6 EXON 16&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LANCET (JOURNAL)&quot;">
      <data key="d0">"PUBLICATION TYPE BY JOURNAL TITLE"</data>
      <data key="d1">("relationship"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;SNP -13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TT genotype at SNP -13910 is a genomic variant related to lactase persistence."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Lactase persistence is a dietary pattern linked to the TT genotype at SNP -13910."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT MRNA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LCT mRNA is a protein involved in lactase persistence, regulated by the TT genotype at SNP -13910 and LOC100507600 silencing."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"CRISPR-Cas9 is used as a technique to study the impact of intronic deletions on Lct regulation and lactase persistence."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;INTRONIC DELETIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Intronic deletions in LCT or Mcm6 are studied as part of the physiological process affecting lactase persistence."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE REGULATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Lactase regulation is a metabolic pathway influenced by intronic deletions and regulatory elements such as CRISPR-Cas9 induced mutations."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;MCM6 INTRON 13 DELETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The deletion in Mcm6 intron 13 impacts lactase regulation through a segment-specific reduction in LCT mRNA levels."&lt;SEP&gt;"The deletion in Mcm6 intron 13 specifically impacts segment-specific regulation of LCT mRNA, suggesting its role in lactase persistence."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;ENTEROCYTE-LIKE CELLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Decreased expression of LCT is linked to the disease state seen in enterocyte-like cells of Caco-2, induced by CRISPR-Cas9 deletions at regulatory elements."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;DIFFERENTIATION STATE&quot;">
      <data key="d0">"LCT EXPRESSION"</data>
      <data key="d1">"Epigenetic Modification"</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9 INDUCED DELETIONS&quot;">
      <data key="d0">"MCM6 INTRON 13"</data>
      <data key="d1">"Epigenetic Modification"</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT INTRON 2 DELETION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The deletion in LCT intron 2 resulted in greater reduction of LCT mRNA, suggesting stronger control by the evolutionary conserved intron in adulthood."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9 INDUCED DELETIONS">
      <data key="d0">"CACO-2 CELLS"</data>
      <data key="d1">"Epigenetic Modification"&lt;SEP&gt;"Technique Used To Study Intronic Regions' Impact on LCT mRNA Expression"</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT INTRON 1 DELETION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The deletion of LCT intron 1 serves as a positive control for studying the impact on lactase regulation and is involved in a molecular interaction with regulatory elements impacting lactase persistence."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9N-INDUCED DELETIONS">
      <data key="d0">"LACTASE REGULATION"</data>
      <data key="d1">"Technique Used To Study Targeted Intronic Regions"</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;INTRON 13 DELETION IN MCM6&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The deletion in Mcm6 intron 13 impacts LCT mRNA levels through a molecular interaction that affects lactase regulation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs4988235 is a genomic variant that has different allele frequencies in various countries."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CC GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype at rs4988235 is associated with the non-persistent lactase phenotype."&lt;SEP&gt;"The CC genotype is a genomic variant associated with an increased occurrence of Colorectal Cancer."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27&lt;SEP&gt;chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lactase persistence, or the lack thereof, is a nutrient-related trait influencing milk consumption behaviors."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK DRINKING&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Higher rates of milk drinking were observed among individuals with the lactase non-persistent phenotype."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;NEVER HAVING CONSUMED MILK&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Individuals without the lactase persistence allele are more likely to report never having consumed milk."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;GENOTYPE FREQUENCY&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Genotype frequency refers to the number of different genotypes in a study sample, which can be affected by nutrient intake or other environmental factors."&lt;SEP&gt;"The minor allele for rs4988235 is common in southern and eastern Europe but not in regions further north and west."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;EDUCATIONAL ATTAINMENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Higher levels of educational attainment were associated with milk consumption in all countries analyzed."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;SMOKING&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Smoking was also found to be positively associated with milk consumption in the Czech Republic, an outlier for RCC risk."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CANCER RISK&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"An elevated risk of renal cell carcinoma (RCC) has been observed among individuals who consume milk compared to those who do not drink milk at all."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RS4988235 GENOTYPE&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"Genomic variants associated with lactase persistence, such as rs4988235, are linked to an elevated risk of renal cell carcinoma (RCC).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT GENOTYPE&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"There was nominal evidence for an association between lactase non-persistent genotypes and educational attainment in certain populations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MILK DRINKING PATTERN&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"An elevated risk of RCC has been observed among milk consumers compared to those who never consume milk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RCC RISK&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"An elevated risk of RCC has been observed among milk consumers compared to those who never consume milk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYDROXYUREA (HU)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Hydroxyurea (HU) is a drug used for its therapeutic effects on hematological parameters, including improved hematological parameters post-exposure as observed in the study."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HBF&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"HbF (hemoglobin fraction) is a measurable parameter that can be influenced by genetic factors and dietary or therapeutic interventions."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;SNP HBG2-XMN1-RS7482144&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP, with its very low allele frequency in the Brazilian cohort, was excluded from further analysis due to its minimal impact on study results."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;BCL11A RS1427407 AND BCL11A RS4671393&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These two SNPs are associated with increased baseline and MTD HbF levels in the studied population, indicating a genetic influence on hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;BCL11A RS11886868&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This SNP is only slightly associated with baseline HbF but shows significant association with MTD and delta HbF levels in the study population, suggesting a possible influence on hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HMIP-2 RS9399137 AND HMIP-2 RS9402686&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"These SNPs are associated with increased baseline HbF levels for the HMIP-2 gene, suggesting a genetic component in hematological parameters influenced by this nutrient."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HAPLOTYPE G-G-T&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"This haplotype is significantly linked to higher baseline and MTD HbF levels when compared to the reference wild-type alleles, indicating a strong genetic influence on hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HAPLOTYPE T-A-C&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"This haplotype is associated with higher baseline and MTD HbF levels in our cohort, suggesting significant genetic impact on hematological measures as compared to the reference G-G-T haplotype."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;REFERENCE ALLELE T&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The reference allele T for HMIP-2 is associated with higher baseline HbF levels and could influence hematological parameters in this population, as observed in the study results."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;COHORT AGE AT START OF HU TREATMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This covariate represents an important factor to be considered when analyzing the association between genetic variants and hematological measures post-treatment."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;ANCS AT MTD&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Another covariate used in our study, representing demographic information on patient health status at baseline of HU treatment, affecting hematological parameters measured in this study."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;INTERLEUKIN-6 (IL-6)&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"IL-6 is a cytokine that plays a significant role in inflammation and hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;FETOFERRIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Fetoferrin is a protein involved in iron transport during fetal development, influencing postnatal hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;CD36 GENE&quot;">
      <data key="d0">"GENE TYPE"</data>
      <data key="d1">"The CD36 gene encodes for a protein relevant to lipid metabolism and its expression can impact various physiological processes including hematology."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;GLYCATED HEMOGLOBIN (HBA1C)&quot;">
      <data key="d0">"MEASUREMENT"</data>
      <data key="d1">"HbA1c is used as an indicator of long-term glucose control in diabetes management, influencing overall health and hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;VON WILLEBRAND FACTOR (VWF)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"vWF is a protein involved in hemostasis that affects blood clotting processes relevant to hematological measures."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;MEGALIN AND CUBILIN&quot;">
      <data key="d0">"PROTEINS"</data>
      <data key="d1">"These proteins are involved in renal tubular reabsorption of nutrients, influencing overall health status which can impact hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML)&quot;">
      <data key="d0">"DISEASE TYPE"</data>
      <data key="d1">"JMML is a rare pediatric cancer characterized by the overproduction of white blood cells, impacting various hematological measures significantly."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;IRON REGULATORY PROTEINS (IRPS)&quot;">
      <data key="d0">"PROTEINS"</data>
      <data key="d1">"These proteins play key roles in iron homeostasis and their dysregulation can influence overall health status affecting hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;CD47 SIGNALING PATHWAY&quot;">
      <data key="d0">"BIOCHEMICAL PATHWAY"</data>
      <data key="d1">"The CD47 signaling pathway influences immune response and inflammation, which are critical factors impacting hematological measures."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;FCΓRIIA POLYMORPHISM&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"This polymorphism in FcγRIIa gene is associated with altered function of the protein involved in phagocytosis and inflammation, influencing hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR)&quot;">
      <data key="d0">"BIOMARKER"</data>
      <data key="d1">"suPAR levels are implicated in immune response and can influence overall health status impacting various hematological measures."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;LYSYL OXIDASES (LOX)&quot;">
      <data key="d0">"ENZYME TYPES"</data>
      <data key="d1">"These enzymes are involved in the cross-linking of collagen, which is critical for connective tissue integrity affecting hematological parameters through their impact on skin and blood vessels' health."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;THROMBOSPONDIN 1 (TSP1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TSP1 is a protein involved in hemostasis and angiogenesis, influencing vascular integrity which can affect hematological parameters significantly."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;FANCONI ANEMIA CELL LINE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The subject presented at birth with bilateral radial aplasia, absent thumbs, microcephaly, micrognathia, café au lait spots, absent left kidney. The subject has not developed bone marrow failure."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;BILATERAL RADIAL APLASIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Bilateral radial aplasia is a condition where the radius bones are missing or absent at birth."&gt;</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;ABSENT THUMBS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The subject presented with absent thumbs, indicating a congenital absence of thumbs."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;MICROCEPHALY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Microcephaly is a condition where the head circumference is smaller than normal even before birth."&gt;</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;CAFÉ AU LAIT SPOTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cafe au lait spots are light brown to dark brown pigmented areas on the skin, often seen in individuals with genetic disorders including Fanconi Anemia."&gt;</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;ABSENT LEFT KIDNEY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The subject presented with an absent left kidney, which is a congenital malformation."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;CHROMOSOMAL BREAKAGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Chromosomal breakage involves the formation of breaks and alterations in chromosomes, seen in individuals with Fanconi Anemia."&gt;</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;SOMATIC MOSAICISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A small subset of FA patients display increasing evidence of somatic mosaicism in their hematopoietic compartment over the years."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;HYPERSENSITIVITY TO CROSSLINKING AGENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fibroblasts derived from subject are hypersensitive to crosslinking agents."&gt;</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION DEFICIENCY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"RA2627 cells display deficiency for FANCD2 monoubiquitination, while LCLs show normal levels. This indicates a specific interaction between the FA pathway and other factors in this cell line."&gt;</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FA CORE COMPLEX&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Deficiency of FA pathway activation suggests deficiency or absence of core complex components such as FANCD2."&lt;SEP&gt;"The FA core complex is involved in double-stranded DNA break (DSB) repair; it interacts with proteins like the encoded protein and FANCI, altering metabolic pathways related to DSB repair."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;ID2 COMPLEX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The ID2 complex is associated with deficiency of FA pathway activation in this cell line."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"UBE2T is a gene associated with Fanconi anemia, T subtype, due to its role in rescuing cellular defects and restoring monoubiquitination of FANCD2."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RA2627 CELLULAR DEFECTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"RA2627 cellular defects are caused by deficiency of UBE2T, leading to Fanconi anemia-T subtype."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RA2627 FIBROBLASTS&quot;">
      <data key="d0">"ORGANISM TYPE"</data>
      <data key="d1">"RA2627 fibroblasts are used as a model organism to study the effects of UBE2T deficiency, leading to Fanconi anemia-T subtype.")</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RPS19&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPS19 is a gene involved in aminoacyl-tRNA biosynthesis and glycine, serine and threonine metabolism."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AFFYMETRIX GENECHIP HUMAN GENOME U133A 2.0 ARRAYS&quot;">
      <data key="d0">"PRODUCT"</data>
      <data key="d1">"Affymetrix GeneChip Human Genome U133A 2.0 Arrays is a microarray platform used for gene expression profiling, allowing the screening of transcripts and genes."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Dermal fibroblasts are skin cells involved in tissue repair and connective tissue formation."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MUTATION C.58DELG&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutation c.58delG is a frameshift mutation found in the RPS19 gene, affecting protein coding regions."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MUTATION C.1-1G&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutation c.1-1G&gt;A is a splice site mutation located within intron 1 of the RPS19 gene, potentially leading to exon skipping and reduced expression."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS MUT P.ARG62TRP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Dermal fibroblasts from patients carrying mutations have specific protein changes such as p.Arg62Trp in RPS19, affecting aminoacyl-tRNA biosynthesis."&lt;SEP&gt;"Dermal fibroblasts from patients carrying the mutation p.Arg62Trp in RPS19 are affected by a frameshift mutation affecting aminoacyl-tRNA biosynthesis.")</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS MUT P.ARG101HIS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Dermal fibroblasts from patients carrying mutations have specific protein changes such as p.Arg101His in RPS19, affecting aminoacyl-tRNA biosynthesis."&lt;SEP&gt;"Dermal fibroblasts from patients carrying the mutation p.Arg101His in RPS19 are affected by a frameshift mutation affecting aminoacyl-tRNA biosynthesis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS MUT C.58DELG&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Dermal fibroblasts from patients carrying the mutation c.58delG have specific protein changes that likely affect RPS19 function due to exon skipping or other splicing alterations."&lt;SEP&gt;"Dermal fibroblasts from patients carrying the mutation c.58delG in RPS19 are affected by a frameshift mutation potentially leading to exon skipping and reduced expression."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS MUT C.1-1G&gt;A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Dermal fibroblasts from patients carrying the mutation c.1-1G&gt;A have specific protein changes that likely affect RPS19 function due to splicing alterations."&lt;SEP&gt;"Dermal fibroblasts from patients carrying the mutation c.1-1G&gt;A in RPS19 are affected by a splice site mutation potentially leading to exon skipping and reduced expression."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;NMD (NONSENSE MEDIATED DECAY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"NMD (Nonsense Mediated Decay) is a process involved in the degradation of transcripts with premature stop codons, affecting genes like RPS19."&lt;SEP&gt;"NMD (Nonsense Mediated Decay) is a process involved in the degradation of transcripts with premature stop codons, affecting genes like RPS19.")&gt;7</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AMINOACYL-TRNA BIOSYNTHESIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Aminoacyl-tRNA biosynthesis pathways are likely affected by mutations found in the RPS19 gene, such as p.Arg62Trp and p.Arg101His.")&gt;8</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;GLYCINE, SERINE AND THREONINE METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Glycine, serine and threonine metabolism pathways are likely impacted by mutations in the RPS19 gene, affecting PSAT1, PHGDH, GARS, CTH, SARS, SHMT2.")&gt;9</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DEATH RECEPTOR SIGNALING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Death receptor signaling involves CASP9, NFKBIA, NFKBIE, APAF1, NFKB2, NFKB1, BIRC3 proteins and is likely impacted by RPS19 mutations.")&gt;10</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;ROLE OF PKR IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The role of PKR in interferon induction and antiviral response is likely affected by CASP9, NFKBIA, NFKBIE, APAF1, NFKB2, NFKB1, BIRC3 proteins found in RPS19 mutation-carrying cells.")&gt;11</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RAR ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"RAR activation is likely impacted by SRC, PRMT2, RDH11, ADCY3, PRKACA, NFKB2, NFKB1, MAPKAPK2 proteins found in cells with RPS19 mutations.")&gt;12</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RP GENES (RIBOSOMAL PROTEINS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"RP genes such as RPL22, RPL27A, RPL29, RPL31, RPL14, RPL18A, RPS3, RPL18, RPL13, RPL3, RPL34, RPS2, RPS12, RPL15, RPL28 are likely involved in protein synthesis and cellular development.")&gt;13</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;CELL DEATH&quot;">
      <data key="d0">"MOLECULAR FUNCTION"</data>
      <data key="d1">"Cell death is related to the molecular functions of genes such as CASP9, NFKBIA, NFKBIE, APAF1, NFKB2, NFKB1, BIRC3 found in cells with RPS19 mutation-carrying cells.")&gt;14</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;INTERFERON INDUCTION AND ANTIVIRAL RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The role of PKR in interferon induction and antiviral response is likely affected by CASP9, NFKBIA, NFKBIE, APAF1, NFKB2, NFKB1, BIRC3 proteins found in RPS19 mutation-carrying cells.")&gt;15</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;TOP BIO FUNCTIONS&quot;">
      <data key="d0">"MOLECULAR FUNCTION"</data>
      <data key="d1">"The Top Bio Functions related to genes such as CASP9, NFKBIA, NFKBIE, APAF1, NFKB2, NFKB1, BIRC3 found in RPS19 mutation-carrying cells indicate a significant involvement in processes like death receptor signaling and RAR activation.")&gt;16</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AMPD3&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"The expression of AMPD3 was found consistent with that detected by microarray analysis for both up-regulated and down-regulated genes, including CCND2 which is involved in cellular development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CCND2&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"The expression of AMPD3 was found consistent with that detected by microarray analysis for both up-regulated and down-regulated genes, including CCND2 which is involved in cellular development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SOD2&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"SOD2 showed similar expression trends to those observed for the gene TNFAIP3 as per microarray analysis results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TNFAIP3&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"SOD2 showed similar expression trends to those observed for the gene TNFAIP3 as per microarray analysis results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMP&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"COMP and WARS, both involved in cellular development processes and expressed differently between DBA patients and controls, displayed consistent patterns of differential expression with their counterparts detected by microarray analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WARS&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"COMP and WARS, both involved in cellular development processes and expressed differently between DBA patients and controls, displayed consistent patterns of differential expression with their counterparts detected by microarray analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ZIC1&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"While ZIC1 was down-regulated in the study population, CCND2 showed up-regulation indicative of cellular development processes, which could suggest complex interactions between these genes and their functions related to disease states.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PUBMED&quot;">
      <data key="d0">"DATABASE"</data>
      <data key="d1">"PubMed is a database containing biomedical research articles."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;WEB OF SCIENCE&quot;">
      <data key="d0">"DATABASE"</data>
      <data key="d1">"Web of Science is another database that contains scientific and academic papers, including those in the field of medicine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;COCHRANE DATABASE&quot;">
      <data key="d0">"DATABASE"</data>
      <data key="d1">"The Cochrane Database is a collection of databases covering various medical topics with an emphasis on systematic reviews."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;STUDY SELECTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Study selection involves identifying and retrieving relevant scientific papers for further analysis, which falls under the physiological process of research methodology."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;QUALITY ASSESSMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Quality assessment of studies is a critical step in ensuring that only credible data gets included in systematic reviews or meta-analyses."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;META-ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A meta-analysis is a statistical technique used to synthesize findings from multiple independent studies."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;HETEROGENEITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Differences in percentage of CAD between patients and controls indicate a large part of the disease heterogeneity can be explained by individual genetic variation."&lt;SEP&gt;"Heterogeneity refers to the variability among study results, which can make it difficult to draw clear conclusions in areas like metabolic pathways linked to gene polymorphisms."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;ALLELE MODEL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The allele model is used in genetic studies to understand how gene polymorphisms affect biological pathways such as those involved in migraine susceptibility."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;DATABASE&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"Related to each other as they are all databases used for scientific studies in various fields including medicine. They collectively provide access to an extensive body of research on different health-related topics.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PUBMED&quot;,&quot;WEB OF SCIENCE&quot;, &quot;COCHRANE DATABASE&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"Related to each other as they are all databases used for scientific studies in various fields including medicine. They collectively provide access to an extensive body of research on different health-related topics.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY SELECTION&quot;,&quot;QUALITY ASSESSMENT&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"Both Study Selection and Quality Assessment are critical steps within the overall process of conducting a scientific study or systematic review, essential for making credible conclusions about complex physiological processes such as gene-disease associations."&gt;)&gt;2) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;PATIENT 1&quot;">
      <data key="d0">"PERSON"</data>
      <data key="d1">"A 48-year-old Caucasian woman who developed severe paradoxical psoriasiform reactions after anti-TNF therapy."&lt;SEP&gt;"The oldest sibling, born by in-vitro fertilization at 25 weeks gestation. She experienced severe postnatal growth failure and was hospitalized for pneumonia with sepsis."|</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;PATIENT 2&quot;">
      <data key="d0">"PERSON"</data>
      <data key="d1">"A 40-year-old Caucasian man with a positive family history of HS and paradoxical dermatitis responses to adalimumab treatment."&lt;SEP&gt;"Born appropriate for gestational age at 37 weeks, he had severe short stature and displayed a GHI phenotype similar to Patient 1."|</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;PATIENT 3&quot;">
      <data key="d0">"PERSON"</data>
      <data key="d1">"A 27-year-old Caucasian male with severe HS who developed pustular lesions following biological therapy for paradoxical skin reactions."&lt;SEP&gt;"Born at 35 weeks of gestation, she presented with severe short stature and facial dysmorphism. She experienced failure to thrive and recurrent infections requiring antibiotics and supplemental oxygen."|</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;ADALIMUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Adalimumab is a biological therapy used in the treatment of autoimmune conditions like rheumatoid arthritis and Crohn's disease, which was associated with paradoxical dermatitis responses in these patients."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HS (HIDRADENITIS SUPPURATIVA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HS is a chronic inflammatory skin condition characterized by painful lesions and abscesses commonly found in the armpit and groin areas, affecting three individuals analyzed in this study."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Paradoxical psoriasis refers to an unexpected exacerbation of skin conditions like HS following treatment with targeted biologic therapies."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ANTI-TNF THERAPY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adalimumab is a monoclonal antibody that targets TNF-alpha, a cytokine involved in the inflammatory process driving both classical and paradoxical psoriasis manifestations."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD15+ NEUTROPHILS&quot;">
      <data key="d0">"NEUTROPHILS"</data>
      <data key="d1">"Increased levels of CD15+ neutrophils were observed in the dermis of patients with paradoxical psoriasiform reactions, suggesting an enhanced immune response against biologic therapy."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;BDCA2+ PLASMAS CELLS (DENDRITIC CELL)&quot;">
      <data key="d0">"PLASMAS CELLS"</data>
      <data key="d1">"Patients with paradoxical skin reactions showed a significant increase in the presence of BDCA2+ plasmacytoid dendritic cells, which are involved in antiviral responses."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;IL-17A&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"IL-17A was detected at similar levels in patients with classical psoriasis and paradoxical skin reactions, indicating a potential role in the pathogenesis of both conditions.") ("entity"</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;SARTORIUS SCORE&quot;">
      <data key="d0">"DISEASE SEVERITY SCORE"</data>
      <data key="d1">"The Sartorius score quantifies the number and types of lesions present in HS patients, providing a measure of disease severity for clinical assessment."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CCHCRICU572&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">{"rs1576", "rs130079", "rs746647"}&gt;</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">{"rs11209026", "rs72676067", "rs1004819"}&gt;</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS72676067&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">{"rs11209026", "rs1004819"}&gt;</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;DRWD DOMAIN (RESIDUES 109–294)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The DRWD domain spans residues 109-294 of the human FANCL protein and has a fused bilobal shape with dimensions of 70 × 25 × 20 Å consisting of four α-helices and nine β-strands."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;FANCL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene encoding the DRWD domain is part of the FANCL gene, which is involved in a central biological process that may influence human health."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HUMAN DRWD DOMAIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The predicted human DRWD domain is structurally characterized and provides insights into the protein's architecture."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DMFANCL (PDB CODE 3K1L)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"DmFANCL (PDB code 3K1L) is used as a structural homologue for comparison in this study, indicating it has similar overall structure but different details."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;UBE2 ENZYMES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"E2 UBE2 enzymes are structurally most similar to the C-terminal lobe of human DRWD domain and exhibit an RWD fold without the triple turn YPXXXP motif, differing in their catalytic cysteine positioning."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DMDRWD (DROSOPHILA)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The Drosophila structure (DmDRWD) is used for comparison with human DRWD domain, highlighting structural differences such as the absence of a YPXXXP motif and presence of an RWD fold in both lobes."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;UBE2T&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Ube2T is another E2 enzyme used as part of the structural comparison for its similarity to human DRWD domain, specifically noting the conserved cysteine position similar to catalytic E2s."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;THIOESTER CHARGE ASSAY&quot;">
      <data key="d0">"ASSAY"</data>
      <data key="d1">"The study includes a thioester charge assay on the URD region of human FANCL protein to determine its ability to form a thioester linkage with ubiquitin, suggesting it lacks the catalytic capability of E2 enzymes."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HYDROPHOBIC RESIDUES&quot;">
      <data key="d0">"CHEMICAL COMPOUND"</data>
      <data key="d1">"The study investigates hydrophobic residues and their conservation between DmDRWD and URD domains. This analysis suggests differences in surface composition relevant for protein-protein interactions.") ("entity"</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HUMAN DRWD DOMAIN (RESIDUES 109–294)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The human DRWD domain, as studied in the text, is a specific segment of the FANCL protein that has been structurally characterized and analyzed for its role in biological processes."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;Α-HELICES&quot;">
      <data key="d0">"BIOLOGICAL COMPONENT"</data>
      <data key="d1">"Four α-helices are part of the structural composition of the DRWD domain of human FANCL, contributing to the overall architecture of this region within the protein."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;Β-STRANDS&quot;">
      <data key="d0">|"BIOLOGICAL COMPONENT"</data>
      <data key="d1">|&gt;"Nine β-strands form another major component of the structure of the DRWD domain in human FANCL, providing structural stability and interaction potential for other proteins or molecules."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;UBE2T BINDING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The URD interacts with Ube2T in a complex formation. The interaction was assessed using size-exclusion chromatography and ITC, showing no change indicative of complex formation.")</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;UBIQUITIN-LIKE EXTENSION FACTOR (ELF) DOMAIN IN DROSOPHILA RING DOMAIN E2 BINDING&quot;">
      <data key="d0">"SUBSTRATE BINDING"</data>
      <data key="d1">"Physiological Process"</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;FANCI AND FANCD2 BINDING TO HUMAN CENTRAL DOMAIN OF RING E3&quot;">
      <data key="d0">"CENTRAL DOMAIN INTERACTION"</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;URD&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Urd is a nutrient involved in purine metabolism, which may be relevant to the gene's function."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCI&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCI is one of two subunits required for the formation of the FA core complex and interacts with the encoded protein."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCD2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCD2 is another component of the FA core complex, involved in DNA damage repair."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;DNA DAMAGE REPAIR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process of DNA damage response and repair is affected by the gene and its encoded protein."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;MUTANT L248A/F252A/L254A/I265A&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"Mutations in specific hydrophobic patches on the C-terminal lobe of the encoded protein reduce substrate binding, indicating a molecular interaction with FANCI and possibly other substrates."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;MUTATION W212A/L214A&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"Another set of mutations within different regions of the protein do not affect its interaction as observed in pulldown arrays."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;C-TERMINAL LOBE&quot;">
      <data key="d0">"MOLECULAR STRUCTURE"</data>
      <data key="d1">"The exposed hydrophobic patches on the C-terminal lobe are required for substrate binding and likely interact with other proteins involved in DNA damage repair."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;N-TERMINAL LOBE&quot;">
      <data key="d0">"MOLECULAR STRUCTURE"</data>
      <data key="d1">"Mutations within the N-terminal lobe behave as wild type, suggesting a different role or interaction area in protein structure."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;DNA DAMAGE REPAIR PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The mutations identified affect components of the DNA damage repair pathway and may impact metabolic processes related to this pathway.") ("entity"</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;RING DOMAIN OF HUMAN RING E3&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISTINCT DIFFERENCES BETWEEN SPECIES&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Physiological Process"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ELECTROSTATIC POTENTIAL SURFACE OF HUMAN RING E3 AND DROSOPHILA DRWD&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Physiological Process"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUBSTRATE BINDING&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Physiological Process"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCH REQUIREMENTS&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCHES ON C-TERMINAL LOBE OF HUMAN RING E3 AND SUBSTRATES BINDING&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATIONS AT HYDROPHOBIC PATCHES AND SUBSTRATE BINDING AFFINITY&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CENTRAL DOMAIN INTERACTION&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C-TERMINAL LOBE HYDROPHOBIC PATCH MUTATIONS ON HUMAN RING E3 AND SUBSTRATE BINDING AFFINITY&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"The mutations at hydrophobic patches on the C-terminal lobe, particularly in mutants L248A/F252A/L254A/I265A and W212A/L214A, reduced substrate binding affinity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCH REQUIREMENTS&quot;&lt;|&quot;&gt;&quot;MOLECULAR INTERACTION&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"The mutations at hydrophobic patches on the C-terminal lobe, particularly in mutants L248A/F252A/L254A/I265A and W212A/L214A, reduced substrate binding affinity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATIONS AT HYDROPHIC PATCHES AND SUBSTRATE BINDING AFFINITY&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGFR4 RS351855&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Gly388Arg variant in FGFR4 rs351855 is associated with differential colesevelam treatment effect on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;RS351855 GA/AA GENOTYPE GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"In the rs351855 GA/AA genotype group, colesevelam significantly delayed CT with increased AC t1/2 compared to placebo."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 GLY388ARG VARIANT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The FGFR4 Gly388Arg variant is associated with differential treatment effects on the pharmacokinetics of colesevelam."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;RS17618244 ARG728GLN VARIANT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The rs17618244 Arg728Gln variant is associated with modest but not statistically significant differential treatment effects on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;RS4975017 CA/AA GENOTYPE GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"In the CA/AA genotype group, colesevelam treatment compared to placebo was associated with a lower GC24 value."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;RS4975017 CC GENOTYPE GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant differential colesevelam treatment effects were observed in the group with CC genotype."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 RS376618&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FGFR4 rs376618 SNP was not associated with significant differential treatment effects on AC t1/2 or GC24, and showed good satisfaction in Hardy–Weinberg equilibrium."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;COLESEVELAM TREATMENT EFFECT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Differential colesevelam treatment effects are observed based on FGFR4 genotype variations at rs351855 and rs4975017, impacting pharmacokinetics of the drug."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;TABLE 1 HARDY-WEINBERG EQUILIBRIUM ASSESSMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hardy–Weinberg equilibrium was satisfied in four out of five candidate SNPs assessed for their functional significance in previous study.") ("entity"</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;RS376618&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"FGFR4 rs376618 was not associated with significant differential treatment effects and showed good Hardy–Weinberg equilibrium satisfaction."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;COLESEVELAM&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Colesevelam is a drug used in studies to assess pharmacokinetics based on FGFR4 genotype variations at rs351855, rs4975017, and rs17618244."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;PHARMACOKINETICS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Differential colesevelam treatment effects are associated with specific FGFR4 genotype variations, impacting pharmacokinetics of the drug."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;BODY MASS INDEX (BMI)&quot;|">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Body mass index is a measure of body fat and is used to classify individuals into subgroups for analysis.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;ESTIMATED DAILY FAT INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary intake, specifically daily fat intake, is measured as part of participant demographics in the study.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;CHOLECYSTECTOMY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Previous cholecystectomy is a factor that influences disease outcomes and subgroup analysis.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;IBS-D (IRRITABLE BOWEL SYNDROME - DIARRHEA)&quot;|">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IBS-D is one of the subgroups analyzed in the study, characterized by diarrhea predominant symptoms.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;IBS-C (IRRITABLE BOWEL SYNDROME - CONSTIPATION)&quot;|">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IBS-C is another subgroup in the study, focusing on constipation predominant IBS patterns.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;HV (HEALTHY VOLUNTEERS)&quot;|">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"HV represents a control group or healthy standard for comparison against which other groups are analyzed.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FGF19 (FIBROBLAST GROWTH FACTOR 19)&quot;|">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum FGF19 levels are measured and associated with disease outcomes in the study population.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL FAT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Stool fat is a measurable environmental factor that correlates with other studied variables.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL WEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Stool weight and total stool BA are measured parameters associated with physiological processes in the study population.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;SERUM C4 (COMPLEMENT COMPONENT 4)&quot;|">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum levels of C4, a biomarker for inflammation or disease activity, show differences between subgroups in the study.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL BA (BILE ACIDS)&quot;|">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Stool bile acids are measured and associated with physiological processes like fat excretion within the gut."] ("entity"</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FAAP20&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20 is a 20 kDa protein that contains a conserved UBZ domain in its C terminal extremity and interacts with FANCA through its N-terminal region."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FANCA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FAAP20 plays a role in the specific interaction between FAAP20-UBZ and Ub chains, regulating nitric oxide production."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;SURFACE PLASMON RESONANCE (SPR)&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"SPR spectroscopy was used to measure the affinity of FAAP20-UBZ with different Ub2 species."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;GST-PULLDOWN ASSAY&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"GST-pulldown assay tested interactions between FAAP20 and K63-, K48- or M1-linked Ub2."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;HYDROPHOBIC INTERACTIONS&quot;">
      <data key="d0">"INTERACTIONS TYPE"</data>
      <data key="d1">"Hydrophobic interactions and hydrogen bonds contribute to the interaction between FAAP20 and Ub, influencing vascular function."&lt;SEP&gt;"In the decamer complex, hydrophobic interactions between the peptide backbone and MHC residues play a role in stabilizing the p/MHC complex. Specifically, there is an increase from 11 to 25 hydrophobic interactions when transitioning from nonamer to decamer structure."&gt;8</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HYDROGEN BOND&quot;">
      <data key="d0">"INTERACTION TYPE"</data>
      <data key="d1">"Hydrogen bonding occurs at Asp164 Oδ atoms of FAAP20-UBZ with amide groups of Ub residues, maintaining vascular function."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBIQUITIN MOLECULE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Hydrophobically interact with the canonical Ile44-centered hydrophobic patch of Ub. The Asp164 Oδ atoms of FAAP20-UBZ further hydrogen bond with the main-chain amide groups of Ala46 and His68 side chains."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FAAP20 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The structure of FAAP20 involves interactions with Ub, forming a complex involved in cardiovascular health."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FAAP20-UBZ COMPLEX&quot;">
      <data key="d0">"COMPLEX"</data>
      <data key="d1">"The complex between FAAP20 and Ubiquitin is involved in maintaining cardiovascular health."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ARG72 MOLECULE&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"Interaction of Arg72 with the central core interactions of FAAP20-UBZ involves hydrogen bonds."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;LEU8 MOLECULE&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"Side chain of Leu8 interacts with hydrophobic residues in Ub as part of the hydrophobic interaction."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ILE44 MOLECULE&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"Hydrophobic interactions at Ile44 involve side chains of several amino acids, including Leu8 and Val70."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;THR66 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Side chain of Thr66 contributes to hydrophobic interactions in the Ub molecule."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;HIS68 MOLECULE&quot;">
      <data key="d0">"MOLECULE"</data>
      <data key="d1">"Side chain of His68 is part of the hydrophobic interaction with the canonical Ile44-centered hydrophobic patch of Ub."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;VAL70 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Hydrophobic interactions at Val70 contribute to the formation of the canonical hydrophobic patch in Ub."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;NEMO-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NEMO-UBZ is a protein that interacts with ubiquitin in a manner different from RAD18-UBZ and WRNIP1-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;POLΗ-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Polη-UBZ is another protein interacting with ubiquitin, differing in its β-loop structure compared to NEMO-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;UBIQUITIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Ubiquitin interacts differently with proteins such as NEMO-UBZ and Polη-UBZ. The interaction involves charged residues that should disrupt hydrophobic interactions but do not in these cases, suggesting a different mode of binding."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;FAAP20-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20-UBZ is another protein with conserved residues involved in Ub-binding, differing from NEMO-UBZ in its interaction with ubiquitin."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;WRNIP1-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"WRNIP1-UBZ is a protein that interacts differently with ubiquitin compared to NEMO-UBZ and Polη-UBZ, involving different residues involved in the Ub interaction."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;RAD18-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"RAD18-UBZ is another protein interacting with ubiquitin, differing from FAAP20-UBZ in its mode of binding to Ub according to structural analysis.") ("relationship"</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;CD PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CD patients are a group of people with chronic diarrhea, abdominal pain, anorexia and abdominal distension."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HEALTHY CONTROLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"158 healthy controls were also included as a comparison group for studying disease characteristics."&lt;SEP&gt;"Healthy children showed low levels of IL-8 in both serum and mRNA compared to asthmatic patients."&lt;SEP&gt;"Healthy controls included in the study comprised a total of 212 unrelated individuals."&lt;SEP&gt;"Healthy controls represent individuals without the symptoms or autoimmune manifestations associated with CD."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;CONSANGUINEOUS PARENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The study included participants born to consanguineous parents, indicating a potential influence of familial factors on disease risk."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ2.5 HAPLOTYPE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Homozygous HLA-DQ2.5 haplotype is significantly high in CD patients compared to healthy controls, suggesting a possible dietary influence or genetic predisposition for this haplotype."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ8 HETEROZYGOUS CARRIERS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"No heterozygous DQ2.5 carriers were predicted among either patient or control groups in the study, indicating a specific pattern of molecular interactions related to disease risk."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;OSTEOMALACIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Few non-autoimmune disease manifestations like osteomalacia are observed in CD patients and healthy controls."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS&quot;">
      <data key="d0">"AUTOIMMUNE MANIFESTATION"</data>
      <data key="d1">"32% of study participants had type 1 diabetes mellitus, indicating a significant autoimmune component among the patient group."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;AUTOIMMUNE THYROIDITIS&quot;">
      <data key="d0">"AUTOIMMUNE MANIFESTATION"</data>
      <data key="d1">"8% of study participants had autoimmune thyroiditis, another indication of an autoimmune condition in this population."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS&quot;">
      <data key="d0">"AUTOIMMUNE MANIFESTATION"</data>
      <data key="d1">"3% of study participants had systemic lupus erythematosus, suggesting a presence of diverse autoimmune diseases within the sample.") ("entity"</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ABDOMINAL PAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abdominal pain is another symptom commonly reported by individuals with CD, suggesting gastrointestinal distress or inflammation."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ANOREXIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Anorexia can be associated with conditions like CD, reflecting a disruption in appetite regulation or food intake patterns."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ABDOMINAL DISTENSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abdominal distension may also indicate gastrointestinal issues such as gas accumulation or digestive disorders common in inflammatory bowel diseases (IBD) including CD."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS RISK ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Type 1 diabetes mellitus is observed in a significant percentage of the study participants, indicating genetic risk factors for this autoimmune condition."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;COMBINATION THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Paclitaxel-carboplatin combination therapy is a treatment pattern for ovarian cancer."|&lt;SEP&gt;"Patients also received combination therapies that included a mix of both anti-CTLA-4 and anti-PD-1 medications administered to 45 individuals in the study population."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1&lt;SEP&gt;chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;CARBOPLATIN MONO-THERAPY&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Carboplatin mono-therapy is another treatment pattern for ovarian cancer, specifically used in 56 patients."|</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;HEMATOLOGICAL TOXICITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hematological toxicity was analyzed in 290 patients participating in the study."|</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;NEUROTOXICITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"For neurotoxicity, 56 patients treated with carboplatin monotherapy were excluded as they presented a lower risk of sensory neuropathy."|</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;SECONDARY OBJECTIVES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"All patients treated with paclitaxel-carboplatin (n = 266) were included for the secondary objectives related to PFI and OS."|</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;PFI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"PFI (Progression-Free Interval) is associated with the survival of cancer patients and involves various physiological processes including tumor growth and metastasis."&lt;SEP&gt;"The median follow-up was 2.5 years, during which there were 157 events of disease progression and 84 events of overall survival."|</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;OS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The study aimed to analyze the impact of genetic variants on ovarian cancer outcomes including PFI (progression-free interval) and OS (overall survival)."|</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ALLELE FREQUENCIES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The study also looked at allele frequencies of SNPs (single nucleotide polymorphisms) among patients, adhering to Hardy-Weinberg equilibrium."|</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ERCC2 G &gt; A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1799793 is a genomic variant that has been significantly correlated with PFI."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ERCC2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ERCC2 gene encodes for a protein involved in DNA repair, which may influence PFI through its regulatory effects on cellular processes related to cancer progression."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;KAPLAN-MEIER SURVIVAL ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Kaplan-Meier survival analysis is used to estimate the time until an event occurs, such as disease recurrence in cancer patients."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;HR&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Hazard Ratio (HR) represents the risk of occurrence of PFI per unit of time and provides insights into the strength of association between genetic variants and disease progression."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;FIGO STAGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"FIGO stage is a clinical factor used in medical research to classify cancers, influencing the overall outcome including OS (Overall Survival)."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RESIDUAL DISEASE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Residual disease after debulking surgery affects patients' prognosis and may be influenced by metabolic pathways related to cancer biology."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;TUMOR GRADE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Tumor grade is an important factor in determining the risk of PFI and OS, as it reflects tumor characteristics that can impact treatment response and outcomes."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;TUMOR HISTOLOGY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The type of tumor (histology) is a factor that influences both physiological processes in cancer cells and overall patient prognosis."&lt;SEP&gt;"Tumor histology refers to the microscopic study of tumors and provides insights into disease progression and potential therapeutic targets."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;COLON CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colon cancer is a type of gastrointestinal cancer that affects millions of individuals worldwide, influencing factors such as PFI and OS."&lt;SEP&gt;"This data refers to colon cancer patients and their relationship with dietary and genetic factors affecting PFI in the context of overall disease progression."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;NUTRITIONAL STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Nutritional status can influence cellular functions critical to disease-free survival, including those related to PFI in colon cancer patients."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;DNA REPAIR PROTEINS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ERCC2 (excision repair cross complementing 1) is a protein involved in DNA repair which may impact PFI through its regulatory effects on cellular processes important for disease progression."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;HAZARD RATIO (HR)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"HR represents the risk of occurrence per unit of time and provides insights into the strength of association between genetic variants and disease-free survival rates in colon cancer patients."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;G &gt; A VARIANT OF ERCC2&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The GG genotype carriers of rs1799793 showed a significant advantage in PFI compared to AA or GA carriers, suggesting an impact on overall survival.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ERCC2 G &gt; A VARIANT&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The association between the ERCC2 variant and FIGO stage suggests that this genetic factor may influence disease progression in relation to established clinical factors such as FIGO staging.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATED VARIANTS OF PFI&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"Variants rs12762549 (ABCC2 A &gt; G) and rs6104 (SERPINB2 C &gt; G) are significantly associated with PFI but did not survive correction for multiple testing.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCED BY TUMOR CHARACTERISTICS&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The dietary patterns of colon cancer patients can be influenced by tumor characteristics such as histology and residual disease, which in turn affect PFI rates.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;POTENTIAL THERAPEUTIC TARGETS&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"While no significant correlations were found for Overall Survival (OS), the association with PFI is important for identifying potential therapeutic targets that may influence both disease progression and patient outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP ARRAY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A SNP array was used for genetic analysis, which is an environmental factor that can influence genomic variants.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;CHROMOSOME 3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A de novo 6.4 Mb deletion on chromosome 3 (chr3:121233326–127618464) is a genomic variant that can affect phenotypic expression.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;UMPS GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The UMPS gene contains the genetic variants found in individuals I4, I7, I10, and I11.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;REFSEQ GENES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"RefSeq genes such as UMPS are involved in protein function and may be influenced by nutritional factors.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;AGENESIS OF THE CORPUS CALLOSUM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"No known gene for agenesis of the corpus callosum was found within the deleted region on chromosome 3, indicating that this condition is not likely caused by genomic variants in these genes.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;PROTEIN TRUNCATION OR NONSENSE-MEDIATED MRNA DECAY (NMD)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The heterozygous alterations found in UMPS are predicted to lead to protein truncation via nonsense-mediated decay, affecting normal protein function.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;HETEROZYGOUS ALTERATIONS IN INDIVIDUALS I4, I7, I10, AND I11&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Heterozygous alterations in UMPS are predicted to lead to loss of normal protein function through mechanisms such as NMD.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;COPY NUMBER VARIATIONS IN UMPS EXCLUDED&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No copy number variations were found in the UMPS region, suggesting that other environmental factors may influence genetic variation in this gene.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;SNP ARRAY OF I1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SNP array analysis detected a large deletion containing multiple RefSeq genes, including UMPS, suggesting a genetic basis for phenotypic expression.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I4 HARBORS THE C.302DELA (P.LYS101ARGFS*9)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In individual I4, a specific deletion mutation (c.302delA) results in a premature stop codon leading to loss of Lys101.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I7 HARBORS THE C.385G&gt;T (P.GLY129*)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In individual I7, a heterozygous alteration (c.385G&gt;T) results in a premature stop codon leading to loss of Gly129.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I10 AND I11 HOMOLOGOUS ALTERATIONS GCN&quot;.&quot;889G&gt;T (P.GLU297*)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Both individuals I10 and I11 have homologous alterations (c.889G&gt;T) resulting in a premature stop codon affecting Gln297.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I4 C.302DELA (P.LYS101ARGFS*9)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In individual I4, the specific deletion mutation results in a premature stop codon affecting Lys101.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I7 C.385G&gt;T (P.GLY129*)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygous alteration at position 385 affects Gly129 in individual I7, indicating a potential impact on protein function.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I10 C.889G&gt;T (P.ERU297*)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygous alteration at position 889 affects Gln297 in both individuals I10 and I11, indicating a potential impact on protein function.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I3 C.224C&gt;A (P.PRO75HIS)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygous alteration at position 224 affects Pro75 in individual I3, with uncertain inheritance pattern.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I5 C.310G&gt;A (P.GLY104ARG)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygous alteration at position 310 affects Gly104 in individual I5, indicating a potential impact on protein function.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I6 C.689G&gt;A (P.ARG230HIS)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Hetzygous alteration at position 689 affects Arg230 in individual I6, with inheritance pattern noted.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I7 C.688C&gt;T (P.ARG230CYS)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Hetzygous alteration at position 688 affects Arg230 in individual I7, indicating a potential impact on protein function.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I9 C.857T&gt;A (P.ILE286ASN)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Hetzygous alteration at position 857 affects Ile286 in individual I9, with inheritance pattern noted.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I11 C.451G&gt;A (P.VAL151MET)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Hetzygous alteration at position 451 affects Val151 in individual I11, indicating a potential impact on protein function.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I3 C.286A&gt;G (P.ARG96GLY)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Hetzygous alteration at position 286 affects Arg96 in individual I3, with uncertain inheritance pattern.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I5 C.310A&gt;G (P.GLY104CYS)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Hetzygous alteration at position 310 affects Gly104, with uncertain function-impacting amino acid change.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I6 C.689A&gt;G (P.ARG230CYS)&quot; VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Hetzygous alteration at position 689 affects Arg230, with inheritance pattern noted.")</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;TGF-SS1 POLYMORPHISM&quot;">
      <data key="d0">"TRANSFORMING GROWTH FACTOR-SS1 HAS A POLYMORPHISM AT RS1800469, WHICH IS ASSOCIATED WITH INCREASED RISK OF CRC.")</data>
      <data key="d1">3</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-8 GENE POLYMORPHISM IN PROMOTER REGION&quot;">
      <data key="d0">"THE IL-8 GENE HAS A POLYMORPHISM AT RS4073 IN THE PROMOTER REGION THAT DOES NOT DIFFER SIGNIFICANTLY BETWEEN PATIENTS WITH CRC AND CONTROLS.")</data>
      <data key="d1">4</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-10 GENE POLYMORPHISM IN PROMOTER REGION&quot;">
      <data key="d0">"THE IL-10 GENE HAS A POLYMORPHISM AT RS1800896, WHERE HETEROZYGOUS AG IS SIGNIFICANTLY DECREASED AMONG PATIENTS WITH CRC.")</data>
      <data key="d1">5</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-22 GENE POLYMORPHISMS AT RS1179251 AND RS2227485&quot;">
      <data key="d0">"THE IL-22 GENE HAS POLYMORPHISMS AT RS1179251 AND RS2227485 THAT SHOW SIGNIFICANT ASSOCIATIONS WITH CRC RISK IN THIS POPULATION.")</data>
      <data key="d1">6</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-27 GENE POLYMORPHISM AT RS17855750&quot;">
      <data key="d0">"THE IL-27 GENE HAS A POLYMORPHISM AT RS17855750 THAT SHOWS AN ASSOCIATION WITH CRC RISK, WITH THE G ALLELE PROVIDING PROTECTIVE EFFECT.")</data>
      <data key="d1">7</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;TGFSS1 GENE POLYMORPHISM IN PROMOTER REGION AT RS1800469&quot;">
      <data key="d0">"THE TGFSS1 GENE HAS A POLYMORPHISM AT RS1800469 THAT SHOWS SIGNIFICANT ASSOCIATIONS WITH CRC RISK AND ITS OCCURRENCE.")</data>
      <data key="d1">8</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;COLORECTAL CANCER RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Association was observed between the CC genotype and occurrence of Colorectal Cancer (p=0.009), indicating a relationship with disease onset."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;CONTROL GROUP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Controls had significantly lower IL-8 serum concentrations than the patient group, indicating a protective effect against asthma severity."&lt;SEP&gt;"The T allele showed lower expression in CRC patients compared to the control group, suggesting potential influences on gene regulation."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68&lt;SEP&gt;chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;ODDS RATIO (OR)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An Odds Ratio of 0.68 between CC genotype and colorectal cancer indicates a significant molecular interaction involving genetic variation and disease risk.") ("entity"</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;COLON CANCER RESEARCH&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Colon cancer research is an area where environmental factors, including genetic variants like the CC genotype, are being studied for their impact on disease occurrence."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;RS1800469 C/T POLYMORPHISM&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Transforming growth factor-ß1 has a polymorphism at rs1800469, which is associated with increased risk of CRC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TGF-SS1&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Transforming growth factor-ß1 has a polymorphism at rs1800469, which is associated with increased risk of CRC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 GENE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-8 gene has a polymorphism at rs4073 in the promoter region that does not differ significantly between patients with CRC and controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERLEUKIN-8 POLYMORPHISM IN PROMOTER REGION&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-8 gene has a polymorphism at rs4073 in the promoter region that does not differ significantly between patients with CRC and controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 GENE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-10 gene has a polymorphism at rs1800896, where heterozygous AG is significantly decreased among patients with CRC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1800896 A/G POLYMORPHISM&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-10 gene has a polymorphism at rs1800896, where heterozygous AG is significantly decreased among patients with CRC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-22 GENE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-22 gene has polymorphisms at rs1179251 and rs2227485 that show significant associations with CRC risk in this population.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1179251 C/G AND RS2227485 C/T POLYMORPHISMS&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-22 gene has polymorphisms at rs1179251 and rs2227485 that show significant associations with CRC risk in this population.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 GENE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-27 gene has a polymorphism at rs17855750 that shows an association with CRC risk, with the G allele providing protective effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS17855750 T/G POLYMORPHISM&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-27 gene has a polymorphism at rs17855750 that shows an association with CRC risk, with the G allele providing protective effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1800469 C/T POLYMORPHISM IN PROMOTER REGION&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The TGFß1 gene has a polymorphism at rs1800469, which shows significant associations with CRC risk and its occurrence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TGFSS1 GENE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The TGFß1 gene has a polymorphism at rs1800469, which shows significant associations with CRC risk and its occurrence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALLELE DISCRIMINATION ASSAY USING TAQMAN METHOD&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The genotyping of SNPs in this study was performed using an allele discrimination assay with the TaqMan method, ensuring accurate and reliable results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPING METHOD&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f&lt;SEP&gt;chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"The genotyping of SNPs in this study was performed using an allele discrimination assay with the TaqMan method, ensuring accurate and reliable results.")&lt;SEP&gt;9</data>
      <data key="d0">"THE STUDY INVOLVES GENOTYPING METHODS TO IDENTIFY SPECIFIC POLYMORPHISMS LINKED TO ASPIRIN INSENSITIVITY IN THE COX-2 AND ITGA2 GENES.")</data>
    </node>
    <node id="&quot;ASTHMATIC PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Asthmatic patients were studied in the context of NYUBAR population comprising a total of 387 unrelated cases."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA RISK FACTOR&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Asthmatic patients and healthy controls showed higher BMI compared to the control group."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;IGE LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Atopic individuals had higher total IgE levels, indicative of atopic tendencies."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;FEV1/FVC RATIO&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Lower FEV1/FVC ratio observed in asthmatic patients compared to healthy controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TSLP GENE VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1898671 was associated with asthma susceptibility, particularly in ex-smokers and never-smokers."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA SUSCEPTIBILITY FACTOR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Protein expression of TSLP is linked to increased risk of asthma according to the study findings."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;RISK FACTOR FOR ASTHMA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"TSLP haplotype analysis showed an association with asthma susceptibility, particularly in never-smokers and ex-smokers.") ("entity"</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMATICS VS. HEALTHY CONTROLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Comparison between asthmatic patients and healthy individuals revealed differences in physiological parameters such as lung function measurements."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;AGE OF PATIENTS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"There was a significant difference in average age among the study participants, with asthma cases being older than health controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;PTPN2:RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP at PTPN2:rs478582 was associated with higher expression of IFN-γ, indicating a potential risk factor for CD development."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PTPN22:RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs in PTPN22:rs2476601 were also present and associated with increased expression of IFN-γ, suggesting a genetic link to immune response in CD."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECTS WITHOUT MAPBACTEREMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CD subjects without evidence of MAPbacteremia have different gene expressions related to T-cell functionality compared to healthy controls."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;HEALTHY CONTROL SUBJECTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Healthy control subjects have distinct gene expression patterns, with no presence of SNPs or MAPbacteremia as identified in the study."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PHA TREATMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"T-cell proliferation response was measured after PHA treatment in CD subjects and healthy controls, showing significant differences in functionality based on genetic variations."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAP PPD-LIKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Treatment with MAP PPD-like also induced different fold changes in T-cells from the two groups: CD subjects showed higher response than healthy control subjects."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;SNPS IN PTPN2:RS478582 AND PTPN22:RS2476601&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNPs in PTPN2:rs478582 and PTPN22:rs2476601 demonstrated a molecular interaction that influences the T-cell response, potentially impacting CD development."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;T-CELL RESPONSE TESTED IN FIVE CD AND FIVE HEALTHY CONTROL SUBJECTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The study tested T-cell responses in both CD and healthy control subjects to understand how genetic factors influence immune function."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;FOLD CHANGE MEASURED IN T-CELLS TREATED WITH PHA FROM CD SUBJECTS TESTED FOR MAPBACTEREMIA PRESENCE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measurements of fold changes showed differential responses between CD subjects with and without evidence of MAPbacteriemia, implicating a pathway related to immune response."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;AVERAGE OVERALL FOLD CHANGE IN T-CELLS TREATED WITH PHA FROM CD SUBJECTS TESTED POSITIVE FOR MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"In the presence of MAPbacteriemia, there was an increased fold change in T-cells from CD subjects compared to those without such evidence."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;AVERAGE OVERALL FOLD CHANGE IN T-CELLS TREATED WITH MAP PPD-LIKE FROM CD SUBJECTS WITHOUT EVIDENCE OF MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"In the absence of MAPbacteriemia, there was a different fold change in response to MAP PPD-like between CD subjects and healthy controls."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAPBACTERIEMIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"MAPbacteriemia presence is an environmental factor that influenced T-cell response measurements."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECTS WITH MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CD subjects with evidence of MAPbacteriemia showed different fold changes in immune responses compared to those without such presence."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;T-CELL FUNCTIONALITY IN CD SUBJECTS WITHOUT SNPS AND MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In CD subjects without SNPs and evidence of MAPbacteriemia, T-cell functionality is distinct from that observed in individuals with both features."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PHA TREATMENT OF HEALTHY CONTROL SUBJECTS TREATED WITH PHA WITHOUT ANY SNPS OR EVIDENCE OF MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Healthy control subjects without any identified genetic variations or evidence of MAPbacteriemia showed a fold change in T-cells after PHA treatment."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAP PPD-LIKE TREATMENT IN HEALTHY CONTROL SUBJECTS WITHOUT SNPS OR EVIDENCE OF MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Healthy control subjects without any identified genetic variations or evidence of MAPbacteriemia showed a fold change in T-cells after treatment with MAP PPD-like."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECT'S T-CELL RESPONSE WHEN TREATED WITH PHA AND POSITIVE FOR EVIDENCE OF MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In CD subjects with both evidence of SNPs and positive for MAPbacteriemia presence, the fold change in response to PHA treatment was higher than those without such indicators."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECT'S T-CELL RESPONSE WHEN TREATED WITH PHA AND NEGATIVE FOR EVIDENCE OF MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In CD subjects negative for evidence of MAPbacteriemia, the fold change in response to PHA treatment was distinct from those with positive indicators."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;HEALTHY CONTROL SUBJECTS TREATED WITH PHA WITHOUT ANY SNPS OR EVIDENCE OF MAPBACTERIEMIA PRESENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Healthy control subjects without any identified genetic variations or evidence of MAPbacteriemia showed a standard fold change in T-cells after PHA treatment."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PTPN22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PTPN22 is a gene that encodes for PTPN22 protein which plays a role in regulating immune responses, particularly affecting calcium flux and MAPK/ERK signaling pathways.")&gt;1&lt;SEP&gt;"PTPN22 is a gene that is more highly expressed in Treg as compared to Tconv, indicating potential involvement in autoimmune disorders."&lt;SEP&gt;"The PTPN22 gene is associated with differential modulation of T cell activation markers in Tconv and Tregs."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b&lt;SEP&gt;chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;LYP-620R&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"LYP-620R variant is a drug that overexpressed reduces APC-mediated proliferation of both Tconv and Tregs."&lt;SEP&gt;"The non-risk allele at rs2476601 encodes for the LYP-620R variant which is associated with reduced risk of T1D. This variant also results in decreased expression of PTPN22.")&gt;2</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b&lt;SEP&gt;chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP-620R TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript encoding the non-risk LYP-620R variant is associated with reduced risk for T1D, indicating a potential role in modulating immune responses through PTPN22 expression.")&gt;3</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD4+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD4+ T cells are a subset of T cells present in the immune system, involved in regulating inflammatory responses and cellular differentiation."&gt;&lt;SEP&gt;"CD4+ T cells are involved in the activation and regulation of immune responses. Naïve, memory, and regulatory subsets were examined for their expression levels of PTPN22 under different conditions.")&gt;4&lt;SEP&gt;"CD4+ T cells show higher expression levels of the IL27RA and IL6ST (gp130) genes, indicating their specific sensitivity to the effects of IL-27 in this cell type."&lt;SEP&gt;"The transcript of the CTLA4 gene influences expression levels in CD4+ T cells, which are critical for immune response."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;NAIVE CD4+ T CELLS&quot;">
      <data key="d0">"T CELL SUBSET"</data>
      <data key="d1">"Naïve CD4+ T cells express lower levels of PTPN22 compared to memory and regulatory subsets, suggesting distinct functional roles in immune response regulation among these cell types.")&gt;5</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;MEMORY CD4+ T CELLS&quot;">
      <data key="d0">"T CELL SUBSET"</data>
      <data key="d1">"Memory CD4+ T cells express higher levels of PTPN22 than naïve cells but still less compared to regulatory subsets, indicating a potential role in immune response regulation and signaling pathways.")&gt;6</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;REGULATORY CD4+ T CELLS&quot;">
      <data key="d0">"T CELL SUBSET"</data>
      <data key="d1">"Regulatory CD4+ T cells express the highest levels of PTPN22 among tested cell types, suggesting a key role in regulating immune responses through PTPN22 expression.")&gt;7</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;POLYCLONAL ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Polyclonal activation results in increased expression of PTPN22 across all CD4+ T cell subsets, potentially affecting calcium flux and downstream signaling pathways.")&gt;8</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CA2+&quot; FLUX">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Decreased Ca2+ flux is associated with the non-risk LYP-620R allele in PTPN22 expressing cells, suggesting a role in regulating immune responses through altered signaling pathways.")&gt;9</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;PERK SIGNALING">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Activation of T cells results in increased pERK signaling. The LYP-620R allele is associated with decreased pERK, indicating a potential role in modulating immune responses through altered signaling pathways.")&gt;10</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;SURFACE MARKERS EXPRESSION">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Activation markers such as CD69, ICOS, and PD-1 were assessed to study the impact of PTPN22 variants on T cell activation. These markers dynamically change upon antigen presentation, suggesting a role in immune response regulation.")&gt;11) ("entity"</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;APC&quot;S">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Antigen-presenting cells (APCs), such as autologous APCs were used to activate stably transduced T cells expressing the LYP variants, facilitating study of their impact on immune responses.")&gt;2</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD69&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD69 is a protein involved in Tconv activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;ICOS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ICOS is a protein observed to be dynamically expressed following Tconv activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD25&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD25, also known as IL-2Ralpha, is involved in Tconv and Treg activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PD-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PD-1 is a protein expressed on activated T cells including Tconv and Tregs."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TREGS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Tregs are also known as regulatory T cells, involved in immune regulation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD226&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD226 is a protein observed to have unique activation marker kinetics on Tregs."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CTLA-4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CTLA-4, also known as CD152, is involved in the regulation of immune response by inhibiting T cell activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP-620W&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"LYP-620W variant, when overexpressed, can block Treg proliferation to a similar degree as LYP-620R but does not affect Tconv proliferation significantly."&lt;SEP&gt;"The expression of LYP-620W resulted in inhibition to a lesser degree compared to LYP variant, though this difference was not significant."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;APCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"APCs are professional antigen-presenting cells that activate T cells upon encounter with antigens."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IL-2R&quot;">
      <data key="d0">"PROTEIN COMPLEX"</data>
      <data key="d1">"IL-2R is involved in the regulation of immune response through its high-affinity component, CD25."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TH1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Th1 refers to a subset of T cells associated with driving immunity against intracellular pathogens such as Mycobacterium tuberculosis."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TH2&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Th2 refers to another subset of T cells that drives immunity against extracellular parasites like Schistosoma mansoni."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IL-2&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"IL-2 is a key cytokine involved in the regulation of immune response by upregulating its high-affinity component, CD25."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IFNΓ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"IFNγ is another cytokine important in driving immunity against intracellular pathogens like Listeria monocytogenes."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP VARIANT&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Both variants of the LYP protein result in similar levels of effector cytokine secretion."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;EFFECTOR CYTOKINE SECRETION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The level of effector cytokine secretion by the LYP protein is influenced by both genetic variants (LYP Variant) and environmental factors such as overexpression of PTPN22 gene."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;RADIATION-IRRADIATED APCS&quot;">
      <data key="d0">"ENVIRONMENT FACTOR"</data>
      <data key="d1">"Radiation-irradiated autologous peripheral blood mononuclear cells (APCs) are used to assess suppressive capacity of Treg and Tconv during co-cultures."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;EGFP REPORTER TREGS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The eGFP reporter gene is used in Tregs for tracking purposes during experiments, indicating their ability to be transduced or manipulated."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;EGFP&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"EGFP (Enhanced Green Fluorescent Protein) is a fluorescent protein that has been genetically incorporated into various cells and molecules for the purpose of visualization and monitoring in research settings."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TCONV PROLIFERATION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Expression of LYP-620R variant reduces APC-mediated Tconv proliferation by 35.32±15.30%.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG PROLIFERATION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Expression of LYP-620W variant blocks Treg proliferation to a similar degree as LYP-620R, supporting differential impact on Tregs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MITOGENIC ACTIVATION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Overexpression of LYP variants does not alter mitogenic activation by PMA and ionomycin, indicating a specific focus on APC-mediated signals rather than general TCR signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PMA AND IONOMYCIN&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Overexpression of LYP variants does not alter mitogenic activation by PMA and ionomycin, indicating a specific focus on APC-mediated signals rather than general TCR signaling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG SUPPRESSIVE CAPACITY&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Overexpressed LYP variants affect Treg suppressive capacity, with the risk variant potentially enhancing suppressive function.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;ANTI-TUMOR ACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The CAR T cells demonstrated potent anti-tumor activity against specific targets such as those found on ovarian cancer cells, indicating a successful physiological process related to the TAG72 gene and its protein product."&gt;</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OAS3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An OAS3 genomic variant is linked to increased risk of hypertension."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS7&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An OAS7 genomic variant has been associated with decreased expression of TAG72 after 72 h in culture, indicating a potential role in vascular function and disease risk."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;TAG72&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TAG72 is likely related to resistance mechanisms of solid tumors."&lt;SEP&gt;"The protein TAG72 is involved in the regulation of cell surface glycoprotein expression on human ovarian cancer ascites cells."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS3 CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The OAS3 cells express 62% of TAG72 after 72 h in culture, suggesting altered protein levels may influence vascular function and disease risk."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS4 CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The OAS4 cells express 80% of TAG72 after 72 h in culture but then decrease to 53%, indicating a dynamic relationship between culturing conditions and protein expression."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS7 CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The OAS7 cells express 67% of TAG72 after 72 h in culture but then decrease to only 19%, reflecting a significant reduction that may be influenced by the same factors affecting other cell types."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;CAR T CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Dosing compared with a single dose improves therapeutic responses, suggesting an effect on treatment outcomes."&lt;SEP&gt;"Potent and selective CAR-mediated killing of the TAG72-positive OAS4 cells indicates a molecular interaction specific to these proteins, suggesting potential for targeted therapies."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;IFNΓ">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"CAR-mediated killing targets were influenced by IFNγ production from TAG72-BBζ CAR T cells, suggesting a specific molecular interaction driving the therapeutic response."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;IL-2">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"CAR-mediated killing targets were influenced by IL-2 production from TAG72-BBζ CAR T cells, indicating another significant molecular interaction driving the therapeutic response."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;MUC16&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"MUC16 is a cell surface antigen expressed at varying levels in ovarian cancer cells."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MUC1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"MUC1 is a protein that shows heterogeneous expression in solid tumors and appears to be associated with tumor recurrence following CAR T cell therapy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;INTERLEUKIN 2&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"IL-2 is produced in response to specific cellular interactions and may influence physiological processes related to disease risk.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;TUMOR ANTIGEN HETEROGENEITY&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Antigen escape may involve the loss or reduced expression of proteins like TAG72, which correlates with tumor recurrences post-CAR T cell therapy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DURABLE ANTI-TUMOR RESPONSES&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Repeat dosing of CAR T cells promotes more extensive and durable tumor regression compared to single doses, suggesting a potential for improved therapeutic responses over time.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REPEAT DOSING&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Repeat dosing of CAR T cells promotes more extensive and durable tumor regression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HUTTERITES&quot;">
      <data key="d0">&gt;&lt;"POPULATION"/&gt;</data>
      <data key="d1">&gt;&lt;A total number of individuals included in the GWAS and their gender distribution were provided."&gt;</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;FEMALE&quot;">
      <data key="d0">"GENDER CATEGORY"</data>
      <data key="d1">"613 females were part of the study population, representing 53.6% of the total participants."&gt;</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;MALE&quot;">
      <data key="d0">"GENDER CATEGORY"</data>
      <data key="d1">"531 males were also included in the GWAS, making up the remaining 46.4% of the total participants."&gt;</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;NUTRIENT-GENE INTERACTION FOR CARDIOVASCULAR HEALTH&quot;">
      <data key="d0">"THE STUDY HIGHLIGHTS HOW DIETARY FACTORS LIKE FOLATE CAN INFLUENCE BOTH GENETIC VARIANTS AND PHYSIOLOGICAL PROCESSES RELATED TO CARDIOVASCULAR FUNCTION."&gt;) ("ENTITY"</data>
      <data key="d1">"Lung Function Measures"</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;POPULATION&quot;">
      <data key="d0">"ASIANS AND CAUCASIANS"</data>
      <data key="d1">"Both rs231775 and rs231725 showed significant association with PBC susceptibility across different population groups."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;STUDY DESIGN&quot;">
      <data key="d0">"META-ANALYSIS"</data>
      <data key="d1">"This research is based on a meta-analysis of 16 studies, which included case-controls to investigate the associations between genetic variants and PBC susceptibility."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSIS&quot;">
      <data key="d0">"OMITTED STUDIES"</data>
      <data key="d1">"Sensitivity analysis showed stable and reliable results across all studies included in the research."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS231775&quot;">
      <data key="d0">"SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"</data>
      <data key="d1">"rs231775 is one of the SNPs studied in relation to PBC susceptibility. It represents a specific variant that influences disease risk."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS231725&quot;">
      <data key="d0">"SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"</data>
      <data key="d1">"Another polymorphism, rs231725, also showed significant association with PBC susceptibility in the study."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS3087243&quot;">
      <data key="d0">"SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"</data>
      <data key="d1">"The SNP rs3087243 did not show an association with PBC susceptibility in this analysis."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS5742909&quot;">
      <data key="d0">"SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"</data>
      <data key="d1">"Similarly, the polymorphism rs5742909 also did not demonstrate a significant relationship to PBC susceptibility in the study population."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;CTLA4&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The CTLA4 gene is involved in regulating nitric oxide production and cardiovascular health."&lt;SEP&gt;"The associations between CTLA4 polymorphisms rs231775 showed no evidence of publication bias, as confirmed by statistical tests.")&gt; ("entity"</data>
      <data key="d0">"GENE"</data>
    </node>
    <node id="&quot;POLYMORPHISM&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The associations between CTLA4 polymorphisms rs231775 showed no evidence of publication bias, as confirmed by statistical tests.")&gt; ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD8+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD8+ T cells are another type of T cell that also plays roles in the immune response."&gt;&lt;SEP&gt;"In contrast, CD8+ T cells show no significant trans-eQTL effects at the locus investigated, suggesting a distinct regulation of interferon signaling pathways in these two subsets of T cells."&lt;SEP&gt;"The transcript of the CTLA4 gene also affects CD8+ T cells, involved in adaptive immunity and inflammation."&lt;SEP&gt;"CD8+ T cells are responsible for recognizing and eliminating virus-infected or cancerous cells in vertebrates."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;PBMCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Peripheral Blood Mononuclear Cells (PBMCs) are a component of blood from which purified CD4+ and CD8+ T cells were isolated for genome-wide gene expression analysis."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;1000 GENOMES REFERENCE PANEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The 1000 Genomes reference panel is used as part of the genomic imputation process in this study, providing a genetic background against which SNPs and gene expression data can be compared."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;GENOTYPING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genotyping involves identifying specific variations at single nucleotide polymorphisms (SNPs), which are used to track genetic variation across the population for various studies including this one."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;IMPUTATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Imputation is a statistical method used in genomics to estimate missing data based on related information, aiding in analysis of gene expression and genomic variants."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;DNA METHYLATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"DNA methylation involves the addition of a methyl group to DNA, which can influence how genes are expressed. This study examined DNA methylation across 450,000 CpG sites in purified cells."&gt;&lt;SEP&gt;"Divergent DNA methylation between CD4+ and CD8+ T cells may influence gene expression patterns."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;GENE EXPRESSION ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gene expression analysis involves measuring how RNA is processed from genes into functional proteins within cells, used to study biological processes like inflammation regulation."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;INFLAMMATORY RESPONSES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Inflammatory responses are regulated by immune system components such as T cells and are studied in the context of diseases including type 1 diabetes (T1D) and rheumatoid arthritis (RA)."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;GENE REGULATORY ELEMENTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Gene regulatory elements, like cis-regulatory SNPs identified here, can influence how gene expression is controlled within cells."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;TRANSCRIPTIONAL ACTIVATOR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"STAT6 is a transcriptional activator protein involved in T cell differentiation and function."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;SYNTAXIN 2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Syntaxin 2 (STX2), involved in intracellular transport of vesicles, is another gene regulated by genetic variation studied here."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;RP11−534L20.5&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"RP11-534L20.5 is a coding RNA located downstream of the IKBKE gene and its regulation was examined in this study."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;INHIBITORY IMMUNE CHECKPOINT GENE CTLA4&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CTLA4, an immune checkpoint gene involved in regulating T cell responses, has been studied for its association with autoimmune diseases such as type 1 diabetes and rheumatoid arthritis."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;TISSUE-BY-TISSUE ANALYSIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A tissue-by-tissue analysis combines data from different tissues to understand how genetic factors influence gene expression across various cell types."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;BAYESIAN MODEL AVERAGING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Bayesian model averaging is used in this study to jointly call eQTLs, providing insights into the molecular interactions influencing gene expression across T cells.")&gt; ("entity"</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;POLYCLONAL POPULATION OF T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A polyclonal population refers to a diverse group of T cells derived from multiple sources within an individual, as seen in the study participants contributing PBMC samples."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;DISEASE RISK ALLELES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Disease risk alleles are variations at specific SNPs that have been linked to increased risks for various diseases such as type 1 diabetes and rheumatoid arthritis, studied in the context of T cell function here."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CHI-SQUARE TEST&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The chi-square test is used in this study to determine statistical significance between gene expression levels and genetic variants."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;DIFFERENTIAL METHYLATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"Differential methylation involves comparing DNA methylation patterns across different cell types or conditions, as studied here with CD4+ and CD8+ T cells."&gt;</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;LONG CODING RNA RP11−534L20.5&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"RP11-534L20.5 is a long coding RNA that plays roles in regulating inflammatory responses, studied here as influenced by genetic factors."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;EQTLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"eQTL effects identified suggest differential splicing and regulatory interactions in the CTLA4 gene transcript across different T cell types."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;GWAS SNPS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genome-wide significant GWAS SNPs found to influence expression of genes such as CTLA4, involved in immune response and inflammation."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;T1D RISK GENES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Associated genes with trans-eQTL effects linked to T1D risk include those influencing T cell function and autoimmune responses."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;VITILIGO&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Associated GWAS SNPs identified in the study also have implications for conditions like vitiligo, highlighting a broader genetic influence on immune response genes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;INFLAMMATORY DISEASES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"GWAS SNP associations with gene expression highlight potential links to inflammatory diseases including autoimmune disorders."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IRF1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IRF1 is a gene involved in transcriptional regulation, specifically activating interferon-stimulated response elements (ISRE) and mediating signaling through STAT1."&lt;SEP&gt;"IRF1 protein plays a role in immune response and is influenced by genetic variants such as the missense rs181206[G] variant associated with T1D risk."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;STAT1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"STAT1 is another gene that also responds to IFN regulatory factors, particularly IRF1. It plays a critical role in the immune response by regulating the expression of various genes upon interferon stimulation."&lt;SEP&gt;"STAT1, another gene impacted by trans-eQTL effects, has implications for immune regulation in CD4+ and potentially related diseases like T1D."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;REC8&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"REC8 protein is involved in processes such as DNA replication and repair, influenced by genetic variants associated with autoimmune disorders."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IL27&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A missense SNP rs4788084[T] on chr16p11.2 near the IL27 gene influences T cell function and risk of type 1 diabetes."&lt;SEP&gt;"IL-27 is an environmental factor that influences T cell function through the regulation of genes like IRF1 and STAT1. Its effects are specific to CD4+ cells, as seen in this study."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;VASCULAR FUNCTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Vascular function can be modulated by environmental factors such as diet and lifestyle choices."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IL-27&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"IL-27 is a cytokine produced by innate immune cells that activates the STAT1/STAT3 pathway in T cells. It plays a key role in regulating IRF1 and STAT1 expression."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;EBI3&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"EBI3, along with IL-27, forms the heterodimer that interacts with its receptor IL27RA to activate the STAT1/STAT3 pathway. This protein complex is critical for immune response and gene regulation."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL27RA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL27RA is the receptor for IL-27 cytokine, which couples with EBI3 to initiate signaling pathways affecting genes like IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;B CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"No significant changes were detected in expression levels for B cells and monocytes, indicating that the transcriptional effects observed are specific to certain immune cell types."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;INTERFERON STIMULATED RESPONSE ELEMENTS (ISRE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The ISRE is a DNA sequence motif recognized by IRF1 and STAT1 for gene expression upon interferon stimulation, highlighting their role in response to various stimuli including pathogens or inflammatory signals."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"This study involved T cells, specifically CD4+ and CD8+ subsets, which are key players in immune response and cellular interactions."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;PBMCS (PERIPHERAL BLOOD MONONUCLEAR CELLS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Human PBMCs were used as a source of cells to investigate the effects of IL27 missense SNP on IRF1 and STAT1 expression, indicating their significance in immune response research."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HEK293 CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"HEK293 cells were employed for transfection experiments involving cDNA variants of IL-27 to study the functional effects of genetic variants on gene expression. These cells are commonly used in molecular biology studies due to their ability to express and secrete recombinant proteins."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;EBI3 (DISEASE ANTIGEN, HBIT)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"EBI3 is another protein that forms a heterodimer with IL-27. It plays a role in activating the STAT1/STAT3 pathway upon binding to interferon stimulated response elements (ISRE)."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;INTERFERON STIMULATED GENES (ISGS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These genes, including IRF1 and STAT1, are part of the ISG family that is induced in response to various stimuli such as pathogen exposure or inflammation. They play critical roles in immune responses."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;CYTOKINE RECEPTOR COMPLEXES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The complex formed by IL27RA and EBI3, upon binding with IL-27, is a receptor complex that plays a key role in signaling pathways affecting genes like IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;INTERFERON REGULATORY FACTORS (IRFS)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IRF family members including IRF1 are critical for transcriptional regulation of interferon-stimulated response elements (ISRE)."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IRF1 &amp; STAT1&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"IL-27 influences both IRF1 and STAT1 gene regulation through a region shared by these genes. The interaction between IL-27, its receptors, and the target genes is critical for immune response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFICITY TO CELL TYPE&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"This study highlights that the effects of the IL27 missense SNP are specific to CD4+ T cells; no significant changes were observed in expression levels at this locus in CD8+ T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABSENCE OF SIGNIFICANT EFFECTS&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Despite investigation, there were no detectable effects on B cell or monocyte gene expression within the studied region. This suggests specificity to certain immune cell types.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;B CELLS &amp; MONOCYTES&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Despite investigation, there were no detectable effects on B cell or monocyte gene expression within the studied region. This suggests specificity to certain immune cell types.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-8 protein levels were found to be significantly higher in the patient group than in the control group, indicating a potential role in asthma severity."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA PATIENT GROUP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients with asthma showed elevated IL-8 serum concentrations and mRNA levels compared to healthy controls."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RS4073 POLYMORPHISM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The rs4073 polymorphism was found in a higher frequency among asthmatics, suggesting a link between this genotype and the risk of developing asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RS2227306 POLYMORPHISM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Patients with moderate-to-severe asthma had significantly higher IL-8 mRNA levels compared to those with mild asthma, indicating that genetic variations may contribute to disease severity."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ATOPY GROUP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Children with atopic asthma showed a significant association between specific genotypes and increased risk for developing the condition."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;DIPLOTYPE AT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The presence of the rare diplotype AT was significantly associated with low asthma childhood risk in our population, indicating that environmental factors may influence genetic susceptibility to asthma.") ("entity"</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;PBMC COMPOSITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No significant differences were observed in PBMC composition between asthmatics and healthy controls, indicating that other factors may be influencing IL-8 expression."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;8P22-P21.3 REGION&quot;">
      <data key="d0">"GENOMIC LOCATION ON CHROMOSOME 8"</data>
      <data key="d1">"This region contains several genes such as the ASAH1 gene and other typed SNPs that are involved in various biological processes affecting human traits and diseases.")</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;HAPMAP SNPS&quot;">
      <data key="d0">"SNPS ON 8P22-P21.3"</data>
      <data key="d1">"The HapMap SNPs include genetic variants within the ASAH1 gene region that are associated with different phenotypes such as cardiovascular health and hypertension.")</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;ILLUMINA HUMANHAP550 ARRAY&quot;">
      <data key="d0">"GENOTYPING PLATFORM USED TO ANALYZE 8P22-P21.3 REGION"</data>
      <data key="d1">"This platform is used for genotyping the typed SNPs within the ASAH1 gene region and other genes located in the same genomic location.")</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP-SET FORMATION&quot;">
      <data key="d0">"INCLUSION OF ONLY 14 TYPED SNPS FROM HAPMAP"</data>
      <data key="d1">"Only these 14 typed SNPs are included in the analysis to better understand their functional roles within the ASAH1 gene region and their impact on human traits.")</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP-SET ANALYSIS&quot;">
      <data key="d0">"EMPIRICAL POWER FOR KERNEL MACHINE TEST AND MIN TEST"</data>
      <data key="d1">"The empirical power of the kernel machine SNP-set test (using the linear kernel) is higher than that of the single SNP-based min test in certain scenarios, particularly when there are moderate levels of LD between causal and typed SNPs.")</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;NAT2 GENE&quot;">
      <data key="d0">"GENE ON 8P22"</data>
      <data key="d1">"The NAT2 gene encodes an enzyme involved in the metabolism of drugs and carcinogens. It plays a crucial role in drug efficacy and adverse effects due to its involvement in the oxidative deamination of arylamine substrates.")</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;HAPMAP SNPS FOR NAT2 GENE&quot;">
      <data key="d0">"SNPS ON 8P22"</data>
      <data key="d1">"These SNPs are involved in determining variations in gene expression within the NAT2 region, affecting drug efficacy and adverse effects. They include rs1390358, rs1112005, rs7832071, and rs1208.")</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;TYPED SNPS FOR NAT2 GENE&quot;">
      <data key="d0">"INVOLVED IN DETERMINING VARIATIONS IN EXPRESSION"</data>
      <data key="d1">"The four typed SNPs include rs1390358, rs1112005, rs7832071, and rs1208. These are critical for understanding the impact of genetic variation on drug metabolism within the NAT2 gene region.")</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;ASAH1 GENE&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"The ASAH1 gene region consists of SNPs with a good correlation structure, in which the typed SNPs are typically in high LD with each other and with the causal SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS ON 8P22-P21.3&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"The ASAH1 gene region consists of SNPs with a good correlation structure, in which the typed SNPs are typically in high LD with each other and with the causal SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EMPIRICAL POWER&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"The empirical power of the kernel machine SNP-set test (using the linear kernel) is higher than that of the single SNP-based min test for certain scenarios, particularly when there are moderate levels of LD between the causal SNP and typed SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KERNEL MACHINE TEST&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"The empirical power of the kernel machine SNP-set test (using the linear kernel) is higher than that of the single SNP-based min test for certain scenarios, particularly when there are moderate levels of LD between the causal SNP and typed SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MIN TEST&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"In contrast, the empirical power of the min test can be higher than that of the kernel machine method in specific instances, such as when only a single true causal SNP is tested (or one in high LD with it), which is not likely to occur frequently in actual GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B GENE&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Using MAF as weights in the weighted IBS kernel can upweight rare alleles, leading to higher power for certain SNPs compared to a linear genetic effect scenario where the power of the weighted IBS kernel is no greater than that of the linear kernel.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MAF&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Using MAF as weights in the weighted IBS kernel can upweight rare alleles, leading to higher power for certain SNPs compared to a linear genetic effect scenario where the power of the weighted IBS kernel is no greater than that of the linear kernel.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP-BASED MIN TEST&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Higher Power in Certain SNPs"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGFR2 GENE&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Outperforms Min Test in Some Regions of High LD"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KERNEL MACHINE METHOD&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Outperforms Min Test in Some Regions of High LD"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B GENE WEIGHTED IBS KERNEL&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Using MAF as weights in the weighted IBS kernel can upweight rare alleles, leading to higher empirical power for certain SNPs compared to a linear genetic effect scenario where the power of the weighted IBS kernel is no greater than that of the linear kernel.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MAF (MINOR ALLELE FREQUENCY)&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Using MAF as weights in the weighted IBS kernel can upweight rare alleles, leading to higher empirical power for certain SNPs compared to a linear genetic effect scenario where the power of the weighted IBS kernel is no greater than that of the linear kernel.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAUSAL SNPS">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"In scenarios with moderate levels of LD between causal and typed SNPs, the kernel machine method has higher empirical power than the min test at a nominal level of α = 0.05.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 1 ERROR RATE&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"In scenarios with moderate levels of LD between causal and typed SNPs, the kernel machine method has higher empirical power than the min test at a nominal level of α = 0.05.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBS AND WEIGHTED IBS KERNEL POWER&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Even when survival time is simulated assuming a linear model, the empirical power of the IBS and weighted IBS kernel remains high but does not exceed that of the linear kernel, which corresponds to Cox models with linear genetic effects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SURVIVAL TIME SIMULATED AS LINEAR MODEL&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"Even when survival time is simulated assuming a linear model, the empirical power of the IBS and weighted IBS kernel remains high but does not exceed that of the linear kernel, which corresponds to Cox models with linear genetic effects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METASTATIC MELANOMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Metastatic melanoma is the focus of this study, affecting a population of patients treated with various therapies including anti-CTLA-4 and anti-PD-1."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-CTLA-4&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Anti-CTLA-4 therapy involves treatments such as ipilimumab and tremelimumab administered to 215 patients in the study population."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-PD-1&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Another therapy studied was anti-PD-1, involving drugs like nivolumab and pembrolizumab, used on 176 patients within the study group."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;NYULH&quot;">
      <data key="d0">"LOCATION"</data>
      <data key="d1">"Treatment samples for anti-CTLA-4 were obtained from NYULH, with specific numbers varying by drug used (ipilimumab=150, tremelimumab=15)."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;UCLA&quot;">
      <data key="d0">"LOCATION"</data>
      <data key="d1">"Samples for anti-PD-1 therapy came from UCLA and were divided into groups according to the drugs used: nivolumab=17, pembrolizumab=159."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;MGH&quot;">
      <data key="d0">"LOCATION"</data>
      <data key="d1">"Combination therapy samples were obtained from MGH with a smaller number of participants (n=34 for NYULH and n=11)."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;COMBINATION THERAPY">
      <data key="d0">"RESPONSE RATE"</data>
      <data key="d1">"In combination therapy, a high response rate of 76.74% was observed for this study population."&gt;)&gt;|</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;COMBINATION-THERAPY TREATED PATIENTS&quot;">
      <data key="d0">"RESPONDERS/CONTROLS/CASES"</data>
      <data key="d1">"Patients in combination therapy, including those treated with anti-CTLA-4, anti-PD-1, and other treatments were analyzed."&lt;SEP&gt;"Patients in the combination-therapy group were divided into responders, controls, and non-responders as indicated in Table 2."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;SNPS TESTED&quot;">
      <data key="d0">"STATISTICAL ASSOCIATION"</data>
      <data key="d1">"No significant statistical associations with 23 SNPs tested reached significance after multiple testing adjustments."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;COMBINATION-THERAPY COHORT&quot;">
      <data key="d0">"STATISTICAL POWER"</data>
      <data key="d1">"Due to the small sample size in the combination-therapy cohort, this analysis has a limited statistical power."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;RESPONSE RATE&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The overall response rate for anti-CTLA-4 therapy was 36.91%, with higher rates seen in combination therapies at 76.74%.")&gt;|</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT RESPONSE ASSOCIATION&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"No significant association between treatment response and the tested SNPs was observed across all treatments (Supplementary Table S2).") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"EBNA2 is a gene that binds to specific alleles of MS risk loci in LCLs, regulating expression of associated genes.")&gt;1&lt;SEP&gt;"EBNA2 is a protein that interacts with MS risk loci, altering gene expression."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;LOCUS&quot;">
      <data key="d0">"CD40"</data>
      <data key="d1">"Disease"&lt;SEP&gt;"Genomic Variant"</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;MS RISK LOCI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"MS risk loci are involved in the EBV latency III program proximal to signaling molecules like LMP1 and LMP2."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TRAFL3&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"TRAFL3 is a transcript that shows differential expression influenced by EBNA2 interactions with MS risk alleles."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;CD40&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CD40 is a gene that has one allele protected against EBNA2 binding, resulting in lower relative expression."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TNFAIP8&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TNFAIP8 is another gene with an allele preferentially bound by EBNA2 and showing decreased expression compared to B cells."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TNFRSF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TNFRSF1A, like CD40 and TNFAIP8, has one allele protected against EBNA2 binding in LCLs."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TBX6&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TBX6 is a protein associated with MS risk loci, potentially influenced by the preferential binding of EBNA2 to certain alleles."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;RCOR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RCOR1 is another gene whose expression can be inferred from changes in relative allelic association under EBNA2-TAT treatment."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LMP1">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"LMP1, a signaling molecule involved in the EBV latency III program, interacts with risk loci influenced by EBNA2."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LMP2&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"LMP2 is another signaling molecule that plays a role in the immune evasion suggested by EBNA2's interaction with MS risk loci."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LATENCY III INFECTION CYCLE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Latency III infection cycle, involving LMP1 and LMP2, may be enhanced through alterations in gene expression by EBNA2."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;IMMUNE EVASION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The interaction of EBNA2 with MS risk loci is postulated to increase host immune evasion via altered gene expression profiles such as those seen for TRAF3, CD40, TNFAIP8 and RCOR1."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TRAFF3-RCOVR1&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"Genomic Variant"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRAFF3&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;POPULATION STRATA&quot;">
      <data key="d0">"SEPARATE ANALYSES WERE PERFORMED WITHIN STRATA INVOLVING TWO OR MORE COMPARISONS TO ASSESS THE INFLUENCE OF CATEGORICAL CONFOUNDERS LIKE ASPIRIN SENSITIVITY TYPES ON GENETIC VARIANTS SUCH AS RS1126643 AND RS20417.")</data>
      <data key="d1">11</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ETHNICITY">
      <data key="d0">"RS1126643 IS A GENOMIC VARIANT THAT SHOWS SIGNIFICANT ASSOCIATION WITH ASPIRIN INSENSITIVITY ACROSS DIFFERENT ETHNICITIES INCLUDING CAUCASIANS, CHINESE, AND MIXED POPULATIONS."&gt;</data>
      <data key="d1">12</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;STUDY POPULATION">
      <data key="d0">"THE STUDY POPULATION INVOLVED IN THESE GENETIC INVESTIGATIONS INCLUDES CHINESE AND CAUCASIAN INDIVIDUALS, WITH SPECIFIC FOCUS ON ASPIRIN INSENSITIVITY LINKED TO THE COX-2 AND ITGA2 GENES.")</data>
      <data key="d1">14) ("entity"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ITGA2 GENE&quot;">
      <data key="d0">"ITGA2 PROTEIN, LINKED TO THE ITGA2 GENE, PLAYS A SIGNIFICANT ROLE IN DETERMINING ASPIRIN SENSITIVITY AND RESISTANCE.")</data>
      <data key="d1">16</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS20417&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs20417 is a genomic variant associated with differences in percentage of Coronary Artery Disease between patients and controls."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;CAD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Coronary Artery Disease (CAD) is related to the rs20417 genomic variant."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;PLATELET NUMBER&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Averaged platelet number was a significant source of heterogeneity for rs1126643, indicating its role as an environmental factor impacting disease risk."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;RS1126643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs1126643 is another genomic variant associated with CAD, and it is linked to platelet number."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;PNEUMONIA WITH SEPSIS&quot;">
      <data key="d0">"DISEASE/CONDITION"</data>
      <data key="d1">"Neonatal hospitalization for pneumonia with sepsis required antibiotic treatments and supplemental oxygen to manage the infections."|&gt;2</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SUPPLEMENTAL OXYGEN&quot;">
      <data key="d0">"TREATMENT METHOD"</data>
      <data key="d1">"Supplemental oxygen was used as a treatment for recurrent respiratory infections, reducing the frequency of hospitalizations over time."|&gt;3</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;LEVOTHYROXINE&quot;">
      <data key="d0">"DRUG THERAPY"</data>
      <data key="d1">"All three siblings were diagnosed with autoimmune thyroiditis and treated with levothyroxine to manage their autoimmune conditions."|&gt;4</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SEPSIS&quot;">
      <data key="d0">"DISEASE/CONDITION"</data>
      <data key="d1">"The sibling experienced sepsis requiring hospitalization for pneumonia, a severe infection that necessitated intensive care measures including antibiotics and supplemental oxygen."|&gt;5</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;ANTIBIOTIC TREATMENT&quot;">
      <data key="d0">"TREATMENT METHOD"</data>
      <data key="d1">"Recurrent infections such as pneumonia and urinary tract infections required ongoing antibiotic treatments to manage the conditions effectively."|&gt;6</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SUPPLEMENTAL INSULIN-LIKE GROWTH FACTOR (IGF)-1 THERAPY&quot;">
      <data key="d0">"MEDICAL PROCEDURE"</data>
      <data key="d1">"Recombinant human insulin-like growth factor 1 (rhIGF-1) therapy was prescribed for all three siblings, aiming to improve their postnatal growth and development."|&gt;7</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;AUTOIMMUNE THYROIDITIS">
      <data key="d0">"DISEASE/CONDITION"</data>
      <data key="d1">"All three siblings were diagnosed with autoimmune thyroiditis at different ages, indicating a potential genetic predisposition or environmental factors contributing to this condition."|&gt;8</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;CD25+FOXP3+&quot;">
      <data key="d0">"TREGS (REGULATORY T CELLS)"</data>
      <data key="d1">"In young children with STAT5B deficiency, FOXP3 expression is maintained despite reduced Treg numbers.")</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;CD4+CD45+&quot;">
      <data key="d0">"NAÏVE T CELLS"</data>
      <data key="d1">"Both CD4+ and CD8+ naïve T cells are reduced in the presence of STAT5B deficiency.")</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;TCM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"TCM cells are normal cells that remained within their typical ranges."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ TEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"No alterations in the proportion of CD4+ TEM cells were identified."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Increases in CD8+ TEM cell proportions became clinically significant with age, particularly in each sibling (Figure 3D)."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;P2 &amp; P3&quot;">
      <data key="d0">"INDIVIDUALS"</data>
      <data key="d1">"Elevations in CD8+ TEMRA cells detected during infancy in P2 and P3 normalized around age 4."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;P1&quot;">
      <data key="d0">"INDIVIDUALS"</data>
      <data key="d1">"The increase in CD8+ TEMRA cells normalized around age 4, particularly for P1 (Figure 3E)."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;STAT5B DEFICIENCY&quot;">
      <data key="d0">"DISEASE OR SYNDROME"</data>
      <data key="d1">"Patients carrying the LOF STAT5B variant show dysregulation of CD8+ T cells despite normal memory subsets."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ MEMORY T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Despite elevated levels of CD8+ T cells, there were no alterations in the proportion of CD4+ memory T cell subsets observed. This is an observation not previously reported for STAT5B deficiency."&lt;SEP&gt;"The normal levels and proportions of CD4+ memory T cells suggest a balanced state despite alterations observed in CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ MEMORY T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Elevations in CD8+ memory T cells suggest a potential role in disease onset and/or progression. The specific variant under study may influence the homeostasis of these cells."&lt;SEP&gt;"Patients carried elevated proportions of CD8+ memory T cells beginning in infancy, suggesting a critical role for the LOF STAT5B variant in CD8+ T cell activation and homeostasis."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;DYSREGULATION OF CD8+ T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A dysregulation of CD8+ T cells was noted despite normal CD4+ memory T cell subsets, suggesting a critical role for the LOF STAT5B variant in CD8+ T cell activation and homeostasis."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;HOMEOSTASIS OF CD8+ T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Patients carrying elevated proportions of CD8+ memory T cells suggest that this LOF STAT5B variant is involved in the maintenance or homeostasis of CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;FIGURE S4C &amp; FIGURE 3C&quot;">
      <data key="d0">"REFERENCE OR DATA POINT"</data>
      <data key="d1">"These figures depict the typical ranges for various cell types, including TCM cells, indicating normal physiological parameters."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;LOF STAT5B VARIANT&quot;">
      <data key="d0">"DISEASE OR SYNDROME"</data>
      <data key="d1">"The LOF STAT5B variant is associated with an imbalance in CD8+ memory T cells, suggesting a critical role for this genetic factor in disease pathogenesis."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;RHIGF-1 THERAPY&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Recombinant human insulin-like growth factor 1 (rhIGF-1) therapy was prescribed to improve growth in all three siblings, a specific treatment for their GHI phenotype."|&gt;6) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT RESPONSE&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Recombinant human insulin-like growth factor 1 (rhIGF-1) therapy was prescribed to improve growth in all three siblings, a specific treatment for their GHI phenotype."|&gt;6) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NITRIC OXIDE PRODUCTION&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"A genomic variant in the STAT5B gene affects nitric oxide production.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="{&quot;DISEASE OR SYNDROME&quot;: [&quot;STAT5B DEFICIENCY&quot;, &quot;CARDIOVASCULAR DISEASE&quot;]}">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"LOF STAT5B Variant Effects"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD8+ TEMRA CELLS CHANGES&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"Physiological Process or Phenomenon"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCM CELLS &amp; CD4+ MEMORY T CELLS&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"Physiological Process or Phenomenon"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOF STAT5B VARIANT EFFECTS&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"CD8+ Memory T Cells"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-DRB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-DRB1 gene is associated with antigen presentation and has a significant role in immune response."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DQB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-DQB1 gene plays a crucial role in the regulation of immune responses, affecting autoimmune diseases such as type 1 diabetes."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS28383172&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant (rs28383172) is associated with HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS28383172 AG OR GG&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genetic variants in rs28383172 influence molecular interactions within the immune system, affecting HLA class II expression and antigen presentation."&lt;SEP&gt;"The AG or GG genotypes of rs28383172 are associated with increased likelihood of carrying the HLA-DRB1*07:01 allele."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS2395182 TT OR TG&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TT or TG genotypes of rs2395182 are associated with specific alleles related to autoimmune conditions such as type 1 diabetes."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS4713586 TT AND RS7775228 TC OR CC&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs4713586 TT and rs7775228 TC or CC genotypes are linked to specific HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype patterns."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01 ALLELE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The HLA-DRB1*07:01 allele is associated with the intake of specific nutrients that influence immune responses and disease susceptibility."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;DQA1*02:01 AND DQB1*02:02 HAPLOTYPES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype is critical for antigen presentation and immune regulation."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE CARRIER STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Carrying the HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype is associated with a specific physiological process that influences immune response and disease susceptibility."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SENSITIVITY AND SPECIFICITY OF ALGORITHMS II TO V&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The sensitivity and specificity of the genetic testing algorithms were analyzed, indicating their accuracy in predicting HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;POSITIVE PREDICTIVE VALUE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The positive predictive value of the genetic tests was assessed, suggesting their reliability in identifying individuals with HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;NEGATIVE PREDICTIVE VALUE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The negative predictive value of the genetic tests was considered, ensuring their effectiveness in ruling out HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE TAGGING IN ALGORITHMS III AND IV&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNP combinations used for HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype‐tagging were assessed, confirming their use as predictors of autoimmune conditions."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SPECIFICITY AND POSITIVE PREDICTIVE VALUE OF ALGORITHM V IN EUR SUPER POPULATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The specific targeting of HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype with high specificity and positive predictive value was observed, indicating its potential utility in clinical settings.") ("entity"</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;CD40LG&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CD40 ligand (CD40LG) is crucial for the activation of helper T cells and B cells during adaptive immunity."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;FCGAMMARIIB&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FcgammaRIIB is a receptor involved in immune response, specifically modulating FcgammaR-mediated phagocytosis."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DO&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-DO gene product plays a role in downregulating MHC class II expression on antigen-presenting cells without altering classical class I expression."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;IL12RB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL12RB1 gene is essential for interleukin-12 signaling, contributing to immune response and inflammation."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;LTA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LTA gene encodes the leukocyte function antigen-1 (LFA-1), a key component in T cell activation and adhesion during immune responses."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;CD3E&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD3e is part of the CD3 complex on T cells, essential for signaling in adaptive immunity processes."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HIV-INFECTED INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"150 HIV-infected individuals were enrolled in the study, which aimed to investigate their disease characteristics."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TOBACCO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Consumption of tobacco did not differ between tobacco-consuming HIV-infected individuals and nonusers of these substances according to the study results presented in Table 5.") ("entity"</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;CD4 COUNTS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Baseline CD4 counts were mentioned as part of the demographic information, but further details on their correlation with TLR7 polymorphisms or other environmental factors were not provided."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;ALK R1275Q&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ALK R1275Q is a protein associated with non-small cell lung cancer (NSCLC) and has been identified as a potential therapeutic target."&lt;SEP&gt;"ALK R1275Q is a target for neoantigen-directed cancer immunotherapies, with the text discussing its potential in different peptide/HLA interactions."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074&lt;SEP&gt;chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-B*15:01&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"HLA-B*15:01 is a human leukocyte antigen that presents neoantigens to the immune system, including those from ALK R1275Q."&lt;SEP&gt;"The text discusses the binding preferences of HLA-B*15:01 for different neoepitopes, including ALK R1275Q, and how these preferences can impact therapeutic strategies based on neoantigen targeting."&gt;14</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074&lt;SEP&gt;chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ARDIYRASY&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"ARDIYRASY peptide is used as a self-peptide in the text, indicating that forming such complex would compromise therapeutic relevance due to immune tolerance mechanisms limiting T cell response repertoire."&lt;SEP&gt;"ARDIYRASYY and ARDIYRASY are self-peptides used as controls in binding studies with HLA-B*15:01, indicating their minimal potential to form stable complexes with the antigen-presenting molecule."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074&lt;SEP&gt;chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NRAS Q61K&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"NRAS Q61K is a mutation found in melanoma and thyroid cancer, which suggests its involvement in these diseases and relevance for immunotherapies targeting these cancers."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;MELANOMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"NRAS Q61K has been identified in melanoma patients, suggesting it may play a role in the disease progression of this type of cancer."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;THYROID CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Thyroid cancers are associated with NRAS mutations and other genomic variants that contribute to tumor growth and treatment resistance."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;COLORECTAL CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The presence of NRAS Q61K has also been identified in colorectal cancer, indicating its potential role as a therapeutic target for this disease."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;THERAPEUTIC TARGET&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ALK R1275Q is considered a therapeutic target due to its association with NSCLC, suggesting potential for drug development against this mutation."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;IMMUNOTHERAPIES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The identification of neoantigens such as ALK R1275Q in cancers like NSCLC may guide the development of personalized immunotherapies based on dietary patterns and genetic profiles."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;PERSONALIZED THERAPIES&quot;">
      <data key="d0">"DRUG THERAPY"</data>
      <data key="d1">"The presence of specific mutations, including those found in ALK R1275Q, is driving research into more targeted drug therapies for NSCLC patients."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NEOEPITOPE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Neoantigens are peptides displayed by MHC molecules that play a role in immune response."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;LC-MS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Liquid chromatography–mass spectroscopy (LC-MS) used to identify neoepitopes.")&gt;2</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;TUMOR NEOEPITOPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Tumor neoepitopes interact with MHC molecules.")&gt;3</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;RECOMBINANT HLA-B*15:01&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Recombinant HLA-B*15:01 used for refolding tumor neoepitopes.")&gt;5</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;PEPTIDE MELTING TEMPERATURE (TM)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Peptide melting temperatures correlate with predicted IC50 values for immune response.")&gt;7</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;TCR (T-CELL RECEPTOR)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"TCRs interact with neoantigens displayed on MHC molecules, influenced by environmental factors.")&gt;9</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY (LC-MS)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Used for identifying neoepitopes through analyzing peptides displayed by MHC molecules."&gt;2</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;IONOGENIC PEPTIDE ANCHOR RESIDUES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Anchor residues in peptides interact with the binding groove of MHC molecules.")&gt;3</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The decamer peptide forms a compact 310 helical backbone conformation within the MHC groove.")&gt;5&lt;SEP&gt;"The decamer peptide is a protein that forms a stable complex with HLA-A*01:01."&lt;SEP&gt;"The decamer peptide is another component of the antigens presented by HLAs to T cells, aiding in immune responses against cancer."&gt;4</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;CRYSTALLINE STRUCTURE RESOLUTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"X-ray structures of peptides reveal their conformation within the MHC groove under different conditions."&gt;7</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;ILE4&quot;">
      <data key="d0">"PEPTIDE RESIDUE"</data>
      <data key="d1">"Ile4 is a residue in the ALK R1275Q neoepitope that plays a role in the binding affinity for HLA-B*15:01."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TYR5&quot;">
      <data key="d0">"PEPTIDE RESIDUE"</data>
      <data key="d1">"Y Tyr5 is another residue in the ALK R1275Q neoepitope, contributing to peptide binding and stability with HLA-B*15:01."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SER8&quot;">
      <data key="d0">"PEPTIDE RESIDUE"</data>
      <data key="d1">"S Ser8 is part of the neoepitope sequence in the ALK R1275Q molecule that interacts with MHC molecules like HLA-B*15:01."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;Y TYR9&quot;">
      <data key="d0">"RESIDUE"</data>
      <data key="d1">"Y Tyr9 forms a hydrogen bond with a residue from the heavy chain of HLA, contributing to binding affinity in the ALK R1275Q neoepitope."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ARG151&quot;">
      <data key="d0">"MHC RESIDUE"</data>
      <data key="d1">"A Arg151 is a residue on MHC molecule HLA-B*15:01 that undergoes significant structural change when forming a complex with the ALK R1275Q neoepitope peptide."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HYDROGEN BONDS&quot;">
      <data key="d0">"INTERACTIONS TYPE"</data>
      <data key="d1">"In the decamer structure, there is an increase in intra-peptide hydrogen bonds due to more compacted 310 helix conformation, which aids in improving stability of p/MHC complex.")&gt;5</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SALT BRIDGES&quot;">
      <data key="d0">"INTERACTIONS TYPE"</data>
      <data key="d1">"In the decamer structure, there is an increase in salt bridges interactions contributing to improved stability due to more compact peptide packing and favorable interactions with MHC residues."&gt;6</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ELECTROSTATIC INTERACTIONS&quot;">
      <data key="d0">"INTERACTIONS TYPE"</data>
      <data key="d1">"In the decamer structure, there are additional electrostatic interactions involving Asp3 and Arg6 of the decamer peptide that contribute to improved stability due to their more extended positioning within the binding groove."&gt;7</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;MHC COMPLEX STABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Structural Exclusion of Self-Antigen from HLA-B*15:01 Groove is discussed as a mechanism to limit immune response and improve therapeutic relevance. The text describes how the self-antigen/HLA complex does not form efficiently, highlighting differences in peptide conformation compared to neoepitopes."&gt;9</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;STRUCTURAL EXCLUSION OF SELF-ANTIGEN FROM HLA-B*15:01 GROOVE&quot;">
      <data key="d0">"DISEASE TARGETED CANCER IMMUNOTHERAPY"</data>
      <data key="d1">"The text discusses how the self-peptide is excluded from binding within the MHC complex, which helps in limiting immune response and maintains therapeutic relevance for targeted cancer immunotherapies based on ALK R1275Q neoepitopes."&gt;10</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HIGH-THROUGHPUT APPROACH PREDICTING PEPTIDE/HLA INTERACTIONS&quot;">
      <data key="d0">"EVALUATION METHOD"</data>
      <data key="d1">"This approach involves the use of high-resolution X-ray structures to predict peptide/HLA interactions and surface features, aiming to expand T cell response repertoire for targeted cancer immunotherapies based on ALK R1275Q neoepitopes."&gt;11</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;T CELL RESPONSE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Patient’s HLA haplotype plays a major role in determining the outcome of targeted cancer immunotherapies, suggesting that factors such as individual HLA profiles can influence response to ALK R1275Q neoepitopes."&gt;12</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TARGETED CANCER IMMUNOTHERAPY&quot;">
      <data key="d0">"THERAPY TYPE"</data>
      <data key="d1">"The text discusses the use of targeted therapies based on ALK R1275Q neoepitopes, focusing on how individual HLA haplotypes can affect therapeutic response and immunogenicity potential of these peptides."&gt;13</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HLA-BINDING REPERTOIRE PREDICTING&quot;">
      <data key="d0">"EVALUATION METHOD"</data>
      <data key="d1">"This approach involves the prediction of HLA-binding repertoires using computational methods to identify potential individuals who could mount a T cell response against ALK R1275Q neoepitopes."&gt;15) ("entity"</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;CANCER IMMUNOTHERAPY TARGETING NEOANTIGENS&quot;">
      <data key="d0">"THERAPY TYPE"</data>
      <data key="d1">"This approach involves the use of personalized neoantigen-based therapies for targeting and attacking cancer cells with high specificity, based on unique proteins expressed by each patient's tumor.")&gt;17</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TUMOR ANTIGEN PRESENTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process where proteins from a tumor are presented to immune system via MHC molecules like HLA-B*15:01, enabling the body’s T cells to recognize and potentially attack these cancerous cells."&gt;18</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TUMOR MICROENVIRONMENT FACTORS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Factors within a tumor's microenvironment such as immunosuppressive molecules can impact how effectively neoantigens are presented by MHC molecules, influencing the overall immune response against cancer cells."&gt;19</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;IMMUNE TOLERANCE MECHANISMS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Mechanisms that prevent an individual's immune system from recognizing and attacking their own tissues or cells, potentially complicating therapeutic strategies involving neoantigen-based immunotherapies."&gt;20</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HLAS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"HLAs are proteins that play a major role in determining the outcome of targeted cancer immunotherapies. They are involved in displaying specific peptides to T cells for immune response.")&gt;1</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The nonamer peptide is a protein that also forms a stable complex with HLA-A*01:01."&lt;SEP&gt;"The nonamer peptide is part of a protein structure involved in antigen presentation for T cell response.")&gt;3</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-A*01:01&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HLA-A*01:01 is the gene encoding for HLA-A antigen, critical for antigen presentation and immune response."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;HYDROXYL GROUP OF TYR10&quot;">
      <data key="d0">"ATOM"</data>
      <data key="d1">"The hydroxyl group of the Tyr10 in the decamer peptide makes polar contact within the MHC groove when bound to HLA-A*01:01."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;ARG6&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"In the nonamer, Arg6 is flipped outwards from the groove when bound to HLA-A*01:01, altering surface presentation for TCRs."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;TCR INTERACTION PROPERTIES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The altered conformations and surface features of the peptides potentially impact their interactions with TCRs on CD8+ T cells."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;PBMCS FROM HLA-B*15:01-MATCHED HEALTHY DONORS&quot;">
      <data key="d0">"SAMPLE"</data>
      <data key="d1">"PBMCs from two HLA-B*15:01-matched healthy donors were used for the tetramer staining and flow cytometry analysis."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;HLA-B*15:01 TETRAMERS CONJUGATED WITH APC OR PE&quot;">
      <data key="d0">"DEVICE"</data>
      <data key="d1">"APC and PE conjugated HLA-B*15:01 tetramers were used for the identification of T cells that recognize each neoepitope."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;MHC TETRAMER STAINING ASSAY&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"The MHC tetramer staining assay was employed to test whether CD8+ T cells could recognize the altered-self neoepitopes presented by HLA-B*15:01 on their surface."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;FLOW CYTOMETRY ANALYSIS&quot;">
      <data key="d0">"DEVICE"</data>
      <data key="d1">"Multichannel flow cytometry analysis followed the MHC tetramer staining to confirm and quantify T cell recognition of each neoepitope."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;DOUBLE POSITIVE POPULATIONS WITH HLA-B*15:01 TETRAMERS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"The double positive populations identified through flow cytometry were CD8+ T cells that recognized the nonamer or decamer epitopes presented by HLA-B*15:01."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;IMMUNODOMINANT SARS CORONAVIRUS-DERIVED EPITOPE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An immunodominant SARS coronavirus-derived epitope was used as a control for the tetramer staining and flow cytometry analysis to rule out background reactivity."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;TETRAMERS MADE FOR HLA-B*15:01 COMPLEXED WITH AP OR PE&quot;">
      <data key="d0">"DEVICE"</data>
      <data key="d1">"APC and PE conjugated tetramers were used in control experiments to identify double positive populations corresponding to known immunodominant epitopes."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;SARS CORONAVIRUS-DERIVED EPITOPE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The immunodominant SARS coronavirus-derived epitope serves as a control for tetramer staining and flow cytometry analysis, indicating its relevance to the immune response."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;ARDIYRASYY&quot;">
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d1">"The presence of NRAS Q61K in colorectal cancer suggests its potential as a target for immunotherapy given its similarity to other mutations associated with this disease type.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCRS&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"T cells use their T cell receptors (TCRs) to interact with antigens presented by HLAs. This molecular interaction is critical in immune responses against cancer."&gt;6) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;IGM ANTI-PC MEASUREMENT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"IgM anti-PC is a measurement related to general immunoglobulin levels, particularly for IgM class."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;SNP RS74420772&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs74420772 is a single nucleotide polymorphism in the 3p14.1 region that achieved genome-wide significance in TwinGene, indicating its importance for cardiovascular health."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;SNP RS735665&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs735665 is a proxy SNP to rs74420772 and located in the 1p31.3 region of the genome, which achieved genome-wide significance in the GWAS meta-analysis."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;NUCLEOTIDE POLYMORPHISM&quot;&gt;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Nucleotide polymorphisms such as SNPs rs74420772 and rs735665 play a role in molecular interactions that influence cardiovascular health through their association with IgM anti-PC measurements."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GENOTYPE MATCHING&quot;&gt;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genotype matching is an important technique used to analyze the genetic basis of complex traits such as IgM anti-PC measurements and its relevance to cardiovascular disease."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;TWINGENE DATABASE&quot;">
      <data key="d0">"PUBLICATION"</data>
      <data key="d1">"TwinGene is a database where results related to SNPs rs74420772 and rs735665 achieved genome-wide significance were published, indicating their importance in the field of genetics and cardiovascular health."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GWAS META-ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GWAS meta-analysis is a statistical method used to combine results from different studies for more conclusive findings related to IgM anti-PC measurements."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM (LD)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In the discovery phase of GWAS, SNPs rs74420772 and rs735665 were found in strong linkage disequilibrium within a 131 kb block that overlaps with the GRAM domain containing 1B (GRAMD1B) gene."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GRAMD1B GENE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The overlapping of SNPs rs74420772 and rs735665 in the GRAMD1B gene region suggests a possible functional role for this gene in cardiovascular health, as linked to IgM anti-PC measurements."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;CLL GENETIC VARIANT (SNP RS9392504)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The SNP rs9392504 is associated with a higher risk of Chronic Lymphocytic Leukemia (CLL), indicating its importance in understanding the genetic basis of this disease."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;PRS POLYGENIC RISK SCORE ANALYSIS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Polygenic risk score analysis shows an association between increasing alleles for general IgM and higher risk of Chronic Lymphocytic Leukemia (CLL)."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;JONSSON ET AL. SNPS (RS2476601 &amp; RS735665)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Jonsson et al. study identified two SNPs, rs2476601 and rs735665, that were associated with general IgM levels."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;INTERLYMPH CONSORTIUM (SNP RS9392504)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The InterLymph consortium identified SNP rs9392504 as a main genetic variant specific for general IgM and also associated with higher risk of CLL."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;REGULATORY MARKS (HISTONE MARK &amp; DNASEI HYPERSENSITIVITY)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The regulatory marks scanned in leukemia- or immune-cell lines suggest that the variants at locus 11q24.1 may influence gene expression through their proximity to chromatin features such as histone mark monomethylated histone H3 lysine 4 (H3K4Me1) and DNaseI hypersensitivity."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GM12878 LEUKEMIA CELL LINE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The presence of regulatory marks in GM12878 leukemia cell line suggests a possible functional role for the variants at locus 11q24.1, which may influence gene expression and contribute to CLL risk."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;LEUKEMIA-SPECIFIC REGULATORY MARKS (HISTONE MARK &amp; DNASEI HYPERSENSITIVITY)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The presence of leukemia-specific regulatory marks in GM12878 cell line indicates a possible molecular interaction between the variants at locus 11q24.1 and gene expression that may contribute to CLL risk."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;LOCUS 11Q24.1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The locus 11q24.1 shared between IgM anti-PC and CLL is a genomic variant associated with both diseases."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;RS35923643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs35923643 genomic variant is located at the locus 11q24.1, within an LD block that includes regulatory marks in leukemia- or immune-cell lines."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;HISTONE MARK MONOMETHYLATED HISTONE H3 LYSINE 4 (H3K4ME1)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Histone mark monomethylated histone H3 lysine 4 is an environmental factor that has been found at the rs35923643 locus in GM12878, indicating potential regulatory activity."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;DEOXYRIBONUCLEASE I (DNASEI)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Deoxyribonuclease I hypersensitivity is another environmental factor that has been found at the rs35923643 locus in GM12878, CD34+, and GM12865."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTORS (TFS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The region around rs35923643 contains suggested binding sites for 22 different transcription factors, an indication of complex regulatory environment."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;RUNX3 BINDING MOTIFS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The strongest signals observed in the ChIP-seq experiments were for RUNX3 and SPI1, highlighting specific molecular interactions within this region."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;P-VALUE (DEFINED AS PROBABILITY OF MATCH FOR A RANDOM SEQUENCE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A switch from T/A to C/G at rs35923643 increases the P-value and decreases predicted binding affinity, indicating potential impact on transcription factor interactions."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;REGULOMEDB DATABASE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The RegulomeDB database supports rs35923643 as affecting TF binding in general."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;IGM ANTI-PC&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Lower levels of IgM anti-PC are found in prevalent CLL cases compared to matched controls, suggesting potential disease association."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CLL CASES (PREVALENT AND INCIDENT)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"In the nested case–control study, no association between IgM anti-PC levels and incident CLL risk was observed."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;MATCHED CONTROLS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The difference in IgM anti-PC levels between CLL cases and matched controls is not statistically significant over time."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;GM12878&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"GM12878 is a B-cell line used for chromatin immunoprecipitation-sequencing experiments."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CD34+&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"CD34+ is another cell line included in the ChIP-seq experiments from ENCODE, alongside GM12878 and GM12865."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;GM12865&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"GM12865 is a third cell line used in chromatin immunoprecipitation-sequencing (ChIP-seq) experiments, alongside GM12878 and CD34+."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CHIP-SEQ EXPERIMENTS&quot;">
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d1">"The B-cell line GM12878 was used for chromatin immunoprecipitation-sequencing experiments alongside CD34+ cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;HIGH PA ADHERENCE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Low adherence to T2D-GRS is associated with a weaker association between physical activity and lower risk of developing type 2 diabetes in communities like the Atherosclerosis Risk in Communities study.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;TUFM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variants associated with TUFM are predicted to affect transcription factor binding sites and splicing regulation, influencing gene function and expression.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;TRAFF3&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Molecular Interaction"</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;TRANSCRIPT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The text may be referring indirectly to genes and transcripts involved in producing proteins that could match characteristics of immunodominant epitopes, but no direct relationship is explicitly stated.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;RS1444988703&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs1444988703 in GIPR impacts this gene's function, contributing to obesity risk.") ("entity"</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A genomic variant in the HFE gene has been linked to increased risk of hypertension.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;TCF7L2 GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of a genomic variant in the TCF7L2 gene is linked to an increased risk for type 2 diabetes.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;SLC30A8&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"At baseline, a genomic variant at SLC30A8 rs13266634 was significantly associated with higher fasting proinsulin levels."|</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;TRANSCRIPT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genomic variants in TUFM are predicted to alter transcript processing through changes in splicing enhancers, silencers, and sites.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The Genotype is associated with a specific Genomic variant that influences response bias under stressful conditions.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;PROTEIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Certain genomic variants, such as those in HMGA2 and BMP4, influence proteins that may affect Age at first tooth and Number of teeth.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CYP2C9&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A genomic variant in the CYP2C9 gene has been linked to increased risk of cardiovascular disease due to its impact on warfarin metabolism.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;NITRIC OXIDE PRODUCTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A genomic variant in the STAT5B gene affects nitric oxide production.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Participants with the AA genotype had different responses to the low-protein diet, influencing their body composition changes.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The AA genotype was associated with greater decrease in fat distribution on high-protein diets compared to non-AA participants.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The AA genotype may influence expression of eNOS, which plays a critical role in vascular function.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TIME INTERACTION&quot;" target="&quot;LOW-FAT DIET&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genotype-time interactions were noted for body composition changes as per the low-fat dietary pattern, influencing total and trunk fat loss.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRUNK FAT&quot;" target="&quot;HIGH-FAT DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No genotype-time interactions found in response to high-fat diets, suggesting different influences on trunk fat compared to other diet patterns.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)&quot;" target="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"VEGF is essential for angiogenesis and vascular remodeling, crucial processes influenced by genetic factors.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;LIFESTYLE FACTORS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Physical activity is an environmental factor that has been shown in this study to modulate the relationship between adherence to a Mediterranean Diet and metabolic markers like TAG concentrations.") ("entity"</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;TUFM GENOMIC VARIANTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genomic variants in TUFM have been predicted to alter physiological processes such as splicing and transcription factor binding, influencing gene regulation at a fundamental level.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;PROTEIN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Specific proteins, such as those encoded by HMGA2 and BMP4, are key players in the physiological processes affecting Age at first tooth and Number of teeth.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The expression of genes and their associated physiological processes are influenced by environmental factors, including developmental context.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;FOLATE METABOLISM PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The physiological process of folate metabolism, which is influenced by dietary patterns like leafy greens intake, can interact with genes like FokI to affect ovarian cancer risk.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;STUDY SELECTION&quot;,&quot;QUALITY ASSESSMENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both Study Selection and Quality Assessment are critical steps within the overall process of conducting a scientific study or systematic review, essential for making credible conclusions about complex physiological processes such as gene-disease associations."&gt;)&gt;2) ("entity"</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;TREG SUPPRESSIVE CAPACITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Overexpressed LYP variants affect Treg suppressive capacity, with the risk variant potentially enhancing suppressive function.") ("entity"</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;INTERLEUKIN 2&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"IL-2 is produced in response to specific cellular interactions and may influence physiological processes related to disease risk.") ("entity"</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;LIFESTYLE BEHAVIOR&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Diet and lifestyle behaviors are significant environmental influences on cardiovascular health as per the study findings.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;HEME IRON INTAKE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The intake of heme iron showed an interaction with the SLC40A1 rs744653 variant in men, suggesting a potential link to cardiovascular disease risk factors such as hypertension.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;WESTERN DIET&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A Western dietary pattern is associated with higher risk of developing type 2 diabetes among individuals with genetic predispositions, as indicated by the T2D-GRS score. This includes interactions between individual food items like red and processed meat.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;SMOKER V. NON-SMOKER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">&gt;&lt;&gt;In our study, the distinct dietary patterns observed between smokers and non-smokers highlight potential gene-diet interactions that may influence triglyceride levels.&lt;/&gt;) ("entity"</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;TUFM GENOMIC VARIANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"No dietary patterns or nutritional factors are described as being influenced by the genomic variants affecting TUFM.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Dietary patterns modulate both the expression of inflammatory cytokines like IL-10, suggesting a dynamic interaction that influences disease outcomes in cardiovascular health.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;INFLUENCED BY TUMOR CHARACTERISTICS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The dietary patterns of colon cancer patients can be influenced by tumor characteristics such as histology and residual disease, which in turn affect PFI rates.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO&quot;" target="&quot;EDUCATIONAL LEVEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In the stratified analysis by educational level, there was no significant association between the FTO gene and obesity risk in university education individuals. However, non-university individuals showed a higher obesity risk with two A-alleles."&gt;)&gt; ("entity"</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was no significant association of the FTO SNP with obesity risk in individuals who had university studies, though there were indications of an effect within different socioeconomic groups.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;METABOLIC PATHWAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Alterations in specific metabolic pathways may be linked to disease states such as variations seen in Age at first tooth appearance or number of teeth.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;T CELL TRANSFER COLITIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"T cell transfer colitis is associated with an increased Th17 response and involves complex interactions between the immune system and dietary factors.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS1 GENE&quot;" target="&quot;HYDROXYUREA (HU)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Physiological Process"</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The expression of genes associated with dental health is likely influenced by dietary patterns or specific nutrients involved in physiological processes.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;CYP2C9&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The CYP2C9 gene's expression is regulated by transcriptional processes, which influence its function in the body.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;T CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The transcript of the STAT5B gene influences T cell levels and activation.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;FOLATE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Folate is a nutrient associated with dietary patterns that influence the transcript of genes like FokI, which can increase ovarian cancer risk.")&lt;SEP&gt;"Folate is a nutrient found in leafy greens that interacts with genes like NOS1 to regulate nitric oxide production and vascular function, which may be influenced by dietary patterns and genomic variants such as HFE rs1799945.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;TUFM GENOMIC VARIANTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No specific nutrients are directly linked to the genetic changes identified in TUFM that affect splicing and transcription factor binding sites.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;DIETARY PATTERN VS. FOLATE METABOLISM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Dietary patterns influence both the intake and subsequent metabolism of key nutrients like folate, affecting physiological processes related to cardiovascular health.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;METABOLIC PATHWAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Dietary patterns or specific nutrients may influence metabolic pathways that impact genes related to dental health.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;CHOLINE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Maternal dietary choline status was only found in 9.7%, which is low for both treatment and placebo groups."|&gt;1) ("entity"</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NHS AND HPFS PARTICIPANTS&quot;" target="&quot;PROTEIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The NOS1 protein interacts with folate metabolism to maintain vascular function among participants of the NHS and HPFS studies. This interaction may be influenced by genetic variants, including SLC40A1 rs744653.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;TUFM GENOMIC VARIANTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variants affecting TUFM may lead to alterations in protein structure or function due to their impact on gene regulation processes.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;NITRIC OXIDE SYNTHASE (NOS)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"NOS1 Protein"</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The metabolic pathway of nitric oxide synthesis is central to the regulation of vascular function, which may be influenced by genetic variants and dietary patterns such as heme iron intake.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;IRON METABOLISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The HFE gene and its variants are involved in iron metabolism, which may influence cardiovascular disease risk factors such as hypertension. This pathway includes mechanisms for heme iron intake and the regulation of nitric oxide synthesis.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;TUFM GENOMIC VARIANTS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"No specific metabolic pathways are mentioned that are directly affected by the genomic variants identified in TUFM.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOOD ITEM&quot;" target="&quot;RED MEAT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"High intake of red meat increases risk of developing type 2 diabetes among men with a high T2D-GRS, indicating potential interaction with genetic factors such as the HFE gene variants rs1799945 and rs1800562.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;TCF7L2 PROTEIN&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Potential molecular interactions involving the TCF7L2 protein could mediate disease susceptibility.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;TUFM GENOMIC VARIANTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The molecular interactions within and around the TUFM gene region, including transcription factor binding sites, are predicted to be altered due to these genetic changes.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;STRESS CONDITION VS. NO-STRESS CONDITION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In the Stress condition, molecular interactions such as CRHR1 SNPs contribute to reduced response bias compared to no-stress conditions for val carriers and iso homozygotes.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Complex interactions involving SNPs, transcripts, and proteins are influenced by environmental factors affecting genetic influences on dental health.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;TCRS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"T cells use their T cell receptors (TCRs) to interact with antigens presented by HLAs. This molecular interaction is critical in immune responses against cancer."&gt;6) ("entity"</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATINS&quot;" target="&quot;POTENTIAL THERAPEUTIC TARGETS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"While no significant correlations were found for Overall Survival (OS), the association with PFI is important for identifying potential therapeutic targets that may influence both disease progression and patient outcomes.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CITRATE METABOLISM&quot;" target="&quot;PNPLA3&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Incubation with citrate increases PNPLA3 levels, indicating a relationship between citrate metabolism and gene expression related to lipid accumulation.") ("entity"</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;MYO1D&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"FOXO1 mediates negative effect of stress on neurogenesis through interaction with MYO1D.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;TGF-Β1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Transforming Growth Factor, Beta 1 mediates negative effect of stress on neurogenesis through interaction with FOXO1.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARID5B&quot;" target="&quot;ISOC1&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"Isochorismatase Domain Containing 1 interacts with ARID5B to mediate the negative effect of stress on neurogenesis.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISOC1&quot;" target="&quot;LRRN3&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Leucine-rich repeat neuronal protein 3 interacts with ISOC1 to mediate cytokines signaling, TGF- β1 signaling and glucocorticoid receptor signaling.)</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPHA4&quot;" target="&quot;FBXO32&quot;">
      <data key="d4">0.6</data>
      <data key="d5">"EPHA4 interacts with FBXO32 to mediate cytokines signaling, TGF-β1 signaling and glucocorticoid receptor signaling.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PIK3C2B&quot;" target="&quot;PPAP2A&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"Phosphatidylinositol-4-Phosphate 3-Kinase, Catalytic Subunit Type 2 Beta interacts with Phosphatidic Acid Phosphatase Type 2A to mediate cytokines signaling, TGF-β1 signaling and glucocorticoid receptor signaling.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUD1 GENE&quot;" target="&quot;HYPOGLYCAEMIA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The GLUD1 gene was detected in patients with hypoglycaemia, HI and mild HA.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP&quot;" target="&quot;DISEASE RISK&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"SNPs in CRP did not show an association with disease risk, including ovarian cancer.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;PARTICIPANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant deviation from Hardy-Weinberg equilibrium was found among the participants' genotypes for any of the four chosen SNPs.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B&quot;" target="&quot;PTGS1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genetic variant at IL1B rs7596684 in combination with the PTGS1 rs2282169 suggested an association with ovarian cancer risk.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALOX15&quot;" target="&quot;DISEASE RISK&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"No association between ALOX15 genetic variants and disease risk was observed.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL2&quot;" target="&quot;RISK FACTOR&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"No significant relationship found between SNPs at CCL2 and ovarian cancer risk.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL18&quot;" target="&quot;RISK FACTOR&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"No significant associations between IL18 SNPs and disease risk were found.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL6&quot;" target="&quot;DISEASE RISK&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"SNPs in IL6 did not show an association with disease risk, including ovarian cancer.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE RISK&quot;" target="&quot;CYP2C9 STAR VARIANT GROUP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The CYP2C9 star variant group is linked to an increased risk of cardiovascular diseases due to its impact on warfarin metabolism and dosage requirements.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARTICIPANTS&quot;" target="&quot;GENOTYPING SUCCESS RATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genotyping success rate was between 96.7% to 98.3%, indicating high rates of successful SNP identification in the study participants.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARTICIPANTS&quot;" target="&quot;DIET GROUPS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Baseline Characteristics"</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2520397&quot;" target="&quot;SNP&quot;">
      <data key="d4">5.88</data>
      <data key="d5">"The SNP rs2804391 in the FAM155E–EDA gene has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the FAM155E–EDA gene.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS8069452&quot;" target="&quot;SNP&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"The SNP rs17105278 in the IGF2BP1 locus has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the IGF2BP1 locus.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS9894411&quot;" target="&quot;SNP&quot;">
      <data key="d4">5.88</data>
      <data key="d5">"The SNP rs2804391 in the FAM155E–EDA gene has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the FAM155E–EDA gene.")&lt;SEP&gt;"The SNP rs2804391 in the KCNJ2 KCNJ160 region has been associated with 'number of ]; may influence this trait through its regulation of gene expression within the KCNJ2 KCNJ160 region.")&lt;SEP&gt;"The SNP rs2804391 in the KCNJ2 KCNJ160 region has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the KCNJ2 KCNJ160 region.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1472259&quot;" target="&quot;SNP&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"The SNP rs17101923 in the HMGA2 region has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the HMGA2 region.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17563&quot;" target="&quot;SNP&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs17563 is a SNP that is located within the BMP4 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of BMP4 expression.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS10740993&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs10740993 is a SNP located in the CACNB2 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of CACNB2 expression.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS4937076&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs4937076 is a SNP located in the CDON gene, which has been associated with 'number of teeth' and may influence this trait through its regulation of CDON expression.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS1799922&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs1799922 is a SNP located in the CALU/OPN1SW gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of CALU/OPN1SW expression.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS997154&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs997154 is a SNP located in the AJUBA/C14orf93 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of AJUBA/C14orf93 expression.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS7924176&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs7924176 is a SNP located in the ADK gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of ADK expression.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS412000&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs412000 is a SNP located in the TEX14/RAD51C gene, which has been associated with 'number of teeth' and may influence this trait through its regulation of TEX14/RAD51C expression.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS9316505&quot;">
      <data key="d4">1.96</data>
      <data key="d5">"The SNP rs2804391 in the IGF2BP1 gene has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the IGF2BP1 gene.")&lt;SEP&gt;"rs9316505 is a SNP located in the DLEU7 gene, which has been associated with 'age at first tooth' and may influence this trait through its regulation of DLEU7 expression.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS17101923&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs17101923 is a SNP located in the HMGA2 region, which has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the HMGA2 region.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS10932688&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs10932688 is a SNP located in the 2q35 region, which has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the 2q35 region.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS6568401&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"rs6568401 is a SNP located in the 6q21 region, which has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the 6q21 region.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RAD51L1&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"The SNP rs17105278 in the RAD51L1 locus has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the RAD51L1 locus.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS9788982&quot;">
      <data key="d4">6.859999999999999</data>
      <data key="d5">"The SNP rs2804391 in the KCNJ2 KCNJ160 region has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the KCNJ2 KCNJ160 region.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS1458991&quot;">
      <data key="d4">4.9</data>
      <data key="d5">"The SNP rs2804391 in the BMP4 gene has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the BMP4 gene.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;RS2804391&quot;">
      <data key="d4">0.98</data>
      <data key="d5">"The SNP rs2804391 in the FAM155E–EDA gene has been associated with 'number of teeth' and may influence this trait through its regulation of gene expression within the FAM155E–EDA gene.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;CARD9−/− MICE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The susceptibility of Card9−/− mice to colitis suggests their gut microbiota may be altered or predisposed towards inflammation and impaired recovery mechanisms compared to wild-type counterparts.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;EPITHELIAL CELL PROLIFERATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In Card9−/− mice, reduced epithelial cell proliferation was observed during DSS-induced colitis, suggesting a potential role for CARD9 in regulating this process.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;REGENERATING ISLET-DERIVED 3 GAMMA (REG3G)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Expression of Reg3g was increased in intestinal epithelial cells of Card9−/− mice during DSS-induced colitis, potentially playing a role in modulating gut inflammation and healing.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDEL RAG1&quot;" target="&quot;REGULATORY T CELLS PRESENCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"IL-10RαMdel RAG1 plays a critical role in maintaining vascular function and is influenced by dietary patterns, particularly folate intake.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGULATORY T CELLS PRESENCE&quot;" target="&quot;RAG1 GENOMIC BACKGROUND&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The presence of regulatory T cells in RAG1 genomic background suggests an essential role in modulating inflammatory responses and vascular health.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASED IL-10RΑMDEL RAG1−/− AND CONTROL RAG1−/− MICE" target="&quot;LP MΦS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Th17 Cell Differentiation"</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM&quot;" target="&quot;LCT GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The LCT gene, found on chromosome 2 near other protein-coding genes, is associated with regulating the abundance of Bifidobacterium in the gut microbiota.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT GENE&quot;" target="&quot;MILK PRODUCTS INTAKE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals homozygous for the low-function LCT haplotype show positive correlation with milk products intake, suggesting gene-diet interaction regulates Bifidobacterium abundance.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITABILITY CORRELATION&quot;" target="&quot;SIGNIFICANT CORRELATION ACROSS TESTED TAXA AND HERITABILITY SIGNIFICANCE&quot;&gt;">
      <data key="d4">8.0</data>
      <data key="d5">"A significant correlation between SNP-based meta-analysis results shows strong heritability across tested taxa, with some loci showing significant correlations (R=0.244).")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ETHNICITY AND AGE HETEROGENEITY&quot;" target="&quot;VARIANTS LOCATED AT 2Q21.3 SHOW ETHNICITY AND AGE HETEROGENEITY IN BIFIDOBACTERIUM ABUNDANCE&quot;&gt;">
      <data key="d4">10.0</data>
      <data key="d5">"The strongest association signal for variants located at 2q21.3 shows evidence of ethnicity and age heterogeneity across cohorts, particularly among children contributing to detected heterogeneity.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG GROUP&quot;" target="&quot;MULTIPLE ALLELES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was a significant negative correlation between the multiple alleles and IFG risk.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGT GROUP&quot;" target="&quot;MULTIPLE ALLELES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The IGT group also showed a strong inverse relationship with these alleles.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX4 GENE&quot;" target="&quot;SELENIUM METABOLISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The GPX4 gene contains a genomic variant linked to colorectal tumor risk, likely affecting selenium metabolism. This suggests a role for genetic factors in selenium's protective effects against colorectal cancer."]</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENIUM METABOLISM&quot;" target="&quot;COLORECTAL CANCER RISK REDUCTION &quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Higher serum selenium levels are associated with a lower risk of colorectal cancer, supporting an inverse relationship between these factors."]</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9−/− MICE&quot;" target="&quot;COLITIS SUSCEPTIBILITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The gut microbiota of Card9−/− mice contributes to susceptibility to colitis by altering the IL-22 signaling pathway via impaired tryptophan metabolism, leading to reduced AHR activation.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22&quot;+ CELLS&quot;" target="&quot;CARD9 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"CARD9 modulates the expression and localization of IL-22+ cells involved in gut inflammation during DSS-induced colitis, suggesting a potential mechanism by which CARD9 influences susceptibility to inflammation.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22&quot;+ CELLS&quot;" target="&quot;REG3B GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Reg3b is induced by IL-22 and may play a role in the response to bacterial and fungal infections, suggesting its involvement in modulating gut inflammation during DSS-induced colitis.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22&quot;" target="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"IL-22 is required for the production of AHR ligands by influencing tryptophan metabolism.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION&quot;" target="&quot;FECAL METABOLITES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Fecal metabolites from individuals with IBD showed lower ability to activate AHR compared to healthy subjects, indicative of impaired tryptophan metabolism and defective AHR signaling.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION BY MICROBIOTA DERIVED METABOLITES&quot;" target="&quot;CARD9 RS10781499 ALLELE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The risk allele associated with CARD9 was found to be linked with reduced AHR activation by microbiota-derived metabolites, suggesting a connection between genetic variation and impaired AHR signaling.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9 GENE POLYMORPHISM&quot;" target="&quot;IBD SUSCEPTIBILITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The IBD-associated CARD9 SNP was associated with reduced AHR activation in vitro, indicating a potential link between genetic variants and human disease susceptibility.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARMS2 GENE&quot;" target="&quot;HEALTHY LIFESTYLE SCORE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of a healthy lifestyle score significantly reduces odds for AMD among women in the subsample assessed.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPLEMENT PATHWAY GENES&quot;" target="&quot;HEALTHY LIFESTYLE SCORE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There is no evidence of main effects of C3 and CFI genotypes on odds of AMD when considered with a healthy lifestyle score.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;CYP2C9&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"SNPs such as rs1799853 and rs1057910 are associated with reduced CYP2C9 activity, impacting warfarin dosing.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;PAI-1 -675 4G/5G&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There is an association between MTHFR C677T and PAI-1 -675 4G/5G, likely due to shared genetic or environmental factors.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"No direct relationship between MTHFR C677T and Prothrombin G20210A is described in the literature.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR A1298C&quot;" target="&quot;PAI-1 -675 4G/5G&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No direct relationship observed between MTHFR A1298C and PAI-1 -675 4G/5G in the reviewed literature.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR A1298C&quot;" target="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No information provided on a relationship between MTHFR A1298C and Prothrombin G20210A.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"No relationship between PAI-1 -675 4G/5G and Prothrombin G20210A is mentioned in the studies.")&lt;SEP&gt;"The relationship between Prothrombin G20210A and PAI-1 -675 4G/5G is not directly addressed in the articles.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;FACTOR V G1691A&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No clear relationship between Factor V G1691A and PAI-1 -675 4G/5G is suggested in the studies.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;MTHFR C677T OR A1298C&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"There is no direct relationship identified between PAI-1 -675 4G/5G and MTHFR C677T or A1298C in the reviewed literature.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;PAI-1 A844G&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"No direct relationship between PAI-1 A844G and PAI-1 -675 4G/5G is mentioned in the studies.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;FACTOR V G1691A&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"No relationship between Factor V G1691A and Prothrombin G20210A was discussed in any of the studies.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;PAI-1 -675 4G/5G OR A844G&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"No relationship between Prothrombin G20210A and PAI-1 -675 4G/5G or PAI-1 A844G is mentioned in the studies.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;PAI-1 -675 4G/5G OR A844G&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"No direct relationship between Factor V G1691A and PAI-1 -675 4G/5G or PAI-1 A844G is suggested in the literature.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;BLOOD CLOTTING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Factor V G1691A protein plays a role in blood clotting processes that may be affected by the variant's influence on nitric oxide synthesis and regulation."|&lt;&gt;4) ("entity"</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T OR A1298C&quot;" target="&quot;PAI-1 -675 4G/5G OR A844G&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"No direct relationship between MTHFR C677T, A1298C, PAI-1 -675 4G/5G, and PAI-1 A844G is identified in the literature.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G OR A844G&quot;" target="&quot;MTHFR C677T, A1298C, OR PAI-1 -675 4G/5G AND PAI-1 A844G&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"No direct relationship between these SNPs is identified in the literature.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G OR A844G&quot;" target="&quot;REGIONAL DISTRIBUTION OF LV PATIENTS ACROSS DIFFERENT ETHNIC GROUPS AND COUNTRIES WITHOUT DETAILED RACIAL INFORMATION IN STUDIES&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"No direct relationship between these SNPs is suggested due to lack of detailed regional information.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NO DIRECT RELATIONSHIP BETWEEN THESE SNPS IS IDENTIFIED IN THE LITERATURE.&quot;)" target="&quot;PAI-1 -675 4G/5G OR A844G, MTHFR C677T, A1298C, PAI-1 -675 4G/5G AND PAI-1 A844G&quot;">
      <data key="d4">1.0</data>
      <data key="d5">17) ("entity"</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILE105VAL SNP (GSTP1)&quot;" target="&quot;NORMAL GSTP1 PROTEIN (LIMBO ANALYSIS)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Amyloid Propensity"</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WARFARIN&quot;" target="&quot;TARGET PREDICTIVE DOSE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The target therapeutic dose for warfarin is within a specific range determined by clinical trials.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA ALGORITHM&quot;" target="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The AA algorithm outperforms the IWPC pharmacogenomics algorithm, as measured by MAE within predicted dose ranges.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA ALGORITHM&quot;" target="&quot;CLINICAL ALGORITHM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Incorporating our novel AA algorithm into practice represents a molecular interaction between innovative technology and clinical decision-making processes.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;" target="&quot;PREDICTED DOSE REQUIREMENTS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Warfarin"</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;" target="&quot;PERCENT ADMIXTURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A strong inverse correlation between percent WAA and predicted dose within the 20% therapeutic range indicates an association with higher doses required by patients requiring doses of ≥60 mg/week.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NNG&quot;" target="&quot;PRECISION IN DOSE PREDICTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The NNG reflects precision, indicating how many patients need to be genotyped versus using the IWPC clinical algorithm for dose prediction.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOSE PREDICTION ALGORITHMS&quot;" target="&quot;POPULATION-SPECIFIC VARIABLES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Our novel AA algorithm does not show association because population-specific variables are incorporated and therefore may account for WAA.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FACTORS&quot;" target="&quot;THERAPEUTIC WARFARIN DOSE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Dietary factors can influence the amount of warfarin required to achieve an effective dosage.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXPRESSION LEVELS&quot;" target="&quot;SELENOPROTEIN H&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Selenoprotein H mRNA levels are lower in cells expressing the IDI-C variant compared to those expressing the IDI-T variant.") ("entity"</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;RS2228285&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The variant rs2228285 in the context of this study increases the risk of hypertension, supporting a significant association between genotype and disease phenotype.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;RS116549037&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The other genomic variant rs116549037 also contributes to increased risk of hypertension in the study population.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;HUA RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Hyperuricemia, as measured by high sUA level, increases the risk of developing hypertension in individuals homozygous for certain genotypes.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228285&quot;" target="&quot;RS2231142&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both genetic variants are related and contribute to increased risk of hypertension, indicating a complex relationship between different genomic loci and cardiovascular disease."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVEL&quot;" target="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Elevated sUA levels are a cardiovascular risk factor and correlate with higher HUA risk among those carrying specific genetic variants.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. JEJUNI WITH QUINOLONE SENSITIVITY&quot;" target="&quot;QUINOLONE-SENSITIVE C. JEJUNI&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"526 isolates were from C. jejuni and showed sensitivity to quinolones, indicating they did not exhibit quinolone resistance.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. COLI WITH QUINOLONE RESISTANCE&quot;" target="&quot;QUINOLONE-RESISTANT C. COLI&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"152 isolates were from C. coli and were found to be quinolone-resistant, indicating this strain's resistance.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTED FORMULA&quot;" target="&quot;MEDIUM-CHAIN TRIGLYCERIDES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A diet restricted in medium-chain triglycerides was used to manage the condition of an LPL deficiency patient."] ("entity"</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILK DRINKING&quot;" target="&quot;RS4988235 GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CC genotype at rs4988235 is associated with higher rates of milk consumption among the population.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATIONAL ATTAINMENT&quot;" target="&quot;LACTASE NON-PERSISTENT GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There was nominal evidence for an association between lactase non-persistent genotypes and educational attainment in certain populations.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING&quot;" target="&quot;LACTASE NON-PERSISTENT GENOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The association between smoking and high levels of milk consumption was observed only in the Czech Republic, an outlier for RCC risk.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CANCER RISK&quot;" target="&quot;RS4988235 GENOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genomic variants associated with lactase persistence, such as rs4988235, are linked to an elevated risk of renal cell carcinoma (RCC).")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILK DRINKING PATTERN&quot;" target="&quot;RCC RISK&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"An elevated risk of RCC has been observed among milk consumers compared to those who never consume milk.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COHORT AGE AT START OF HU TREATMENT&quot;" target="&quot;ANCS AT MTD&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Physiological Process"</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T GENE&quot;" target="&quot;RA2627 CELLULAR DEFECTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The UBE2T gene is associated with Fanconi anemia and its expression rescues cellular defects in RA2627 fibroblasts.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMPD3&quot;" target="&quot;CCND2&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The expression of AMPD3 was found consistent with that detected by microarray analysis for both up-regulated and down-regulated genes, including CCND2 which is involved in cellular development.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCND2&quot;" target="&quot;ZIC1&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While ZIC1 was down-regulated in the study population, CCND2 showed up-regulation indicative of cellular development processes, which could suggest complex interactions between these genes and their functions related to disease states.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOD2&quot;" target="&quot;TNFAIP3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SOD2 showed similar expression trends to those observed for the gene TNFAIP3 as per microarray analysis results.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMP&quot;" target="&quot;WARS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"COMP and WARS, both involved in cellular development processes and expressed differently between DBA patients and controls, displayed consistent patterns of differential expression with their counterparts detected by microarray analysis.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DATABASE&quot;" target="&quot;PUBMED&quot;,&quot;WEB OF SCIENCE&quot;, &quot;COCHRANE DATABASE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Related to each other as they are all databases used for scientific studies in various fields including medicine. They collectively provide access to an extensive body of research on different health-related topics.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T BINDING&quot;" target="&quot;RING DOMAIN OF HUMAN RING E3&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Molecular Interaction"</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITIN-LIKE EXTENSION FACTOR (ELF) DOMAIN IN DROSOPHILA RING DOMAIN E2 BINDING&quot;" target="&quot;SUBSTRATE BINDING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Physiological Process"</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCI AND FANCD2 BINDING TO HUMAN CENTRAL DOMAIN OF RING E3&quot;" target="&quot;CENTRAL DOMAIN INTERACTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Molecular Interaction"</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISTINCT DIFFERENCES BETWEEN SPECIES&quot;" target="&quot;ELECTROSTATIC POTENTIAL SURFACE OF HUMAN RING E3 AND DROSOPHILA DRWD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Physiological Process"</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC PATCH REQUIREMENTS&quot;" target="&quot;HYDROPHOBIC PATCHES ON C-TERMINAL LOBE OF HUMAN RING E3 AND SUBSTRATES BINDING&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Molecular Interaction"</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC PATCH REQUIREMENTS&quot;" target="&quot;MUTATIONS AT HYDROPHOBIC PATCHES AND SUBSTRATE BINDING AFFINITY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Molecular Interaction"</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC PATCH REQUIREMENTS&quot;" target="&quot;MUTATIONS AT HYDROPHIC PATCHES AND SUBSTRATE BINDING AFFINITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Molecular Interaction"</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-TERMINAL LOBE HYDROPHOBIC PATCH MUTATIONS ON HUMAN RING E3 AND SUBSTRATE BINDING AFFINITY&quot;" target="&quot;HYDROPHOBIC PATCH REQUIREMENTS&quot;&lt;|&quot;&gt;&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The mutations at hydrophobic patches on the C-terminal lobe, particularly in mutants L248A/F252A/L254A/I265A and W212A/L214A, reduced substrate binding affinity.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO-UBZ&quot;" target="&quot;RAD18-UBZ&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"WRNIP1-UBZ"</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PFI&quot;" target="&quot;ERCC2 G &gt; A&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The ERCC2 gene variant rs1799793 is significantly correlated with the Progression-Free Interval (PFI) in colon cancer patients, indicating a potential influence on disease progression.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KAPLAN-MEIER SURVIVAL ANALYSIS&quot;" target="&quot;G &gt; A VARIANT OF ERCC2&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The GG genotype carriers of rs1799793 showed a significant advantage in PFI compared to AA or GA carriers, suggesting an impact on overall survival.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIGO STAGE&quot;" target="&quot;ERCC2 G &gt; A VARIANT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The association between the ERCC2 variant and FIGO stage suggests that this genetic factor may influence disease progression in relation to established clinical factors such as FIGO staging.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESIDUAL DISEASE&quot;" target="&quot;ASSOCIATED VARIANTS OF PFI&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variants rs12762549 (ABCC2 A &gt; G) and rs6104 (SERPINB2 C &gt; G) are significantly associated with PFI but did not survive correction for multiple testing.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1800469 C/T POLYMORPHISM&quot;" target="&quot;TGF-SS1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Transforming growth factor-ß1 has a polymorphism at rs1800469, which is associated with increased risk of CRC.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 GENE&quot;" target="&quot;INTERLEUKIN-8 POLYMORPHISM IN PROMOTER REGION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The IL-8 gene has a polymorphism at rs4073 in the promoter region that does not differ significantly between patients with CRC and controls.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 GENE&quot;" target="&quot;RS1800896 A/G POLYMORPHISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The IL-10 gene has a polymorphism at rs1800896, where heterozygous AG is significantly decreased among patients with CRC.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 GENE&quot;" target="&quot;RS1179251 C/G AND RS2227485 C/T POLYMORPHISMS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The IL-22 gene has polymorphisms at rs1179251 and rs2227485 that show significant associations with CRC risk in this population.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27 GENE&quot;" target="&quot;RS17855750 T/G POLYMORPHISM&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The IL-27 gene has a polymorphism at rs17855750 that shows an association with CRC risk, with the G allele providing protective effect.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1800469 C/T POLYMORPHISM IN PROMOTER REGION&quot;" target="&quot;TGFSS1 GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The TGFß1 gene has a polymorphism at rs1800469, which shows significant associations with CRC risk and its occurrence.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLELE DISCRIMINATION ASSAY USING TAQMAN METHOD&quot;" target="&quot;GENOTYPING METHOD&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The genotyping of SNPs in this study was performed using an allele discrimination assay with the TaqMan method, ensuring accurate and reliable results.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620R&quot;" target="&quot;TCONV PROLIFERATION&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"Expression of LYP-620R variant reduces APC-mediated Tconv proliferation by 35.32±15.30%.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620R&quot;" target="&quot;TREG PROLIFERATION&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Expression of LYP-620R variant significantly reduces Treg proliferation to the same degree observed for Tconv, indicating a specific focus on inhibiting Tregs.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ T CELLS&quot;" target="&quot;SPECIFICITY TO CELL TYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This study highlights that the effects of the IL27 missense SNP are specific to CD4+ T cells; no significant changes were observed in expression levels at this locus in CD8+ T cells.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD69&quot;" target="&quot;PD-1&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"CD69 and PD-1 are both proteins involved in the dynamic expression following Tconv activation, suggesting they may have overlapping or interrelated functions.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD69&quot;" target="&quot;CD25&quot;">
      <data key="d4">0.4</data>
      <data key="d5">"CD25 is a component of the IL-2Ralpha complex, which may be related to protein expression dynamics such as those observed for CD69.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ICOS&quot;" target="&quot;CTLA-4&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"Both ICOS and CTLA-4 are involved in regulating immune response through inhibitory signaling mechanisms.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620W&quot;" target="&quot;TREG PROLIFERATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Expression of LYP-620W variant blocks Treg proliferation to a similar degree as LYP-620R, supporting differential impact on Tregs.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620W&quot;" target="&quot;TCONV PROLIFERATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Expression of LYP-620W variant does not significantly impact Tconv proliferation but blocks Treg proliferation to the same degree as LYP-620R.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MITOGENIC ACTIVATION&quot;" target="&quot;PMA AND IONOMYCIN&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"Overexpression of LYP variants does not alter mitogenic activation by PMA and ionomycin, indicating a specific focus on APC-mediated signals rather than general TCR signaling.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72&quot;" target="&quot;TUMOR ANTIGEN HETEROGENEITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Antigen escape may involve the loss or reduced expression of proteins like TAG72, which correlates with tumor recurrences post-CAR T cell therapy.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAR T CELLS&quot;" target="&quot;DURABLE ANTI-TUMOR RESPONSES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Repeat dosing of CAR T cells promotes more extensive and durable tumor regression compared to single doses, suggesting a potential for improved therapeutic responses over time.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DURABLE ANTI-TUMOR RESPONSES&quot;" target="&quot;REPEAT DOSING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Repeat dosing of CAR T cells promotes more extensive and durable tumor regression.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4&quot;" target="&quot;POLYMORPHISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The associations between CTLA4 polymorphisms rs231775 showed no evidence of publication bias, as confirmed by statistical tests.")&gt; ("entity"</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRF1&quot;" target="&quot;STAT1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"These two genes involved in interferon signaling pathways respond to similar genetic variants such as the missense SNP rs181206 at the IL27 locus, affecting their expression and likely immune response capabilities.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27&quot;" target="&quot;IRF1 &amp; STAT1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"IL-27 influences both IRF1 and STAT1 gene regulation through a region shared by these genes. The interaction between IL-27, its receptors, and the target genes is critical for immune response.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABSENCE OF SIGNIFICANT EFFECTS&quot;" target="&quot;B CELLS &amp; MONOCYTES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Despite investigation, there were no detectable effects on B cell or monocyte gene expression within the studied region. This suggests specificity to certain immune cell types.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NAT2 GENE&quot;" target="&quot;SNP-BASED MIN TEST&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Higher Power in Certain SNPs"</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE&quot;" target="&quot;SNPS ON 8P22-P21.3&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The ASAH1 gene region consists of SNPs with a good correlation structure, in which the typed SNPs are typically in high LD with each other and with the causal SNPs.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EMPIRICAL POWER&quot;" target="&quot;KERNEL MACHINE TEST&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The empirical power of the kernel machine SNP-set test (using the linear kernel) is higher than that of the single SNP-based min test for certain scenarios, particularly when there are moderate levels of LD between the causal SNP and typed SNPs.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EMPIRICAL POWER&quot;" target="&quot;MIN TEST&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"In contrast, the empirical power of the min test can be higher than that of the kernel machine method in specific instances, such as when only a single true causal SNP is tested (or one in high LD with it), which is not likely to occur frequently in actual GWAS.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B GENE&quot;" target="&quot;MAF&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Using MAF as weights in the weighted IBS kernel can upweight rare alleles, leading to higher power for certain SNPs compared to a linear genetic effect scenario where the power of the weighted IBS kernel is no greater than that of the linear kernel.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR2 GENE&quot;" target="&quot;KERNEL MACHINE METHOD&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Outperforms Min Test in Some Regions of High LD"</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B GENE WEIGHTED IBS KERNEL&quot;" target="&quot;MAF (MINOR ALLELE FREQUENCY)&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Using MAF as weights in the weighted IBS kernel can upweight rare alleles, leading to higher empirical power for certain SNPs compared to a linear genetic effect scenario where the power of the weighted IBS kernel is no greater than that of the linear kernel.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUSAL SNPS" target="&quot;TYPE 1 ERROR RATE&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"In scenarios with moderate levels of LD between causal and typed SNPs, the kernel machine method has higher empirical power than the min test at a nominal level of α = 0.05.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBS AND WEIGHTED IBS KERNEL POWER&quot;" target="&quot;SURVIVAL TIME SIMULATED AS LINEAR MODEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Even when survival time is simulated assuming a linear model, the empirical power of the IBS and weighted IBS kernel remains high but does not exceed that of the linear kernel, which corresponds to Cox models with linear genetic effects.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-CTLA-4&quot;" target="&quot;RESPONSE RATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The overall response rate for anti-CTLA-4 therapy was 36.91%, with higher rates seen in combination therapies at 76.74%.")&gt;|</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-PD-1&quot;" target="&quot;RESPONSE RATE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"For anti-PD-1 treatments, the response rate was found to be 52.04%.")&gt;|</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMBINATION-THERAPY TREATED PATIENTS&quot;" target="&quot;TREATMENT RESPONSE ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant association between treatment response and the tested SNPs was observed across all treatments (Supplementary Table S2).") ("entity"</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOCUS&quot;" target="&quot;TRAFF3-RCOVR1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genomic Variant"</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOCUS&quot;" target="&quot;TNFAIP8&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Nutrient"&lt;SEP&gt;"Physiological Process"</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCM CELLS&quot;" target="&quot;CD4+ TEM CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The normal range and proportion of TCM cells remained within their typical ranges (Figure S4C, Figure 3C).")</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ MEMORY T CELLS&quot;" target="{&quot;DISEASE OR SYNDROME&quot;: [&quot;STAT5B DEFICIENCY&quot;, &quot;CARDIOVASCULAR DISEASE&quot;]}">
      <data key="d4">1.0</data>
      <data key="d5">"LOF STAT5B Variant Effects"</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RHIGF-1 THERAPY&quot;" target="&quot;TREATMENT RESPONSE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Recombinant human insulin-like growth factor 1 (rhIGF-1) therapy was prescribed to improve growth in all three siblings, a specific treatment for their GHI phenotype."|&gt;6) ("entity"</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="{&quot;DISEASE OR SYNDROME&quot;: [&quot;STAT5B DEFICIENCY&quot;, &quot;CARDIOVASCULAR DISEASE&quot;]}" target="&quot;LOF STAT5B VARIANT EFFECTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CD8+ Memory T Cells"</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ TEMRA CELLS CHANGES&quot;" target="&quot;TCM CELLS &amp; CD4+ MEMORY T CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Physiological Process or Phenomenon"</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;HLA-B*15:01&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"ALK R1275Q and HLA-B*15:01 form a molecular interaction that presents neoantigens to the immune system, potentially facilitating targeted immunotherapies.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NRAS Q61K&quot;" target="&quot;ARDIYRASYY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of NRAS Q61K in colorectal cancer suggests its potential as a target for immunotherapy given its similarity to other mutations associated with this disease type.")</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;IGM ANTI-PC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There is a lower level of IgM anti-PC in prevalent CLL cases compared to matched controls, suggesting potential disease association between the two.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;CLL CASES (PREVALENT AND INCIDENT)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There is no statistically significant association between IgM anti-PC levels and incident CLL risk, according to the stratified Cox proportional hazards model.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC&quot;" target="&quot;MATCHED CONTROLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The difference in IgM anti-PC levels over time showed a declining but not statistically significant trend, with no clear association between these differences and CLL risk.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GM12878&quot;" target="&quot;CHIP-SEQ EXPERIMENTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The B-cell line GM12878 was used for chromatin immunoprecipitation-sequencing experiments alongside CD34+ cells.")</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
  </graph>
</graphml>
